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SIDS Initial Assessment Report 
For 
SIAM 18 
Paris, France, 20-23 April 2004 
 
1. Chemical  Name:  The category of gluconic acid and its derivatives:  
gluconic acid,  
glucono-delta-lactone,  
sodium gluconate,  
calcium gluconate and  
potassium gluconate 
2. CAS  Number:  526-95-4;  
90-80-2;  
527-07-1;  
299-28-5 /18016-24-5 and  
299-27-4 
3. Sponsor  Country:  Belgium 
4.  Shared Partnership with:  Japan 
5. Roles/Responsibilities  of 
the Partners: 
 
•  Name of industry sponsor 
/consortium 
Dr. T. Lakhanisky 
Institute of Public Health – Division Toxicology 
Rue J. Wytsman 16, B-1050 Brussels 
Tel. + 32 2 642 5104, 
Fax. + 32 2 642 5224, 
 
•  Process used   
6. Sponsorship  History   
•  How was the chemical or 
category brought into the 
OECD HPV Chemicals 
Programme? 
The initiative of this filing came from the industry who contacted 
Belgian Authorities for Sponsorship.  One substance (sodium 
gluconate) of the category was already sponsored by the 
Japanese Government and in the process of being presented in 
2004.  This resulted to the co-sponsoring of the gluconic acid 
and its derivatives by Japan and Belgium.  The industry 
consortium collected existing data and conducted literature 
search with the collaboration of the Belgian Authorities.  
IUCLID dossiers were prepared by the industry consortium as 
well as draft versions of the SIAR and SIAP.  Belgian 
Authorities peer-reviewed the documents. 
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    testing      (  ) 
7.  Review Process Prior to 
the SIAM: 
 
8.  Quality check process:   
9.  Date of Submission:   
10. Date of last Update:   
11. Comments:   
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SIDS INITIAL ASSESSMENT PROFILE 
 
CAS No.  Chemical  Structural formula 
526-95-4 D-Gluconic  acid 
 
 
 
90-80-2  Glucono-delta-
lactone 
 
 
 
527-07-1  Sodium  
D-gluconate 
 
 
 
299-28-5 
18016-24-5 
Calcium  
D-gluconate 
 
 
 
299-27-4  Potassium   
D-gluconate 
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SUMMARY CONCLUSIONS OF THE SIAR 
 
Category Rationale 
 
Gluconate derivatives are presented as a category. Gluconic acid and its mineral salts freely dissociate to the 
gluconate anion and the respective cations. Glucono-delta-lactone (GDL), the 1,5-inner ester of gluconic acid, is 
formed from the free acid by the removal of water. On the basis of these spontaneous chemical rearrangements, 
glucono-delta-lactone, gluconic acid and its sodium, calcium and potassium salts can be considered as a category, 
with all members  sharing the same representative moiety, the gluconate anion. Manufacturing and uses of the 
category members are also interlinked. The data summarized in this report are focused on the environmental and 
health effects from the gluconate anion and read-across to the lactone but do not deal with specific effects of the 
cations. Thus toxicological effects related to the cationic components are not part of the present report.  
 
Human Health 
 
Gluconic acid and its derivatives are naturally occurring substances.  In mammalian organisms both D-gluconic 
acid and its 1,5-lactone are important intermediates in the carbohydrate metabolism. Gluconate is a metabolite of 
glucose oxidation. The daily production of gluconate from endogenous sources is about 450 mg/kg for a 60 kg 
person. A significant portion (60-85%) of parenterally administered gluconate is excreted unchanged in the urine.   
 
The LD50 calculated after oral administration (gavage) of potassium gluconate on Wistar rats is 6060 mg/kg bw.  
 
None of the repeated dose toxicity studies of any duration (4 weeks, 6 months, or 24 months) showed any 
significant toxicological effects of gluconates.  Potential side effects were attributed to high doses of cation 
intake, evidenced by results from assays designed for the gluconate anion effect specifically.  The NOAEL of 
sodium gluconate determined from the 28 days studies on rats was equal to 1000 mg/kg bw for males and 2000 
mg/kg bw for females.  These compounds are neither irritant to the eye or the skin nor show sensitizing 
properties. 
 
The available in vitro and in vivo mutagenicity data with glucono-delta-lactone, sodium or calcium gluconate 
were negative. No carcinogenicity studies, and no inhalation toxicity data were available for any of the gluconates 
of the category. 
 
SIDS testing requirements regarding reproductive toxicity were satisfied with histopathology of the reproductive 
organs in repeat dose studies on sodium gluconate and with developmental toxicity studies on glucono-delta-
lactone. Indeed no changes were observed on the reproductive organs in 28 days oral studies with sodium 
gluconate (dosage up to 4400 mg/kg bw) and developmental toxicity studies on GDL on different species were all 
negative. 
 
Environment 
 
Gluconates are readily biodegradable both in aerobic and anaerobic conditions.  As the sequestering tendency of 
gluconates decreases rapidly upon dilution or lowering pH, their chelated metal complexes are destroyed 
effectively and quickly by biological waste water treatment as well. 
 
A closed bottle test for sodium D-gluconate showed that the Theoretical Oxygen Demand (ThOD) was 89% 
after 28 days which predicts 100% degradation; and an anaerobic study showed that 100% of sodium D-
gluconate was degraded after 35 days.   
 
Gluconic acid, its salts of sodium, potassium and calcium as well as glucono-delta-lactone are all characterised 
by a low vapour pressure (from 2.41e-009 hPa to 1.58e-022 hPa, estimated from the modified Grain Method), 
and a low octanol/water partition coefficient (estimated as -5.99 for the sodium salt, -7.51 for the calcium salt, - 
5.99 for the potassium salt, -1.87 for the free acid and -1.98 for GDL).  The dissociation constant of gluconic 
acid is in the range of 3.5 to 3.8.  Because of their good water solubility (from 30 g/L for calcium gluconate to 
590 g/L for sodium gluconate) and low Log Ko/w, no bioaccumulation effects are to be expected, the substances 
were also shown to be readily metabolised. 
 
Estimations from a level II/III fugacity model show that the main target compartments of gluconates are water 
(38.8 – 49.8 %) and soil (48.9-61.2%). The calculated Henry’s law constants (1.38 x 10
-4 Pa.m
3/mole for GDL, 
4.74 x 10
-8 Pa.m
3/mole for gluconic acid and 4.76 x 10
-8 Pa.m
3/mole for sodium gluconate) indicate a low OECD SIDS    GLUCONIC ACID AND DERIVATIVES 
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potential for volatilization and the estimated indirect photodegradation in the atmosphere with OH radicals ( 
AOP (v1.91) program) gives a t1/2 between 1.7 and 4.0 hours. The good water solubility and low vapour pressure 
designate water to be a major target compartment for these substances.   
 
Acute toxicity to aquatic organisms (fish, daphnia, algae) was tested on sodium gluconate.  In the range of 
concentrations tested, sodium gluconate did not show toxicity to any of the aquatic species: fish (LC0-96 hrs > 
100 mg/l), daphnids (NOEC 24-48 hrs > 1000 mg/l), algae (NOECr (24-72 h): 560 mg/l - ErC50 (24-72 h): > 
1000 mg/l)) The data from these studies were used for the other members of the category.   
 
No terrestrial toxicity data for gluconates are available.   
 
Exposure 
 
Gluconic acid and its derivatives presented in this category are naturally occurring substances.  In mammalian 
organisms both D-gluconic acid and its 1,5-lactone are important intermediates in the carbohydrate metabolism.  
 
Most of these compounds are listed as permitted food additives, which may be added to all foodstuffs, following 
the "quantum satis" principle, as long as no special regulations restrict their use. 
 
The manufacturing of gluconic acid is based on a fermentation process. Estimation of the worldwide industrial 
production per year for all the members of the gluconate category is around 65000 - 100000 tonnes.  There is no 
production site in Belgium. 
 
The typical industrial applications for the category are both dispersive and non-dispersive.  The main non- 
dispersive applications are industrial cleaning, metal surface treatment, textile bleach stabiliser and aluminium 
processing.  
 
When gluconates are used in wide dispersive applications such as chelating agents in cement set retarding, 
institutional and household cleaning, personal care products, pharmaceuticals and foodstuffs, their use might 
result in exposure to the environment. However, when used as sequestering agents in the building industry 
(concrete and mortar), the gluconate ions react with calcium ions present in the cement to form an insoluble and 
impermeable layer of calcium gluconate. Therefore, the gluconate is bound within the microcrystalline fibres of 
cement and is not free to migrate to cause any environmental pollution. Food applications could potentially 
contribute to spreading gluconates and glucono-delta-lactone in the environment, as these products are added in 
their crystalline or powder forms to food components such as meat, milk or soma at levels below 5 %w/w. 
However, since the final food is meant for human consumption and mostly gets ingested, there is no real 
potential for environmental distribution of gluconates from this application either. 
 
Human exposure by all routes (including inhalation) is possible. Workers exposure will mainly be by inhalation 
and by skin contact.  Consumers’ exposure may be from the oral and dermal routes.  Individual exposure of 
consumers to gluconates is expected to be limited because gluconates are mostly used as additives in the 
different consumer products typically in low dosages.  Furthermore, Consumer exposure in personal care 
products, pharmaceuticals and foodstuffs applications are subject to specific regulatory provisions requiring an 
authorization procedure where the evaluation of the hazardous properties as well as the actual exposure is taken 
into account. 
 
 
RECOMMENDATION 
 
The chemicals in this category are currently of low priority for further work.  
 
 
RATIONALE FOR THE RECOMMENDATION AND  
NATURE OF FURTHER WORK RECOMMENDED 
 
The chemicals in this category are currently of low priority for further work because of their low hazard 
potential.   
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FULL SIDS SUMMARY 
 
Gluconic acid and derivatives Category 
 
CAS Nos: 527-07-1, 90-80-2, 526-95-4, 299-28-5 and 18016-24-5, 299-27-4 
Endpoint  Chemical  Species  Protocol  Result 
Physical-Chemical 
Sodium 
gluconate  N/A No  data 
205-209°C 
 (decomposition at ≥ 210°C)
Glucono-delta-
lactone  N/A No  data  153 °C (decomposition at ≥ 
153°C) 
Gluconic acid  N/A  No data  131 °C 
Calcium 
gluconate  N/A No  data  120 
2.1 Melting point  
Potassium 
gluconate  N/A No  data 
174-176 °C 
(decomposes at 180°C) 
Sodium 
gluconate  N/A 613.1°C 
Glucono-delta-
lactone  N/A 398.5°C 
Gluconic acid  N/A  417.1°C 
Calcium 
gluconate  N/A 731.1°C 
2.2 Boiling point  
Potassium 
gluconate  N/A 
Estimated with 
MPBPWIN 
(v1.41) program 
from US EPA 
(EPI v3.11) 
613.1°C 
Sodium 
gluconate  N/A  No data  1.789 g/cm³ 
Glucono-delta-
lactone  N/A  No data  1.68 (relative density) 
Gluconic acid  N/A  No data  1.23 g/cm³  
Calcium 
gluconate  N/A No  data  0.30-0.65 g/cm³ (bulk 
density) 
2.3 Density at 20°C 
Potassium 
gluconate  N/A  No data  0.80 g/cm
3 (bulk density) 
Sodium 
gluconate  N/A 4.53
-17  hPa at 25°C 
Glucono-delta-
lactone  N/A 2.41
-9  hPa at 25°C 
Gluconic acid  N/A  10.87
-10  hPa at 25°C 
Calcium 
gluconate  N/A 1.58
-22  hPa at 25°C 
2.4 Vapour pressure 
Potassium 
gluconate  N/A 
Estimated with 
MPBPVP (v1.41) 
program from US 
EPA (EPI v3.11):-
modified grain 
method): 
11.89
-17  hPa at 25°C 
Sodium 
gluconate  N/A -5.99 
Glucono-delta-
lactone  N/A -1.98 
2.5 Partition coefficient 
(log Pow) 
Gluconic acid  N/A 
Estimated with 
Kowwin (v1.67) 
Program from US 
EPA (EPI v3.11) 
-1.87 OECD SIDS    GLUCONIC ACID AND DERIVATIVES 
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Endpoint  Chemical  Species  Protocol  Result 
Calcium 
gluconate  N/A -7.51 
 
Potassium 
gluconate  N/A 
 
-5.99 
Sodium 
gluconate  N/A  No data  590 g/l at 25°C 
Glucono-delta-
lactone  N/A  No data  590 g/l at 25°C 
Gluconic acid  N/A 
Estimated with 
Water sol (v1.01) 
program from US 
EPA (EPI v3.11) 
1000 g/l at 25°C 
Calcium 
gluconate  N/A  No data  35 g/l at 25°C 
2.6.1 Solubility in water 
Potassium 
gluconate  N/A  No data  450-1000 g/l at 20°C 
Sodium 
gluconate  N/A No  data 
Glucono-delta-
lactone  N/A No  data 
Gluconic acid  N/A  No data 
Calcium 
gluconate  N/A No  data 
2.12 Dissociation 
constant 
Potassium 
gluconate  N/A No  data 
 
 
KA at 25°C= 1.99 x 10
-4 
pKA = 3.70 
Environmental Fate and Pathway 
Sodium 
gluconate  N/A  t1/2 = 3.366 Hrs 
Glucono-delta-
lactone  N/A t1/2 = 3.96 Hrs 
Gluconic acid  N/A t1/2 = 3.033 Hrs 
Calcium 
gluconate  N/A t1/2 = 1.683 Hrs 
3.1.1 Photodegradation  
Potassium 
gluconate  N/A 
Estimated with 
AOP (v1.91) 
program from US 
EPA (EPI v3.11) 
t1/2 = 3.366 Hrs 
Sodium 
gluconate  N/A  No data 
Glucono-delta-
lactone  N/A No  data 
Gluconic acid  N/A No  data 
Calcium 
gluconate  N/A No  data 
3.1.2. Stability in water  
Potassium 
gluconate  N/A No  data 
The dissociation in water  
expected to be complete as 
the pKa is 3.70 
3.3.1.Transport 
between environmental 
compartments  
Sodium 
gluconate  N/A 
Estimated with 
the Level III 
Fugacity Model 
program 
Air: 1.2 % 
Water: 49.8 % 
Soil: 48.9 % 
Sediment: 0.0743 % OECD SIDS    GLUCONIC ACID AND DERIVATIVES 
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Endpoint  Chemical  Species  Protocol  Result 
Glucono-delta-
lactone  N/A 
Air: 0.8 % 
Water: 46.8 % 
Soil: 52.3 % 
Sediment: 0.0698% 
Gluconic acid  N/A 
Air: 0.00821 % 
Water: 38.8 % 
Soil: 61.2 % 
Sediment: 0.0345 % 
Calcium 
gluconate  N/A 
Air: 1.06
-7 % 
Water: 38.8 % 
Soil: 61.2 % 
Sediment: 0.0345% 
 
Potassium 
gluconate  N/A 
LEVEL3NT from 
US EPA (EPI 
v3.11) 
Air: 4.78
-7 % 
Water: 42.8 % 
Soil: 57.1 % 
Sediment: 0.0638% 
Sodium 
gluconate  N/A 
KH= 4.76
-13 atm-m
3/mole at 
25 °C 
Glucono-delta-
lactone  N/A 
KH= 1.38
-9 atm-m
3/mole at 
25 °C 
Gluconic acid  N/A 
KH= 4.74
-13 atm-m
3/mole at 
25 °C 
Calcium 
gluconate  N/A  Not estimated 
3.3.2.  Distribution  
Potassium 
gluconate  N/A 
Henry's law 
constant 
estimated with 
HENRY (v3.10) 
program from US 
EPA (EPI v3.11) 
 
Not estimated 
N/A 
Aerobic : 
Directive 
92/69/EEC, C.4-
E 
+/- 89 % of ThOD after 28 
days  Sodium 
gluconate 
 
N/A 
Anaerobic: 
DIN EN ISO 
11734 
100 % after 35 days 
Glucono-delta-
lactone     See  sodium  gluconate 
Gluconic acid      See sodium gluconate 
Calcium 
gluconate      See sodium gluconate 
3.5.  Biodegradation  
Potassium 
gluconate     See sodium gluconate 
Ecotoxicity 
Sodium gluconate 
Oryzias latipes 
(Fish, fresh 
water) 
OECD Guideline 
203  LC0 (96 hrs) > 100 mg/l 
Glucono-delta-
lactone     See  sodium  gluconate 
Gluconic acid      See sodium gluconate 
4.1  Acute toxicity to 
fish  
Calcium 
gluconate      See sodium gluconate OECD SIDS    GLUCONIC ACID AND DERIVATIVES 
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Endpoint  Chemical  Species  Protocol  Result 
  Potassium 
gluconate      See sodium gluconate 
Sodium gluconate 
Daphnia 
magna 
(Crustacea) 
OECD Guideline 
202 
(2 studies) 
NOEC (24 hrs): > 1000 
mg/l 
  
NOEC (48 hrs): > 1000 
mg/l 
Glucono-delta-
lactone     See  sodium  gluconate 
Gluconic acid      See sodium gluconate 
Calcium 
gluconate      See sodium gluconate 
4.2  Acute toxicity to 
aquatic invertebrates  
Potassium 
gluconate 
 
    See sodium gluconate 
Selenastrum 
capricornutum 
(Algae) 
OECD Guideline 
201 
NOECb (0-72 h) = 560 mg/l 
EbC50 (72 h): > 1000 mg/l 
NOECr (24-72h) : 560 mg/l  
ErC50 (24-72 h): > 1000 
mg/l 
 
Sodium gluconate 
Desmodesmus 
subspicatus 
OECD Guideline 
201 
NOEC (72 hrs)> 100 mg/l 
 
cell growth inhibition (72 
hrs): 70% inhibition at 1000 
mg/l 
 
Average specific growth 
rate inhibition: (72 hrs): 
42% inhibition at 1000 mg/l 
Glucono-delta-
lactone     See  sodium  gluconate 
Gluconic acid      See sodium gluconate 
Calcium 
gluconate      See sodium gluconate 
4.3  Acute toxicity to 
aquatic plants  
Potassium 
gluconate 
 
    See sodium gluconate 
Sodium gluconate  Pseudomonas 
putida  DIN 38 412 L8  EC0 (16 hrs)> 5000 mg/l 
Glucono-delta-
lactone 
Pseudomonas 
putida  DIN 38 412 L8 
EC0 (16 hrs)> 500 mg/l (not 
reliable.  See sodium 
gluconate) 
Gluconic acid      See sodium gluconate 
Calcium 
gluconate      See sodium gluconate 
4.4  Toxicity to 
microorganisms  
Potassium 
gluconate 
 
    See sodium gluconate OECD SIDS    GLUCONIC ACID AND DERIVATIVES 
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Endpoint  Chemical  Species  Protocol  Result 
Toxicity 
Rat Crj: 
CD(SD)   LDL0 > 2000 mg/kg bw  Sodium 
gluconate 
Dog beagle   LDL0 > 2000  mg/kg bw 
Glucono-delta-
lactone      See sodium gluconate 
Gluconic acid      See sodium gluconate 
Calcium 
gluconate      See sodium gluconate 
5.1.1  Acute oral toxicity  
Potassium 
gluconate  Rat Wistar   LD50 = 6060  mg/kg bw 
Sodium 
gluconate      See gluconic acid 
Glucono-delta-
lactone      See gluconic acid 
Gluconic acid  Rabbit 
Directive 
79/831/EEC, B.4. 
"Acute toxicity" 
(skin irritation) 
Not irritant 
Calcium 
gluconate      See gluconic acid 
5.2.1  Skin Irritation  
Potassium 
gluconate      See gluconic acid 
Sodium 
gluconate      See gluconic acid 
Glucono-delta-
lactone      See gluconic acid 
Gluconic acid  Rabbit  Draize Test  Not irritant 
Calcium 
gluconate      See gluconic acid 
5.2.2  Eye Irritation  
Potassium 
gluconate      See gluconic acid 
Rat Crj: 
CD(SD)   
Sub-acute:(gavage- 28 days)
NOAEL =  1000  mg/kg bw 
male 
NOAEL = 2000 mg/kg bw 
female 
Sodium 
gluconate 
Dog Beagle   
Sub-acute (oral – 4 weeks) 
NOAEL= 500 mg/kg bw 
Rat Sprague 
Dawley   
Chronic (oral – 6 months) 
NOAEL= not determined  Glucono-delta-
lactone  Rat Sprague 
Dawley   
Chronic (oral – 24 months) 
NOAEL= not determined 
Gluconic acid     See  sodium  gluconate 
5.4  Repeated dose 
toxicity  
Calcium 
gluconate     See  sodium  gluconate OECD SIDS    GLUCONIC ACID AND DERIVATIVES 
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Endpoint  Chemical  Species  Protocol  Result 
  Potassium 
gluconate 
 
   See  sodium  gluconate 
Saccharomyce
s Cerevisiae 
OECD Guideline 
471 
With and without metabolic 
activation: negative  Sodium 
gluconate  Salmonella 
typhimurium 
OECD Guideline 
471 
With and without metabolic 
activation: negative 
Saccharomyce
s Cerevisiae 
OECD Guideline 
471 
With and without metabolic 
activation: negative  Glucono-delta-
lactone  Salmonella 
typhimurium 
OECD Guideline 
471 
With and without metabolic 
activation: negative 
Gluconic acid     See  sodium  gluconate 
Saccharomyce
s Cerevisiae 
OECD Guideline 
471 
With and without metabolic 
activation: negative  Calcium 
gluconate  Salmonella 
typhimurium 
OECD Guideline 
471 
With and without metabolic 
activation: negative 
5.5  Genetic toxicity 
 in vitro  
Potassium 
gluconate 
 
   See  sodium  gluconate 
Sodium 
gluconate  Mouse C57BL   
Single dose: negative 
4-day repeated dose: 
negative 
Glucono-delta-
lactone  Mouse C57BL   
Single dose: negative 
4-day repeated dose: 
negative 
Gluconic acid     See  sodium  gluconate 
Calcium 
gluconate     See  sodium  gluconate 
5.6  Genetic toxicity 
in vivo  
Potassium 
gluconate     See  sodium  gluconate 
Sodium 
gluconate     See  glucono-delta-lactone 
Rat wistar   
NOAEL maternal tox.: > 594 
.  mg/kg bw 
NOAEL teratogen.:> 594 .  
mg/kg bw 
Rat Sprague-
Dawley   
NOAEL maternal tox.: > 
4000 . mg/kg bw 
NOAEL teratogen.:> 4000.  
mg/kg bw 
Mouse CD-1   
NOAEL maternal tox.: > 695 
. mg/kg bw 
NOAEL teratogen.:> 695.  
mg/kg bw 
5.8.2  Developmental 
toxicity/teratogenicity  
Glucono-delta-
lactone 
Mouse ICR   
NOAEL maternal tox.: > 
4000 . mg/kg bw 
NOAEL teratogen.:> 4000.  
mg/kg bw OECD SIDS    GLUCONIC ACID AND DERIVATIVES 
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Endpoint  Chemical  Species  Protocol  Result 
Rabbit Dutch   
NOAEL maternal tox.: > 780 
. mg/kg bw 
NOAEL teratogen.:> 780.  
mg/kg bw 
 
Hamster   
NOAEL maternal tox.: > 560 
.  mg/kg bw 
NOAEL teratogen.:> 560.  
mg/kg bw 
Gluconic acid     See  glucono-delta-lactone 
Calcium 
gluconate     See  glucono-delta-lactone 
 
Potassium 
gluconate     See  glucono-delta-lactone 
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SIDS Initial Assessment Report 
1  IDENTITY 
1.1  Identification of the Substance 
Category name:    
Gluconic acid and its derivatives  
Acid: (C6H12O7); 
Lactone: (C6H12O7 ) . (-H2O);  
Salts: (C6H12O7). (Na); or (C6H12O7) . (1/2 Ca) or (C6H12O7) .(K)   
 
CAS Number:  526-95-4 
IUPAC Name:  D-Gluconic acid 
Molecular Formula:   
Structural Formula:   
 
 
Molecular Weight:  196.16 
Synonyms: EINECS  Number  208-401-4 
 
 
CAS Number:  90-80-2 
IUPAC Name:  Glucono-delta-lactone 
Molecular Formula:   
Structural Formula:   
 
 
Molecular Weight:  178.14 
Synonyms: EINECS  Number  202-016-5 
 
 
CAS Number:  527-07-1 
IUPAC Name:  Sodium D-gluconate 
Molecular Formula:   OECD SIDS    GLUCONIC ACID AND DERIVATIVES 
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Structural Formula: 
 
 
Molecular Weight:  218.14 
Synonyms: EINECS  Number  208-407-7 
 
 
CAS Number:  299-28-5 
18016-24-5 
IUPAC Name:  Calcium D-gluconate  monohydrate 
anhydrous 
Molecular Formula:   
Structural Formula:   
 
 
Molecular Weight:  448.4 
Synonyms: EINECS  Number  206-075-8 
 
 
CAS Number:  299-27-4 
IUPAC Name:  Potassium D-gluconate 
Molecular Formula:   
Structural Formula:   
 
 
Molecular Weight:  234.25 
Synonyms: EINECS  Number  206-074-2 
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Information below originates from the Gluconate Handbook, unless specified otherwise. 
 
Anhydrous gluconic acid is a white, odorless, crystalline powder. (Ullman's Encyclopedia, 1999). It 
is a mild organic acid. The commercial form is a 50 % aqueous solution, which is a colorless to 
brownish liquid. Glucono-delta-lactone is also a white solid, which in aqueous solution slowly 
hydrolyses to gluconic acid until equilibrium is reached. The other members of the category are 
mineral salts of gluconic acid; i.e. sodium gluconate, potassium gluconate (anhydrous) and calcium 
gluconate (both anhydrous and the monohydrate).  
 
Gluconic acid and its derivatives are naturally occurring substances. Besides being naturally present 
at a level up to 1% in wine, honey and other foods and drinks, sodium gluconate (E 576), potassium 
gluconate (E 577), calcium gluconate (E 578), gluconic acid (E 574) and glucono-delta-lactone (E 
575) are all listed as permitted food additives, which may be added to all foodstuffs, following the 
"quantum satis" principle, as long as no special regulations restrict their use.  (European Parliament 
and Council Directive 95/2/EC). The US Food and Drug Administration (FDA) assigned sodium 
gluconate, potassium gluconate, calcium gluconate and glucono-delta-lactone the "generally 
recognised as safe" (GRAS) status and permits their use in food without limitation other than good 
manufacturing practice.  
The Select Committee on GRAS substances has also concluded that there is no evidence in the 
available information on potassium gluconate that demonstrates or suggests reasonable grounds to 
suspect a hazard to the public, should it be used as a food ingredient at levels now used for sodium 
gluconate, or that might be expected in the future. 
 
1.2  Purity/Impurities/Additives 
The purity of the marketed substances may vary depending on the intended uses, but it is generally 
above 97%. For food and/or medical applications the level of impurities complies with the 
restrictions laid down in the corresponding EU Directives.  
 
Purity (%) of : 
Gluconic acid 50% solution :   49-52% 
Glucono-delta-lactone: 99-101% 
Sodium gluconate:   98-102% 
Calcium gluconate:   98-104% 
Potassium gluconate:   97-103% OECD SIDS    GLUCONIC ACID AND DERIVATIVES 
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1.3  Physico-Chemical properties 
Table 1     Summary of physico-chemical properties 
  
Chemical Physical 
state 
Melting 
point 
Boiling 
point 
 
Relative 
Density (at 
20°C) 
Vapor 
pressure 
(at 20ºC) 
Water 
Solubility 
 
octanol 
/water 
partition 
coefficient 
(LogP) 
pKa 
Gluconic 
acid 
White 
solid  
131 °C  Estim. 
417.1 °C  
1.23 g/cm³ 
 
estim. 
10.87e-
010 hPa  
Miscible 
Estim. 
1000 g/l at 
25°C 
estim. 
-1.87 at 
25°C 
3.70 
Glucono-
delta-
lactone 
White 
solid 
153 °C  Estim. 
398.5 °C 
1.68 
(relative 
density) 
estim. 
2.41e-009 
hPa  
590 g/l at 
25°C 
estim. 
-1.98 at 
25°C  
3.70 
Sodium 
gluconate 
White/off 
white 
solid 
205-209 °C 
(decompose
s at ≥ 210 
°C) 
Estim. 
613.1 °C 
1.789/cm³ 
 
estim. 
4.53e-017 
hPa  
590 g/l at 
25°C 
estim. 
-5.99 at 
25°C 
3.70 
Calcium 
gluconate 
White/off-
white 
solid 
120°C Estim. 
731.1 °C 
0.3-0.65 
g/cm³  
(bulk 
density) 
estim. 
1.58e-022 
hPa  
35 g/l at 
25°C 
estim. 
-7.51 at 
25°C 
3.70 
Potassium 
gluconate 
White 
solid 
174-176 °C 
(Decompos
es at 
180°C) 
Estim. 
613.1 °C 
0.8 g/cm
3 
(bulk 
density)
 
 
estim. 
11.89e-
017 hPa  
450-1000 
g/l at 
20°C 
estim. 
-5.99 at 
25°C 
3.70 
 
1.4  Category Justification 
In this report the above gluconate derivatives are presented for a preliminary assessment as a 
category. Gluconic acid, as well as its mineral salts freely dissociate to the gluconate anion and the 
respective cations.  Glucono-delta-lactone (GDL), the 1,5-inner ester of gluconic acid, is formed 
from the free acid by the removal of water. (Gluconic acid also has another inner ester, the 1,4-
lactone, which does not belong to this category because during manufacturing process, the 1,5-
lactone is dominant and the 1,4-lactone is of no commercial interest.)  On the basis of these 
spontaneous chemical rearrangements, glucono-delta-lactone, gluconic acid and its sodium, calcium 
and potassium salts can be considered as a category, with all members  sharing the same 
representative moiety, the gluconate anion.  
As presented in the different sections below, the manufacturing and uses of the category members 
are also interlinked. Gluconic acid is readily produced from glucose by mild oxidation. The 
oxidation can occur chemically, electrolytically or enzymatically, but the commercial production is 
mainly by fermentation. The salts are produced from the acid by neutralization with the 
corresponding alkaline hydroxide solution, while GDL is separated from the acid by crystallisation.  
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The data summarized in this report are focused on the environmental and health related 
characteristics of the gluconate anion and do not deal with specific effects of the cations. Evidence 
from the reviewed literature suggests that the eventual toxicity of the gluconate salts would be 
attributable to the cation rather than of the gluconate moity of these substances. Acute toxicity 
responses to the various gluconate salts are comparable with other salts of the same metals and 
long-term toxicities seem related to the tissue deposition of these metals. Because toxicological 
effects of these gluconates appear to be related to their cationic components, safe and acceptable 
levels in foods are limited only by the nature of the specific cations (Life Science Research Office, 
1978). These effects, however, are not part of the present report, which focuses on the potential 
hazards associated with the gluconate anion.  
2  GENERAL INFORMATION ON EXPOSURE 
2.1  Production Volumes and Use Pattern 
Gluconates are natural substances. In mammalian organisms both D-gluconic acid and its 1,5-
lactone are important intermediates in the carbohydrate metabolism.   
Gluconate pathway 
 
 
 
 
 
 
 
 
 
 
Gluconate is a metabolite of glucose oxidation.  In the tissues, about 20 % of glucose may be 
metabolized through this route.  A rough estimate of the daily production of gluconate in humans 
can be calculated by assuming that approximately 10 % of the glucose utilized by the body is 
metabolized through the phosphogluconate pathway. Therefore, an individual receiving 2800 kcal 
per day from an average diet, would oxidize about 275 g of glucose. Approximately 25 to 30 g of 
this amount would be oxidized through the phosphogluconate pathway to yield roughly the same 
amount of gluconate. Thus, the daily production of gluconate from endogenous sources is about 450 
mg/kg for a 60 kg person (Life Science Research Office, 1978).   
The manufacturing of gluconic acid is based on a fermentation process.  
Glucono-delta-lactone (GDL), the inner ester of gluconic acid, is formed by the removal of water.  
Commercially it is produced by an aerobic fermentation process converting a carbohydrate source 
into gluconic acid. After fermentation gluconic acid is separated from GDL by crystallisation. 
 
 
D-glucose 
D-gluconate 
6-phospho-D-gluconate 
NAD
+ 
NADH 
ATP 
ADP OECD SIDS    GLUCONIC ACID AND DERIVATIVES 
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Sodium gluconate is the sodium salt of gluconic acid. It forms stable chelates with iron, aluminium, 
calcium, zinc and other heavy metals, especially in alkaline solution.  It possesses good 
sequestering activity in cleaning baths and is highly stable, even in concentrated alkaline solutions. 
The calcium and potassium salts are prepared from the acid. Calcium gluconate contains 
approximately 9% calcium in a form that is readily absorbed by plants and animals. The potassium 
salt is very soluble in water, which facilitates its use in pharmaceutical applications. 
Estimation of the worldwide production per year for the members of the category: 
gluconic acid (as 100% substance)   4000-6000 tonnes 
glucono-delta-lactone 10000-20000  tonnes 
sodium gluconate  50000-70000 tonnes 
calcium gluconate  4000-6000 tonnes 
potassium gluconate  1000-2000 tonnes 
 
The primary applications of gluconic acid are based on its most important characteristic: it is a weak 
acid, capable of dissolving the oxides, hydroxides and carbonates of polyvalent cations, forming 
water-soluble complexes without attacking metallic or nonmetallic surfaces. These characteristics 
are exploited in the metal cleaning/finishing applications, aluminium and steel processing and 
detergent uses. Because of its additional physiological properties, D-gluconic acid is also used in 
food and pharmaceutical industries. Gluconic acid salts, like the free acid, form complexes with 
metal ions and the stability of these complexes increase considerably with increasing pH. In many 
applications, glucono-delta-lactone (GDL) is a convenient substitute of the free acid, especially 
where, due to the reversibility between the acid and its lactone form, a gradual change in the pH is 
preferred. 
The typical applications for the category can be classified as dispersive or non-dispersive, 
depending on the potential for the gluconates spreading into the environment.  
The main non- dispersive applications are industrial cleaning, metal surface treatment, textile bleach 
stabiliser and aluminium processing.  
To the contrary, when gluconates are used in applications such as chelating agents in cement set 
retarding, institutional and household cleaning, personal care products, pharmaceuticals and 
foodstuffs, their use might result in exposure to the environment, hence, these uses will be 
considered as dispersive. However, as the following examples illustrate, the different uses of 
gluconates in food and pharmaceutical applications all result in the ingestion of the substances, and 
such do not contribute to their environmental exposure.   
- as food additives and processing aids: 
Gluconic acid and its salts have been used in various applications in the food industry.  As a 
sequestrant, sodium gluconate finds broad application in cleaning solutions for the food industry.  
Also, sodium gluconate has been used in indirect application in washing solutions for eggs, 
denuding tripe, and for preventing the staining of the exteriors of canned goods by cooling and 
retort water.  Sodium and calcium gluconate are used as nutritional supplements in sausage products 
and to increase the water binding properties of the products. 
Over the past ten years, there has been considerable research conducted in Japan using sodium 
gluconate in order to complement sodium chloride in the proteins extraction from fish muscles.  
Sodium gluconate is used as a replacement for phosphates in the processing of Surimi (minced fish 
meat) to improve the whiteness and elasticity of the fish product.  OECD SIDS    GLUCONIC ACID AND DERIVATIVES 
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A process to improve meat tenderness was developed by scientists at the US Meat Animal Research 
Center.  The calcium activated Tenderization process uses post-mortem injected calcium to activate 
the calpain tenderizing enzymes.  While the original work used calcium chloride, more recent tests 
showed that calcium gluconate is equally effective. (Gluconate Handbook) 
Sodium and potassium gluconate have a unique impact on taste perception:  debittering properties 
when used with artificial sweeteners, i.e. saccharine, cyclamates and aspartame. 
Sodium gluconate is sometimes used as an ingredient in sugar replacement packets and diet 
beverages. The artificial sweetener, Aspartame, when used alone has a defect in that its sweetness is 
slightly delayed in onset and tends to remain longer on the tongue; its gustatory quality can be 
improved to be more sucrose-like by addition of sodium gluconate. 
Potassium gluconate has been shown to suppress the sweetness of hydrolized lactose without 
producing bitterness or off-flavors. (Gluconate Handbook)  
- in pharmaceutical applications: 
Sodium, potassium and calcium gluconates are  used as mineral supplements in pharmaceutical 
injection solutions at concentrations up to 55 g/l. (Drug Product Database (DPD)) 
2.2  Environmental Exposure and Fate 
Environmental exposure during production is very limited. Material lost or spilled during 
manufacturing is collected and sent to the wastewater treatment plant. 
The non-dispersive applications cover industrial uses, where subsequent wastewater treatment is  
practiced. As an example, in metal surface treatment, sodium gluconate is an effective sequestering 
agent in alkaline solutions where it forms chelates with earth metals such as calcium and 
magnesium. In this case, as well as in other industrial applications, the product finally flows into the 
wastewater treatment plant of the user's site.  Also in industrial cleaning formulations, where 
gluconates are valuable complexing agents for di- or trivalent metal cations in alkaline solutions, 
they are washed out with clean water during the cleaning process. The washing water most likely 
flows into the wastewater treatment plant of the site.  These applications, as shown by the figures in 
the table below represent about half of the estimated production volumes for sodium gluconate. 
Non-dispersive consumption of sodium gluconate chelating agents in Western Europe and Japan in 
1998 (tonnes) 
 Western  Europe  Japan 
Metal surface treatment applications    5100  900 
Industrial cleaners  5100  600 
Cement set retardant  5100  7600 
Other applications (ie, textile bleach 
stabiliser, aluminium processing) 
1700 900 
Total 17000  10000 
(The Chemical Economics Handbook, 2000)   
In wide-dispersive applications as well, however, the environmental impact is quite limited. When 
used as sequestering agents in the building industry (concrete and mortar), the gluconate ions react 
with calcium ions present in the cement to form an insoluble and impermeable layer of calcium 
gluconate. Therefore, the gluconate is bound within the microcrystalline fibers of cement and is not 
free to migrate to cause any environmental pollution.  OECD SIDS    GLUCONIC ACID AND DERIVATIVES 
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Food applications could potentially contribute to spreading gluconates and glucono-delta-lactone in 
the environment, as these products are added in their crystalline or powder forms to food 
components such as meat, milk or soja at levels below 5 %w/w. However, since the final food is 
meant for human consumption and mostly gets ingested, there is no real potential for environmental 
distribution of gluconates from this application either. 
If dispersed into the environment, the substances of the category will be found predominantly in the 
aquatic compartment.  Indeed, on the basis of the fugacity Level II/III Fugacity Model from US 
EPA, the main target compartments of gluconates are water and soil but their good water solubility 
and low vapor pressure designate water as a major target compartment for these substances.  For 
sodium gluconate the vapor pressure at 20°C is estimated (on the basis of the modified Grain 
Method) as 4.53e-017 hPa, which is negligible; the estimated values for the other members of the 
category are of the same order of magnitude (2.41e-009 hPa for glucono-delta-lactone, 10.87e-010 
hPa for gluconic acid, 1.58e-022 hPa for calcium gluconate and 11.89e-017 hPa for potassium 
gluconate). 
Gluconic acid is a weak acid; its dissociation in water is characterized by the pKa in the range of 3.5 
to 3.8.  Thus, dissociation of gluconates in water is expected to be complete (Ullman’s 
Encyclopedia, 1999).   
Glucono-delta-lactone slowly hydrolyses in aqueous solution until a balance is reached between 
gluconic acid and its lactone ester.  Equilibrium of a 1 % glucono-delta-lactone solution is reached 
after 2 hours.  At an initial concentration of 10 % glucono-delta-lactone, the equilibrium gluconate-
lactone is 80/20.  
The dilution and lowering of pH decrease the stability of metal complexes and the metal ions 
released during the complex degradation can be removed by precipitation or absorption by the 
sludge (Roquette Frères). 
The octanol/water partition coefficient (Log K o/w) is estimated as -5.99 for the sodium salt, -7.51 
for the calcium salt, - 5.99 for the potassium salt, -1.87 for the free acid and -1.98 for GDL. These 
partition data represent the good water solubility of gluconates and their very low solubility in 
organic solvents.  The Henry constants (estimated with HENRY (v3.10) program from US EPA) 
and the calculated half-life of the substances by photodegradation (estimated with AOP (v1.91) 
program from US EPA) are summarized in the table below.     
 
Henrys Law Constant at 25 deg C estimated with 
HENRY (v3.10) program from US EPA 
(EPI v3.11 
Photodegradation Estimated with AOP 
(v1.91) program from US EPA  
 (EPI v3.11) 
 
HALF-LIFE 
GDL  1.38e-009 atm-m3/mole  3.960 Hrs 
Gluconic 
acid  4.74e-013 atm-m3/mole  3.033 Hrs 
Calcium 
gluconate 
Can neither be calculated with the bond estimation 
method nor with the group estimation method 
because of missing values for certain bonds/groups. 
1.683 Hrs 
Potassium 
gluconate 
Can neither be calculated with the bond estimation 
method nor with the group estimation method 
because of missing values for certain bonds/groups. 
3.366 Hrs 
Sodium 
gluconate  4.76e-013 atm-m3/mole  3.36 Hrs 
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The tables further below present that, on the basis of a Level II/III Fugacity Model calculation from 
US EPA, the different gluconates are almost evenly distributed between the water and soil 
compartments, with virtually none being adsorbed to the sediment or volatilized to the air.  
 
Sodium gluconate: 
  Mass Amount (%)  Half-Life (hr)  Emissions (kg/hr) 
Air 1.2 6.73  1000 
Water 49.8  208  1000 
Soil 48.9 208 1000 
Sediment 0.0743  832  0 
 
Gluconic acid: 
  Mass Amount (%)  Half-Life (hr)  Emissions (kg/hr) 
Air 0.00821  6.06  1000 
Water 38.8  55.9  1000 
Soil 61.2 55.9 1000 
Sediment 0.0345  224  0 
 
Glucono-delta-lactone: 
  Mass Amount (%)  Half-Life (hr)  Emissions (kg/hr) 
Air 0.8 7.92  1000 
Water 46.8  208  1000 
Soil 52.3 208 1000 
Sediment 0.0698  832  0 
 
Calcium gluconate: 
  Mass Amount (%)  Half-Life (hr)  Emissions (kg/hr) 
Air 1.06  e-007  3.37  1000 
Water 38.8  55.9  1000 
Soil 61.2  55.9  1000 
Sediment 0.0345  224  0 
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  Mass Amount (%)  Half-Life (hr)  Emissions (kg/hr) 
Air 4.78e-007  6.73  1000 
Water 42.8  208  1000 
Soil 57.1  208  1000 
Sediment 0.0638  832  0 
 
All these data suggest that the gluconates have  a very low potential for bioaccumulation. 
The low potential for bioaccumulation is supported by metabolic in vivo studies showing that 
gluconate is readily catabolized or utilized for glucose synthesis (Life Science Research Office, 
1980). 
The biodegradability capacity of the category is represented by data acquired for sodium gluconate. 
In the aerobic Closed bottle test of sodium D-gluconate, (Hydrotox GmbH, 2001) the 
biodegradation was 89% expressed as the Theoretical Oxygen Demand after 28 days; while under 
anaerobic conditions (Hydrotox GmbH, 2001b), 100% of sodium D-gluconate was determined as 
degraded after 35 days. These data demonstrate that gluconates are readily biodegradable both 
under aerobic and anaerobic test conditions.   
As the sequestering tendency of gluconates decreases rapidly upon dilution or lowering of pH, 
metal complexes of gluconates dissociate and are quickly and effectively destroyed by biological 
waste water treatment. 
2.3  Human Exposure 
Human exposure by all routes (including inhalation) is possible.  However, due to the controlled 
manufacturing conditions in all countries of production and the intended uses, only very limited 
accidental human exposure is expected. For workers the potential routes of exposure will mainly be 
by inhalation and by skin contact, whereas for consumers the main routes of exposure are oral and 
dermal. 
2.3.1  Occupational Exposure 
Gluconic acid is produced by a fermentation process. After fermentation the product is separated 
from the rest of the broth by filtration, followed by demineralization and discoloration. After a 
concentration step the material is crystallized to obtain glucono-delta-lactone on one side and the 
run off on the other side. Separation happens in a centrifuge. All these operations are carried out in 
closed equipment in all countries of production. At this stage no human contact is possible other 
than during maintenance work or sample analysis in the laboratory. Maintenance operators who 
have to be in touch with the product wear the usual safety equipment: protective clothes, gloves and 
goggles. In the control laboratory operators wear the general safety equipment: gloves and goggles, 
so exposure is minimal.   
Gluconic acid is a weak acid and while it only shows weak acidic characteristics, it has to be 
handled as an acid. Workers involved in preparing detergent formulations based on gluconic acid 
are required to take all the necessary measures when handling this type of material in order to avoid 
any skin or eye contact. 
Sodium gluconate is manufactured from gluconic acid by neutralization with sodium hydroxide. It 
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The liquid aqueous solution is used mainly in concrete and mortar preparations. Liquid sodium 
gluconate manufacturers sell the material in large quantities to concrete producers. The material is 
shipped in bulk containers to their facilities, where it is unloaded into a storage tank. From there it is 
pumped into a mixer where other chemicals are also added. The mixture is filled into containers or 
drums in order to be supplied to concrete and mortar producers. 
Workers are not in contact with sodium gluconate during the unloading and the mixing operations, 
since both operations are performed in closed systems.  
Crystalline sodium gluconate is sold in bags. It has to be dissolved in water before further use. 
Some dust may be formed at this stage during the cracking of the paper bags or the emptying of the 
bags into the hopper before dissolution.  Exposure by inhalation or skin contact could potentially 
occur at this stage.  The product is mainly used in industrial detergent formulations and metal 
surface treatment preparations. In both cases it functions as a sequestering or chelating agent after 
blending with other chemicals like sodium peroxide.  Companies making those preparations in large 
production units have already in place efficient safety procedures, including the use of protective 
clothes, gloves, masks and goggles by workers who could be in contact with the material.  
Glucono-delta-lactone is the lactone form of gluconic acid. Because of its higher price it is mainly 
used in food applications. It is shipped and handled in  bags.  
2.3.2  Consumer Exposure 
Exposure of consumers even in the dispersive uses of gluconates is expected to be limited because 
gluconates are mostly used as additives in the different consumer products typically in low dosages: 
 
- in concrete: 0.1-0.2% based on cement weight  
- in institutional and household cleaners: <5% based on formulation weight 
- in personal care products: <1% based on formulation weight.  
- in foodstuffs: <5% based on foodstuff weight 
The daily exposure of consumers to gluconates through these uses is lower than the daily 
production of gluconate from endogenous sources; ie. 20-30 gr/day (Life Science Research, 1978).   
Furthermore, gluconic acid, its salts and glucono-delta-lactone are also present naturally at a level 
up to 0.5% in wine, honey and other foods and drinks and can be ingested as additives or nutritional 
supplements in food.  
 
3  HUMAN HEALTH HAZARDS 
3.1  Effects on Human Health 
3.1.1  Toxicokinetics, Metabolism and Distribution 
Gluconic acid, the anion of potassium gluconate, is a normal metabolic product of glucose 
metabolism, 25-30 g being produced daily.  For these reasons, and because potassium gluconate is 
widely used therapeutically as a source of potassium in cases of hypokalemia, conventional 
toxicological studies of potassium gluconate have not been regarded as necessary, explaining the 
lack of direct animal data on the compound.  Orally administered gluconate is absorbed rapidly; a OECD SIDS    GLUCONIC ACID AND DERIVATIVES 
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major part is excreted in the urine and the remainder is metabolised (Life Science Research Office, 
1980). 
Gluconate is a metabolite of glucose oxidation in mammals.  Its activity is greatest in the liver, 
adipose tissue, adrenal cortex, thyroid, erythrocyte, testis and the lactating mammary gland.  In 
these organs as much as 20 % of the glucose can be metabolized; the daily production of gluconate 
from endogenous sources is about 450 mg/kg for a 60 kg person (Life Science Research, 1978). 
A significant portion (60-85%) of parenterally administered gluconate is excreted unchanged in the 
urine (Life Science Research, 1980). 
In an report evaluating the health aspects of gluconates, an in vivo excretion study is cited where it 
was established that a significant portion (60-85%) of parenterally administered gluconate is 
excreted unchanged in the urine (Life Science Research, 1980). 
3.1.2  Acute Toxicity 
Studies in Animals 
Data on acute oral toxicity for sodium gluconate in rat (Mochizuki, M, Bozo Research Center 1995) 
(doses: 500, 1000, 2000 mg/kg) and dog (Okamoto M., 1995) (doses: 1000 and 2000 mg/kg) fed by 
gavage showed no death at any dose, hence the minimum lethal dose  was estimated > 2000 mg/kg 
for both species.   
Rats were fed by gavage 3000, 3600, 4320, 5190, 6210 mg/kg bw (30% (w/v) aqueous solution) 
potassium gluconate and were observed for signs of toxicity during a 14-day period. One animal 
died in the 5190 mg/kg bw group and four animals in the 6210 mg/kg bw group. Deaths occurred 
between 5 and 21 hours after treatment.  Survivors recovered gradually. The LD50 was calculated 
(according to the method of Weil) to be 6060 mg/kg bw.  However, the effects that were observed 
occurred at doses that exceed the accepted limit dose of 5000 mg/kg bw and the LD50 may be 
related to high dosing (TNO, 1978). 
 No relevant oral toxicity data were found in the literature for the other substances of the category. 
Conclusion 
Studies with sodium gluconate in the rat and dog report LD50 values > 2000 mg/kg bw for both 
species. 
A gavage study with potassium gluconate and rats reported an LD50 of 6060 mg/kg bw.  
3.1.3  Irritation 
Skin Irritation 
Studies in Animals 
Primary dermal irritation tests with 0.5 ml of the 50% solution of gluconic acid (pH: 1.8) in 12 
albino rabbits demonstrated, that – as all the effects have cleared up after a 72 hours observation 
period – the test substance is not a dermal irritant (TNO, 1984).  
No data were found on skin irritation for the other gluconates of the category OECD SIDS    GLUCONIC ACID AND DERIVATIVES 
 UNEP  PUBLICATIONS  26
Eye Irritation 
Studies in Animals 
In-vitro and in-vivo eye irritation tests with 0.1 ml of the 50% solution of gluconic acid (pH: 1.8) in 
9 albino rabbits demonstrated, that – as all the effects have cleared up after a 72 hours observation 
period – the test substance is not an eye irritant (TNO, 1984).  
No data were found on eye irritation for the other gluconates of the category. 
3.1.4  Sensitisation 
No data are available. 
3.1.5  Repeated Dose Toxicity 
Studies in Animals 
A 28-day study was conducted by feeding rats by gavage with sodium gluconate at doses of 0, 500, 
1000, 2000 mg/kg bw in water at a volume of 1 ml/ 100g bw. No death or clinical signs of 
abnormality were observed in any of the groups.  Histopathological examination showed a 
thickening of the limiting ridge of the stomach in 5 out of 12 males at 2000 mg/kg bw per day dose. 
No toxic changes associated with the test article were detected.  As the limiting ridge is a tissue 
specific to rodents, this lesion is not toxicologically relevant for humans. Other lesions occurred 
incidentally and were not treatment -related.  
The NOAEL was estimated to be 1000 mg/kg bw/day for males and 2000 mg/kg bw/day for female 
(Mochizuki, M, Bozo Research Center, 1995a). 
 
 
Another 28-day toxicity study in rats fed with a diet containing up to 5% w/w sodium gluconate 
(max. 4100 mg/kg bw for males and 4400 mg/kg bw for females) was conducted using a control 
group receiving equivalent concentration of sodium in the form of NaCl in order to differentiate the 
potential effects of high doses of sodium intake.  No deaths occurred during the study period.  No 
revisions in the general condition, body weight, or food and water intake were observed in the 
animals over the study period.  No changes were observed in the investigated ophthalmologic tests, 
urinalysis, hematology and blood chemistry over the study period.  In addition, histopathological 
examination indicated no adverse effects as a result of the treatment regime.  Statistically significant 
differences in some urinary parameters reported in animals receiving 2.5 or 5% sodium gluconate 
were comparable to those observed in the NaCl control group, and were interpreted as related to the 
high sodium concentration of the diet.   
 
The authors concluded that the NOAEL was 5% (equal to 4100 mg/kg bw per day).  However, The 
JECFA committee who evaluated this report has concluded that the study was not suitable for 
identifying a NOAEL because of the small group sizes and the positive findings in the qualitative 
analysis, even if they have acknowledged that the effects shown in the qualitative urine analyses 
were related to the high sodium intake (Mochizuki, M. Bozo Research Center, 1997).   
 
Nonetheless, this study demonstrates the lack of effects of the gluconate anion even in large doses 
as the urinary effects were attributed to the high sodium intake and was therefore considered as 
critical for this endpoint.  
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Repeated toxicity studies were also performed on Beagle dogs with sodium gluconate administered 
orally for 4 weeks at 500, 1000, 2000 mg/kg bw. doses. None of the animals died during the period 
of treatment in any dose group and no significantly toxicologically changes were detected in the 
body weight, food intake, water intake, urinalysis, haematological test, blood chemistry analysis, 
ophthalmologic test, electrocardiography, autopsy and organ weight or in histopathological 
examination. However, increased frequency of vomiting and loose or watery stools were observed 
in the 1000 and 2000 mg/kg bw. dose groups, as compared to controls.  
 
On the basis of these results, the non-toxic dose was estimated to be 500 mg/kg bw / day.  However, 
the toxicological effects observed (vomiting, passage of loose or watery stools) were considered 
extremely slight since other tests did not show the same changes (Okamoto, M. Bozo Research 
Center, 1995a). 
 
Oral chronic studies with glucono-delta lactone on rats: 
Glucono-delta-lactone (250, 500, 1000, 2000 and 4000 mg/kgbw. for 6 months) was orally 
administered to Sprague-Dawley rats. In all dose groups, thickening of the stratified squamous 
epithelium was detected at the anterior stomach, particularly the transitional area continuous with 
the pyloric stomach; the frequency and severity of this thickening increased with the dose.  In high 
dose groups, submucosal inflammatory cell infiltration was also detected, but this change was not 
statistically significant. No deaths or other abnormalities were detected (Fukuhara K, 1978).  
 
In Wistar rats fed for 24 months with a diet containing 2.5% and 10% of glucono-delta-lactone (the 
total intake of the drug : 1240-1350 mg/kgbw. in 2.5% GDL group and 4920-5760 mg/kgbw. in the 
10 % GDL group), no changes were observed in the general condition throughout the period of 
testing, but weight gain tended to be slightly reduced 2-3 months after the initiation of the test 
feeding in 10% GDL group.  There was no statistically significant difference in the number and 
time of deaths between the treated and control groups. Histopathological changes accompanying 
aging were observed in all groups including the controls, but no specific changes likely to be 
associated with the test substance were detected (Fukuhara K, 1978a).  
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Substance 
tested 
Species Exposure 
period/route of 
administration 
Doses (mg/kg 
bw/day) 
Results References 
Rat - Sprague 
Dawley 
12 males 
12 females 
4 weeks 
Gavage  
0, 500, 1000, 
2000 
NOAEL males= 
1000 mg/kg 
bw/day 
NOAEL females= 
1000 mg/kg 
bw/day 
Mochizuki, M, 
Bozo Research 
Center, 1995a 
Rat- Sprague 
Dawley 
10 males 
10 females 
28-day 
oral feeding 
0, 1000, 2000, 
4100 
NOAEL= 4100 
mg/kg bw/day 
Mochizuki, M.  
Bozo Research 
Center, (1997) 
Sodium 
gluconate 
Dog – Beagle 
4 males 
4 females 
4 weeks 
oral unspecified 
0, 500, 1000, 
2000 
NOAEL = 500 
mg/kg bw/day 
Okamoto, M. 
Bozo Research 
Center, (1995) 
Rat - Sprague 
Dawley 
10 males 
10 females 
6 months 
oral 
250, 500, 1000-
2000, 4000 
NOAEL : not 
determined 
Fukuhara K., 
(1978) 
Glucono-delta-
lactone 
Rat – Wistar 
30 males 
30 females 
24 months 
oral 
2.5% (1240-1350 
mg/kg bw) and 
10 % (4920-5760 
mg/kg bw) 
NOAEL : not 
determined 
Fukuhara K., 
(1978a) 
 
Conclusion 
In summary, none of the repeated dose toxicity studies of any duration (4 weeks, 6 months or 24 
months) showed significant toxicological effects of gluconates.  Potential side effects were 
attributed to high doses of cation intake, evidenced by results from assays designed for the 
gluconate anion effect specifically.  The NOAEL of sodium gluconate determined from the 28 days 
studies on rats was equal to 1000 mg/kg bw for males and 2000 mg/kg bw for females.   
On the basis of these data and considering that gluconates are used as food additives permitted in 
the EU following the Quantum Satis principle (no maximum level specified), further chronic 
toxicity tests are considered unnecessary.   
3.1.6  Mutagenicity 
Studies in Animals 
In vitro Studies 
Sodium gluconate, glucono-delta-lactone and calcium gluconate were tested on saccharomyces 
cerevisiae and salmonella typhimurium with and without metabolic activation. OECD Guideline 
471 was deviated for the number of strains tested and the choice of positive controls.  The 
substances were tested on saccharomyces cerevisiae (strain D4) and salmonella typhimurium (3 
strains) with and without metabolic activation.  Only 3 concentrations were tested where OECD 
guideline recommends at least 5 concentrations. None of the test substances showed mutagenicity 
on the strains tested. 
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In vitro genetic toxicity results of sodium gluconate, calcium gluconate and glucono-delta-lactone 
Substance tested  Strains  Concentrations 
(µg/ml) 
Cytotoxic 
concentration 
(50% 
survival) 
(µg/ml) 
Result  Reference 
Bacteria 
salmonella 
typhimurium 
TA1535 
TA1537 
TA1538 
 
0.06 
0.012 
0.024 
0.024 negative  Sodium 
gluconate 
Yeast: 
saccharomyces 
cerevisiae strain 
D4 
12.5, 25 and 50  50  negative 
Litton Bionetics, 
Inc. (1975) 
 
Bacteria 
salmonella 
typhimurium 
TA1535 
TA1537 
TA1538 
 
2.5, 5 (5µg/ml plate 
test) 
10 
 
negative  Glucono-delta-
lactone 
Yeast: 
saccharomyces 
cerevisiae strain 
D4 
12.5, 25   50 
 
negative 
Litton Bionetics, 
Inc. (1974) 
Bacteria 
salmonella 
typhimurium 
TA1535 
TA1537 
TA1538 
 
12.5, 25 and 50  50  negative  Calcium 
gluconate 
Yeast: 
saccharomyces 
cerevisiae strain 
D4 
7.5, 15 and 30   30  negative 
Litton Bionetics, 
Inc. (1975a) 
 
 
In vivo Studies 
Sodium gluconate and glucono-delta-lactone were tested for induction of chromosomal aberration 
in mouse bone marrow cells after an oral single and a 4 days repeated dose administration.  At least 
200 metaphase cells per mouse were scored (C57BL male mice) and were examined for the 
presence or absence of chromosomal aberrations (gaps, breaks, translocation, fragments, ring 
chromosomes and minutes chromosomes). None of the tested substances induced chromosomal 
aberration (Tatsuo Yamashita et al, Fujisawa Pharmaceutical Co., Ltd. 1974). 
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Substance No  animal 
tested/group 
Doses Chromosomes’ 
aberration (%) 
Conclusion 
Sodium 
gluconate 
Single dose 
3 
3 
3 
3 
control 
2.5 g/kg 
5 g/kg 
10  g/kg 
0.5 
0.5 
all animals died 
all animals died 
negative 
Positive control 
(mitomycin C) 
2 5  mg/kg 
(intraperitoneal) 
20  
Sodium 
gluconate 
repeated dose 
2 
2 
3 
control 
1.25 g/kg 
2.5 g/kg 
0.5 
0.5 (1 animal died) 
0.5 (1 animal died) 
negative 
Positive control 
(mitomycin C) 
2 5  mg/kg 
(intraperitoneal) 
30  
Glucono-delta-
lactone 
Single dose 
3 
3 
3 
3 
control 
2 g/kg 
4 g/kg 
8  g/kg 
0.5 
0.5 
0.5 
all animals died 
negative 
Positive control 
(mitomycin C) 
2 5  mg/kg 
(intraperitoneal) 
20  
Glucono-delta-
lactone 
repeated dose 
2 
2 
3 
control 
2 g/kg 
4 g/kg 
1 
1 
1 
negative 
Positive control 
(mitomycin C) 
2 5  mg/kg 
(intraperitoneal) 
30  
 
Conclusion 
Although in the in vitro assays the strains used, the concentration tested and positive controls 
differed from OECD guideline 471, none of the test substances showed mutagenic properties on the 
strains tested. 
The available in vitro and in vivo mutagenicity data with glucono-delta-lactone, sodium or calcium 
gluconate were negative. Furthermore gluconates are naturally present in cells. Therefore there is no 
reason to evaluate the potential genotoxicity of these substances further and no genotoxic effects are 
expected.  
3.1.7  Carcinogenicity 
No carcinogenicity studies were available for any of the gluconates of the category. 
3.1.8  Toxicity for Reproduction 
Studies in Animals 
Effects on Fertility 
SIDS testing requirements regarding reproductive toxicity were satisfied with histopathology of the 
reproductive organs in repeat dose studies on sodium gluconate and with developmental toxicity 
studies on glucono-delta-lactone. OECD SIDS    GLUCONIC ACID AND DERIVATIVES 
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Developmental Toxicity 
The only available studies reported on the developmental toxicity for the gluconates of the category 
are for glucono-delta-lactone. These studies (unpublished) investigated teratogenicity following oral 
daily dosing of glucono-delta-lactone in 4 species (Food & Drug Research Laboratories -
Unpublished data (1973). 
The species, doses and results of those studies are summarized in the table below: 
Developmental toxicity results of glucono-delta-lactone in the rat, mouse, hamster and rabbit 
Species  Duration of test  Exposure period  Doses  Result (maternal 
and teratogen) 
Wistar rat  10 days  From day 6 to day 15 
of gestation 
0, 5.94, 27.6, 128.0, 
594.0 mg/kg 
NOAEL > 594 
mg/kg bw 
CD-1 mouse  10 days  From day 6 to day 15 
of gestation 
0, 6.95, 32.5, 150, 
695 mg/kg 
NOAEL > 695 
mg/kg bw 
Hamster  5 days  From day 6 to day 10 
of gestation 
0, 5.60, 6.0, 121, 560 
mg/kg 
NOAEL > 560 
mg/kg bw 
Dutch rabbit  13 days  From day 6 to day 18 
of gestation 
0, 7.80, 36.2, 168.5, 
780.0 mg/kg 
NOAEL > 780 
mg/kg 
 
Two other studies conducted in 1978 to assess the potential teratogenicity of GDL on rats 
(Fukuhara, K. 1978b) and mice (Fukuhara, K. 1978c) reported that GDL was not teratogenic when 
given orally at doses > 4000 mg/kgbw.   
The species, doses and results of those studies are summarized in the table below: 
Species  Duration of test  Exposure period  Doses  Result (maternal 
and teratogen) 
Sprague-Dawley 
rat 
10 days  From day 6 to day 15 
of gestation 
1000 and 4000 
mg/kg 
NOAEL > 4000 
mg/kg bw 
ICR mouse  10 days  From day 6 to day 15 
of gestation 
1000 and 4000 
mg/kg 
NOAEL > 4000 
mg/kg bw 
 
In the above experiments GDL was administered orally to female nulliparous rats and/or mice for 
10 days and the fetuses were observed by laparotomy on pregnancy day 21 or 18, respectively.  
Several dams in each group were allowed to deliver spontaneously, and the offspring were observed 
until postnatal day 21.  The report does not contain specific information on the method used. 
During pregnancy, no abnormalities were observed in the general condition, body weight change or 
food consumption in any of the dose groups, nor were any death. In observation of dams after 
laparotomy, no abnormalities were detected in the number of implantations, dead foetuses, live 
offspring or mean body weight of offspring, nor was there any influence of the drug on the external 
appearance, organs, or skeletons of the foetuses. Observation of the dams allowed to deliver 
spontaneously, protraction of the duration of pregnancy or abnormalities at birth were not observed, 
nor any influence of the drug detected in the mortality rate, body weight gain, behavior, external 
appearance or visceral abnormalities of the offspring during the period of nursing. OECD SIDS    GLUCONIC ACID AND DERIVATIVES 
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In summary, these negative data on the teratogenicity of glucono-delta-lactone, together with the 
natural occurrence of gluconic acid in the human metabolism sufficiently support the lack of 
developmental toxicity for all the gluconates of the category. 
3.2  Initial Assessment for Human Health 
Gluconates of the category are naturally occurring substances.  Most of these compounds are 
listed as permitted food additives, which may be added to all foodstuffs, following the "quantum 
satis" principle, as long as no special regulations restrict their use. 
In mammalian organisms both D-gluconic acid and its 1,5-lactone are important intermediates in 
the carbohydrate metabolism. Gluconate anion is a metabolite of glucose oxidation. The daily 
production of gluconate from endogenous sources is about 450 mg/kg for a 60 kg person (Life 
Science Research Office, 1978).   
A significant portion (60-85%) of parenterally administered gluconate is excreted unchanged in the 
urine (Life Science Research, 1980) 
The LD50 for potassium gluconate (oral toxicity study, wistar rat) is 6060 mg/kg bw (TNO 1978).  
None of the repeated dose toxicity studies of any duration (4 weeks, 6 months, or 4 months) showed 
significant toxicological effects of gluconates.  Potential side effects were attributed to high doses 
of cation intake, evidenced by results from assays designed for the gluconate anion effect 
specifically.  The NOAEL of sodium gluconate determined from the 28 days studies on rats was 
equal to 1000 mg/kg bw for males and 2000 mg/kg bw for females (Mochizuki, M. Bozo Research 
Center, 1995a).  These compounds are neither irritant to the eye or the skin (TNO, 1984). No 
sensitization, acute or chronic inhalation toxicity data are available. 
The available in vitro and in vivo mutagenicity data with glucono-delta-lactone (Litton Bionetics, 
Inc 1974), sodium (Litton Bionetics, Inc 1975) or calcium gluconate (Litton Bionetics, Inc 1975a) 
were negative. No carcinogenicity studies were available for any of the gluconates of the category. 
No reproduction toxicity study was available for any of the gluconates of the category.  However, 
negative results in the histopathology of the reproductive organs in repeat dose studies on sodium 
gluconate and negative data on the teratogenicity of glucono-delta-lactone (Food & Drug 
Laboratories, 1973) support the lack of reproductive toxicity for all the gluconates of the category. 
On the basis of these data showing a lack of toxicity and considering that gluconates have been 
recognized direct food additives, no further tests are considered necessary.   
Exposure: 
The manufacturing of gluconic acid is based on a fermentation process.  Estimation of the 
worldwide industrial production per year for all the members of the gluconate category is around 
65000 - 100000 tonnes.  There is no production site in Belgium.  
Human exposure by all routes (including inhalation) is possible. Workers exposure will mainly be 
by inhalation and by skin contact.  Controlled manufacturing conditions and use of safety 
equipments will limit the accidental occupational exposure.  Consumer exposure may be from the 
oral and dermal routes.  
Exposure of consumers to gluconates is expected to be limited because gluconates are mostly used 
as additives in the different consumer products typically in low dosages (< 5%). Furthermore, 
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subject to specific regulatory provisions requiring an authorization procedure where the evaluation 
of the hazardous properties as well as the actual exposure is taken into account. 
4  HAZARDS TO THE ENVIRONMENT 
4.1  Aquatic Effects 
Acute toxicity to fish 
The acute toxicity to fish in the studies reported in the literature was tested for sodium gluconate 
and glucono-delta-lactone. 
Sodium gluconate was tested on fish (Oryzias laticeps) during 96 hours exposure following the 
procedure of OECD guideline 203. No toxicological symptoms or death were observed at the limit 
test using 100 mg/l nominal concentration. The limit test concentration was determined following a 
range finding test. The measured concentration of the test substance was within +/- 20% of the 
nominal concentration. (Mitsubishi Chemical Safety Institute Ltd, 2002)   
Results of unpublished acute toxicity studies on fish (species not reported), are available for sodium 
gluconate (LC50 > 10 000 mg/l) and glucono-delta-lactone (LC50 = 360 mg/l) (Rübelt C., 1992). 
Although poorly documented and performed, these results support the low toxicity profile of the 
chemicals to fish in test conditions  that were not controlled/corrected for pH effects (a decrease to 
pH 4 was observed in the test medium).  
In summary, when correctly interpreted, these studies demonstrate that gluconates do not have any 
toxic effect on fish within the concentration ranges that are environmentally relevant. 
Acute toxicity to aquatic invertebrates  
The details of the studies on the acute toxicity of sodium gluconate, when tested on Daphnia magna 
are summarized in the table below: 
Test substance: Sodium gluconate 
Exposure period  Biomass 
loading 
Concentration 
tested 
Result  Method  Reference 
24-48 hours  20 
daphnias/con
centration 
0-1000 mg/l 
(nominal)* 
24 hours:  
EC50: > 1000 mg/l 
NOEC: > 1000 mg/l
EC100: > 1000 mg/l 
 
48 hours:  
EC50: > 1000 mg/l 
NOEC: > 1000 mg/l
EC100: > 1000 mg/l 
OECD guideline 202  Mitsubishi 
Chemical Safety 
Institute Ltd, 
(2002a) 
 
24-48 hours  20 
daphnias/con
centration 
0-1000 mg/l   EC0: > 1000 mg/l 
 
OECD guideline 202  Hydrotox 
GmbH, (2001c) 
 
*Measured concentrations of the test substance in the test solution were within +/- 20 % of the 
nominal concentration.  Results were based on the nominal concentrations. 
In summary, the tests suggest that gluconates (represented by sodium gluconate) do not have any 
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Acute toxicity to aquatic plants (algae)  
The details of the studies on the acute toxicity of sodium gluconate when tested on algae are 
summarized in the table below: 
Test substance: Sodium gluconate 
Species  Endpoint/ 
Exposure 
period/ 
Biomass 
loading 
Concentration   Result  Method  Reference 
Selenastrum 
capricornutum 
Biomass 
and 
growth 
rate 
72 hours/ 
1 x 10
4 
cells/ml 
0, 100, 180, 
320, 560, 1000 
mg/l (nominal)* 
EbC50 (0-72 h): > 1000 mg/l 
NOECb (0-72 h): 560 mg/l 
Er C50 (24-48 h): > 1000 mg/l
Er C50 (24-72 h): > 1000 mg/l
 
NOECr (24-48h): 560 mg/l 
NOECr (24-72h) : 560 mg/l 
 
OECD 
guideline 201 
 
Mitsubishi 
Chemical 
Safety Institue 
Ltd. (2002b) 
 
Desmodesmus 
subspicatus 
CHODAT  
Biomass 
and 
growth 
rate/ 
72 hours/ 
10 x 10
4 
cells/ml 
100-1000 mg/l  Cell growth inhibition :  
no inhibition at 100 mg/l 
70% inhibition at 1000 mg/l 
 
Average specific growth rate 
inhibition:  
no inhibition at 100 mg/l 
42% inhibition at 1000 mg/l 
OECD 
guideline 201 
Hydrotox 
GmbH 
(2001d) 
 
*Measured concentrations of the test substance in the test solution were within +/- 20 % of the 
nominal concentration.  Results were based on the nominal concentrations. 
On the basis of these data sodium gluconate can be considered non toxic for algae. 
Acute toxicity to micro-organisms (bacteria)  
Results of a study on toxicity to bacteria (Pseudomonas putida MIGULA ) following the German 
standard DIN 38 412 L8 are available for sodium gluconate (EC0 > 5000 mg/l) and glucono-delta-
lactone (EC0 > 500 mg/l) (Rübelt C., 1992). Although not properly designed and performed, these 
results support that gluconates do not have any inhibiting capacity on the growth of bacteria. 
4.2  Terrestrial Effects 
No data are available for any of the gluconate of the category, however while the fugacity modeling 
reveals water and soil as the main target compartments for the substances, no direct exposure is 
expected to occur at any stage of the life-cycle of gluconates.  Moreover, the demonstrated 
biodegradability and the low intrinsic toxicity of gluconates that was observed for aquatic 
organisms, the available animal toxicokinetic and metabolism data (cfr. human toxicology) and 
their role in mammalian carbohydrate metabolism may predict also a low effect on terrestrial 
organisms. Therefore, no terrestrial toxicity studies would be required. OECD SIDS    GLUCONIC ACID AND DERIVATIVES 
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4.3  Other Environmental Effects 
4.4  Initial Assessment for the Environment 
Gluconic acid, its salts of sodium, potassium and calcium as well as glucono-delta-lactone are all 
characterised by a low vapour pressure and a low octanol/water partition coefficient.  The 
dissociation constant of gluconic acid is in the range of 3.5 to 3.8.  Because of their good water 
solubility and low Log Kow, no bioaccumulation effects are to be expected and the substances were 
also shown to be readily metabolised. 
Gluconates are readily biodegradable in aerobic and anaerobic conditions (Hydrotox GmbH, 2001 
and 2001b).  There is no potential of direct exposure of any environmental compartment. 
Estimations from a Level II/III Fugacity Model from US EPA, show that the main target 
compartments of gluconates are water and soil. The calculated Henrys’ law constants indicate a low 
potential for volatilization and the estimated photodegradation (AOP (v1.91) program) gives a t1/2 
between 1.7 to 4.0 hours. The good water solubility and low vapour pressure designate water to be a 
major target compartment for these substances.   
Acute toxicity to aquatic organisms (fish, daphnia, algae) and bacteria were performed on sodium 
gluconate.  In the range of concentrations tested, exceeding largely any expected environmental 
exposure; sodium gluconate did not show toxicity to any of the aquatic species.  Because gluconates 
freely dissociate in water to the gluconate anion and their respective cation, data on sodium 
gluconate are acceptable for the other members of the category.   
No terrestrial toxicity data for gluconates are available.  However, the demonstrated 
biodegradability and the low intrinsic toxicity of gluconates that was observed for aquatic 
organisms, data on animal toxicokinetic and metabolism (cfr. human toxicology) and their role in 
mammalian carbohydrate metabolism may predict also a low effect on terrestrial organisms.   
Therefore, no terrestrial toxicity studies would be required. 
Based on the physical-chemical properties of these substances, their low toxicity profile and their 
natural presence in living organisms, no toxic effect would be expected to the environment from the 
gluconate anion.  Release of large amounts of gluconate salts in the environment leads also to the 
release of the sodium, calcium and potassium cations, which in certain circumstances may add to 
the overall cation load locally affecting the ecosystem. As these effects would be largely due to the 
presence of counter ions, these scenarios are not considered within the present SIAR document. 
While the lowering of the pH can be observed locally upon the release of gluconates in the aquatic 
environment, this change is adapted readily upon the control of the waste water stream, hence no 
significant impact on the pH of the aquatic environment can be expected in the long term. Further, 
as the sequestering tendency of gluconates decreases rapidly upon dilution or lowering the pH, they 
are destroyed effectively and quickly by biological waste water treatment. 
Environmental exposure from non-dispersive uses is supposed to be limited as waste-water 
treatment is commonplace in such applications.   
In wide dispersive applications, the chelating agents uses in building industry would not result in 
environmental exposure as the gluconate is bound within the microcrystalline fibers of cement and 
is not free to migrate to cause any environmental pollution. 
Food applications could potentially contribute to spreading gluconates and glucono-delta-lactone in 
the environment, as these products are added in their crystalline or powder forms to food 
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meant for human consumption and mostly gets ingested, there is no real potential for environmental 
distribution of gluconates from this application either. 
The only potential exposure to the environment would result from the release of counter-ions at 
high discharge concentration of gluconate salts. 
5  RECOMMENDATIONS 
The chemicals in this category are currently of low priority for further work because of their low 
hazard profile. 
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1.0.1 Applicant and Company Information 
 
Type:             lead organisation 
Name:             The Gluconic acid and its sodium, potassium and calcium salts 
                  and glucono-delta-lactone consortium 
Contact Person:   Jean-Philippe Montfort    Date: 02-APR-2003 
Street:           Rue Blanche 25 
Town:             1060 Brussels 
Country:          Belgium 
Phone:            +32 2 541 05 70 
Telefax:          + 32 2 541 05 80 
Email:            montfort@khlaw.be 
 
Remark:           Sponsor Country for this Category: Belgium; Co-sponsor 
                  country: Japan. 
12-DEC-2005 
 
Type:             manufacturer 
Name:             FUSO Chemical Co. Ltd 
Contact Person:   Ph.D. Shinichi Sugita     Date: 
Street:           Iwamoto-cho Toyo Building, 1-2 Iwamoto-cho 3-chome, Chiyoda-ku 
Town:             101 0032  Tokyo 
Country:          Japan 
Phone:            +81 3 5820 1611 
Telefax:          +81 3 5820 1634 
Email:            Shinichi.Sugita@fusokk.co.jp 
 
03-AUG-2004 
 
Type:             manufacturer 
Name:             Jungbunzlauer International AG 
Contact Person:   Raphaël Singer            Date: 17-APR-2003 
Street:           St. Alban-Vorstadt 90 
Town:             4002 Basel 
Country:          Switzerland 
Phone:            +41 61 295 51 25 
Telefax:          +41 61 295 52 66 
Email:            raphael.singer@jungbunzlauer.ch 
 
17-OCT-2003 
 
Type:             manufacturer 
Name:             Roquette Freres 
Contact Person:   Johnny Pallot             Date: 
Town:             62080 Lestrem Cedex 
Country:          France 
Phone:            +33 3 21 63 37 40 
Telefax:          +33 3 21 63 38 50 
Email:            JOHNNY.PALLOT@roquette.com 
 
31-JUL-2003 
 
 
Type:             manufacturer 
Name:             PURAC 
Contact Person:   Ton van Dongen            Date: 
Street:           PO BOX 21 
Town:             4200 AA Gorinchem OECD SIDS    D- GLUCONIC ACID 
1. GENERAL INFORMATION    ID: 526-95-4 
   DATE:  25.1.2006 
 
 UNEP  PUBLICATIONS  42
Country:          Netherlands 
Phone:            +31 183 695 730 
Telefax:          +31 183 695 603 
Email:            t.van.dongen@purac.com 
 
03-AUG-2004 
 
 
1.0.2 Location of Production Site, Importer or Formulator 
 
 
1.0.3 Identity of Recipients 
 
 
1.0.4 Details on Category/Template 
 
 
Remark:           Glucono-delta-lactone, gluconic acid and its sodium, calcium 
                  and potassium salts have been proposed in a category, as the 
                  salts of gluconic acid freely dissociate to the gluconate 
                  anion and the respective cation. 
 
                  Glucono-delta-lactone (GDL) is the inner ester of gluconic 
                  acid formed by the removal of water. 
 
                  When glucono-delta-lactone is used in aqueous solution, it 
                  is slowly hydrolysed until an equilibrium is reached between 
                  gluconic acid and its delta-lactone. 
12-AUG-2004 
 
 
1.1.0 Substance Identification 
 
IUPAC Name:       D-gluconic acid 
Smiles Code:      O=C (O) C (O) C (O) C (O) C (O) CO 
Mol. Formula:     C6H12O7 
Mol. Weight:      196.16 
 
07-JUN-2003 
 
 
1.1.1 General Substance Information 
 
Purity type:      typical for marketed substance 
Substance type:   organic 
Physical status:  solid 
Purity:           ca. 49 - 52 % w/w 
Colour:           clear, yellow to brownish (for the aqueous solution) 
Odour:            characteristic 
 
Remark:           Gluconic acid is a mild organic acid, neither caustic nor 
                  corrosive and with excellent complexing ability.  Gluconic 
                  acid is prepared by fermentation of pure dextrose, whereby 
                  the physiological d-form is produced. 
                  The substance referred in this dossier is the aqueous 
                  solution (ca. 50%).  Purity of the marketed substance in 
                  aqueous solution is 49-52%. 
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                  Anhydrous gluconic acid is a white, odorless, crystalline 
                  powder. 
14-NOV-2005                                                                 (11) 
 
 
1.1.2 Spectra 
 
 
1.2 Synonyms and Tradenames 
 
D(-)-pentahydroxy caproic acid 
 
05-JUN-2003 
 
dextronic acid 
 
12-AUG-2004 
 
glycogenic acid 
 
12-AUG-2004 
 
glyconic acid 
 
12-AUG-2004 
 
maltonic acid 
 
12-AUG-2004 
 
Pentahydroxy hexanoic acid 
 
25-JUN-2003 
 
 
1.3 Impurities 
 
Purity type:      typical for marketed substance 
 
Remark:           For food and/or medical applications the level of impurities 
                  complies with the restrictions laid down in the 
                  corresponding EU Directives. 
15-JAN-2004 
 
 
1.4 Additives 
 
 
Remark:           For all the chemicals of the category: no additives used 
10-NOV-2005 
 
 
1.5 Total Quantity 
 
Quantity:         ca. 4000 - 6000 tonnes produced in 2000 
 
Remark:           Estimation of the worldwide market per year (as 100% 
                  gluconic acid). There is no production in Belgium. OECD SIDS    D- GLUCONIC ACID 
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Flag:             confidential 
20-OCT-2003 
 
 
1.6.1 Labelling 
 
 
Remark:           For all the chemicals in the category: proposal of Industry: 
                  no labelling required 
10-NOV-2005 
 
 
1.6.2 Classification 
 
Classified:       other, as in legislation 
 
Remark:           For all chemicals of the category: proposal of Industry: no 
                  classification required 
10-NOV-2005 
 
 
1.6.3 Packaging 
 
 
1.7 Use Pattern 
 
Type:             type 
Category:         Non dispersive use 
 
Remark:           Data for the category: see sodium gluconate 
14-AUG-2003 
 
 
1.7.1 Detailed Use Pattern 
 
 
1.7.2 Methods of Manufacture 
 
 
1.8 Regulatory Measures 
 
 
1.8.1 Occupational Exposure Limit Values 
 
 
1.8.2 Acceptable Residues Levels 
 
 
1.8.3 Water Pollution 
 
 
1.8.4 Major Accident Hazards 
 
 
1.8.5 Air Pollution 
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1.8.6 Listings e.g. Chemical Inventories 
 
 
1.9.1 Degradation/Transformation Products 
 
 
1.9.2 Components 
 
 
1.10 Source of Exposure 
 
Source of exposure: other 
 
Remark:             Data for the category: see sodium gluconate 
14-AUG-2003 
 
 
1.11 Additional Remarks 
 
 
Remark:           Gluconic acid is readily produced from glucose by mild 
                  oxidation.  The oxidation may be accomplished chemically, 
                  electrolytically or enzymatically.  Gluconic acid is used in 
                  industry and medicine largely for its ability to form 
                  readily soluble salts or complexes with various metals. 
                  This solubilizing function facilitates the absorption of 
                  cations from the intestine.  In the tissues, the gluconates 
                  readily dissociate, liberating the metallic ion. 
14-NOV-2005                                                                 (12) 
 
Memo:             Regulatory status 
 
Remark:           In the European Parliament and Council Directive 95/2/EC 
                  gluconic acid is listed as a generally permitted food 
                  additive (E 574) and may be added to all foodstuffs, 
                  following the "quantum satis" principle, as long as no 
                  special regulations restrict the use. 
14-AUG-2003 
 
1.12 Last Literature Search 
 
1.13 ReviewsOECD SIDS    D- GLUCONIC ACID 
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2.1 Melting Point 
 
Value:            = 131 degree C 
 
Method:           other: no data 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Reliability:      (2)  valid with restrictions 
                  Data from Handbook or collection of data 
Flag:             Critical study for SIDS endpoint 
10-AUG-2004                                                                 (22) 
 
Value:            ca. 120 - 131 degree C 
 
Method:           other: no data 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Remark:           The spread in melting point values is due to the formation 
                  of intramolecular anhydrides whose presence lowers the 
                  melting point 
Reliability:      (2)  valid with restrictions 
                  Data from Handbook or collection of data 
Flag:             Critical study for SIDS endpoint 
09-AUG-2004                                                                 (23) 
 
 
2.2 Boiling Point 
 
Value:            = 417.1 degree C 
 
Method:           other: calculated 
   GLP:           no 
Test substance:   as prescribed by 1.1 - 1.4 
 
Remark:           Estimated with MPBPVP (v1.41) program from US EPA (EPI 
                  v3.11) 
Reliability:      (2)  valid with restrictions 
                  Accepted calculation method 
Flag:             Critical study for SIDS endpoint 
09-AUG-2004 
 
Value:            = 102 degree C 
 
 
Remark:           Aqueous solution (approximately 50%) 
25-JUN-2003                                                                 (10) 
 
2.3 Density 
 
Type:             density 
Value:            = 1.23 g/cm³ at 20 degree C 
 
Method:           other: no data 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
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Reliability:      (2)  valid with restrictions 
                  Data from Handbook or collection of data 
Flag:             Critical study for SIDS endpoint 
09-AUG-2004                                                                 (23) 
 
Type:             density 
Value:            = 1.24 g/cm³ at 20 degree C 
 
Method:           other: no data 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Reliability:      (4)  not assignable 
                  Data from an MSDS. No data on method used 
Flag:             Critical study for SIDS endpoint 
09-AUG-2004                                                                  (5) 
 
Type:             density 
Value:            = 1.25 g/cm³ 
 
Method:           other: no data 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Reliability:      (4)  not assignable 
                  Data from an MSDS. No data on method used 
Flag:             Critical study for SIDS endpoint 
09-AUG-2004                                                                 (20) 
 
Type:             density 
Value:            = 1.23 - 1.25 g/cm³ at 20 degree C 
 
Method:           other: no data 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Reliability:      (4)  not assignable 
                  Data from an MSDS. No data on method used 
Flag:             Critical study for SIDS endpoint 
09-AUG-2004                                                                 (11) 
 
 
2.3.1 Granulometry 
 
 
2.4 Vapour Pressure 
 
Value:            = .00000000109 hPa at 25 degree C 
 
Method:           other (calculated) 
   GLP:           no 
Test substance:   as prescribed by 1.1 - 1.4 
 
Remark:           Estimated with MPBPVP (v1.41) program from US EPA (EPI 
                  v3.11): 
 
                  Vapor Pressure Estimations (25 deg C): 
                    (Using BP: 417.09 deg C (estimated)) OECD SIDS    D- GLUCONIC ACID 
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                    (Using MP: 131.00 deg C (exp database)) 
                      VP:  6.94E-011 mm Hg (Antoine Method) 
                      VP:  8.17E-010 mm Hg (Modified Grain Method) 
                      VP:  5.9E-007 mm Hg (Mackay Method) 
 
 
                  Selected VP:  8.17E-010 mm Hg = 10.87E-010 hPa (Modified 
                  Grain Method) 
Reliability:      (2)  valid with restrictions 
                  Accepted calculation method 
Flag:             Critical study for SIDS endpoint 
09-AUG-2004 
 
 
2.5 Partition Coefficient 
 
Partition Coeff.: octanol-water 
log Pow:          = -1.87 at 25 degree C 
 
Method:           other (calculated) 
   GLP:           no 
 
Remark:           Estimated with Kowwin (v1.67) program from US EPA (EPI 
                  v3.11) 
Reliability:      (2)  valid with restrictions 
                  Accepted calculation method 
Flag:             Critical study for SIDS endpoint 
09-AUG-2004 
 
2.6.1 Solubility in different media 
 
Solubility in:    Water 
pKa:              3.7 at 25 degree C 
Descr.:           miscible 
 
Method:           other: no data 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Reliability:      (2)  valid with restrictions 
                  Data from Handbook or collection of data 
Flag:             Critical study for SIDS endpoint 
12-AUG-2004                                                                 (23) 
 
Solubility in:    Water 
Value:            > 999999 mg/l at 25 degree C 
 
Method:           other: calculated 
   GLP:           no 
Test substance:   as prescribed by 1.1 - 1.4 
 
Remark:           Estimated with Water sol (v1.01) program from US EPA (EPI 
                  v3.11) : 
 
                  Log Water Sol (moles/L) at 25 dec C  =    0.7074 
 
                  Water Solubility (mg/L) at 25 dec C  =   1e+006 
Reliability:      (2)  valid with restrictions OECD SIDS    D- GLUCONIC ACID 
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                  Accepted calculation method 
Flag:             Critical study for SIDS endpoint 
12-AUG-2004 
 
Solubility in:    Water 
Descr.:           other: freely soluble 
 
Method:           other: no data 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Reliability:      (2)  valid with restrictions 
                  Data from Handbook or collection of data. 
Flag:             Critical study for SIDS endpoint 
12-AUG-2004                                                                 (22) 
 
 
Solubility in:    Water 
Value:            at 25 degree C 
pH       value:   = 1.8 
         Conc.:   50 vol% degree C 
Descr.:           miscible 
 
Method:           other: no data 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Reliability:      (4)  not assignable 
                  Data from an MSDS. No data on method used 
Flag:             Critical study for SIDS endpoint 
12-AUG-2004                                                                 (11) 
 
Solubility in:    Water 
pKa:              3.7 at 25 degree C 
Descr.:           miscible 
 
Method:           other: no data 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Reliability:      (4)  not assignable 
                  Data from an MSDS. No data on method used 
Flag:             Critical study for SIDS endpoint 
12-AUG-2004                                                                 (20) 
 
Solubility in:    other: ethanol 
Descr.:           slightly soluble (0.1-100 mg/L) 
 
Method:           other: no data 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Reliability:      (2)  valid with restrictions 
                  Data from Handbook or collection of data. 
Flag:             Critical study for SIDS endpoint 
12-AUG-2004                                                                 (23) 
 
Solubility in:    other: nonpolar solvents OECD SIDS    D- GLUCONIC ACID 
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Descr.:           insoluble (< 0.1 mg/L) 
 
Method:           other: no data 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Reliability:      (2)  valid with restrictions 
                  Data from Handbook or collection of data. 
Flag:             Critical study for SIDS endpoint 
12-AUG-2004                                                                 (23) 
 
 
2.6.2 Surface Tension 
 
 
2.7 Flash Point 
 
 
2.8 Auto Flammability 
 
 
2.9 Flammability 
 
 
2.10 Explosive Properties 
 
 
2.11 Oxidizing Properties 
 
 
2.12 Dissociation Constant 
 
Acid-base Const.: KA at 25°C= 1.99 x 10 exp-4, pKA = 3.70 
 
Method:           other: no data 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Reliability:      (2)  valid with restrictions 
                  Data from Handbook or collection of data. 
Flag:             Critical study for SIDS endpoint 
09-AUG-2004                                                                 (23) 
 
Acid-base Const.: K at 25°C = 2.5 x 10e-4 
 
Method:           other: no data specified 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Reliability:      (2)  valid with restrictions 
                  Data from Handbook or collection of data. 
Flag:             Critical study for SIDS endpoint 
12-AUG-2004                                                                 (22) 
 
 
2.13 Viscosity 
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2.14 Additional Remarks 
 
 
Remark:           Hydrogenation of gluconic acid in aqueous solution over a 
                  platinum oxide catalyst results in a modest yield of 
                  D-glucose, whereas the 1,5-lactone undergoes this reaction 
                  in high yield. 
 
                  The 6 functional groups of gluconic acid can, in principle, 
                  react with a variety of reagents, such as alcohols, acids, 
                  etc.  Nevertheless, the resulting derivatives tend to be 
                  stable only if reaction is complete.  Partial reaction leads 
                  to nonuniform mixtures that are sensitive to hydrolysis; 
                  such reactions have little significance. 
 
                  In contrast, considerable interest exists in the ability of 
                  gluconic acid and its alkali salts to form complexes with 
                  polyvalent cations.  Some of these complexes are very 
                  stable. 
07-JUN-2003                                                                 (23) OECD SIDS    D- GLUCONIC ACID 
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3.1.1 Photodegradation 
 
Type:             other 
 
Method:           other (calculated): Estimated with AOP (v1.91) program from US 
                  EPA (EPI v3.11) 
   GLP:           no 
Test substance:   as prescribed by 1.1 - 1.4 
 
Remark:           Estimated with AOP (v1.91) program from US EPA (EPI v3.11) 
 
                  OVERALL OH Rate Constant =  42.3224 E-12 cm3/molecule-sec 
 
                  HALF-LIFE =     0.253 Days (12-hr day; 1.5E6 OH/cm3) 
 
                  HALF-LIFE =     3.033 Hrs 
Reliability:      (2)  valid with restrictions 
                  Accepted calculation method 
Flag:             Critical study for SIDS endpoint 
12-AUG-2004 
 
 
3.1.2 Stability in Water 
 
Type:             abiotic 
 
Method:           other: no data 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Remark:           The dissociation in water is expected to be complete as the 
                  pKa is 3.70 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                 (23) 
 
 
3.1.3 Stability in Soil 
 
 
3.2.1 Monitoring Data (Environment) 
 
 
3.2.2 Field Studies 
 
 
3.3.1 Transport between Environmental Compartments 
 
Type:             fugacity model level III 
Media:            other 
Method:           other: calculated 
 
Remark:           Estimated with the Level III Fugacity Model program LEVEL3NT 
                  from US EPA (EPI v3.11) 
 
                  Chem Name   : D-Gluconic acid 
                  Molecular Wt: 196.16 
                  Henry's LC  : 4.74e-013 atm-m3/mole (Henrywin program) 
                  Vapor Press : 8.17e-010 mm Hg  (Mpbpwin program) OECD SIDS    D- GLUCONIC ACID 
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                  Liquid VP   : 9.13e-009 mm Hg  (super-cooled) 
                  Melting Pt  : 131 deg C (user-entered) 
                  Log Kow     : -1.87  (Kowwin program) 
                  Soil Koc    : 0.00553  (calc by model) 
 
                           Mass Amount      Half-Life     Emissions 
                             (percent)            (hr)      (kg/hr) 
                  ------------------------------------------------------ 
                  Air        0.00821             6.06       1000 
                  Water       38.8               55.9       1000 
                  Soil        61.2               55.9       1000 
                  Sediment   0.0345               224         0 
                  _____________________________________________________ 
 
 
                           Fugacity  Reaction   Advection   Reaction  Advection 
                           (atm)     (kg/hr)    (kg/hr)     (%)       (%) 
                  ----------------------------------------------------------- 
                  Air     2.41e-016    2.2       0.193      0.0734   0.00642 
                  Water    1.1e-018  1.13e+003     91         37.6    3.03 
                  Soil    6.42e-017  1.78e+003      0         59.3      0 
                  Sediment 4.89e-019  0.251      0.00162    0.00837  5.4e-005 
 
                  Persistence Time: 78.2 hr 
                  Reaction Time:    80.7 hr 
                  Advection Time:   2.57e+003 hr 
                  Percent Reacted:  97 
                  Percent Advected: 3.04 
 
                  Half-Lives (hr), (based upon Biowin (Ultimate) and Aopwin): 
                  Air:      6.065 
                  Water:    55.92 
                  Soil:     55.92 
                  Sediment: 223.7 
                  Biowin estimate: 3.930  (days) 
 
                  Advection Times (hr): 
                  Air:      100 
                  Water:    1000 
                  Sediment: 5e+004 
Reliability:      (2)  valid with restrictions 
                  Accepted calculation method 
 
Flag:             Critical study for SIDS endpoint 
25-JAN-2006 
 
 
3.3.2 Distribution 
 
Media:            air - biota - sediment(s) - soil - water 
Method:           other (calculation) 
 
Remark:           Henry's law constant estimated with HENRY (v3.10) program 
                  from US EPA (EPI v3.11) 
 
                  HENRYs LAW CONSTANT at 25 deg C = 4.74E-013 atm-m3/mole 
                  ----------------------------------------------------------- 
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                  Soil Adsorption Coefficient estimated with PCKOC (v1.66) 
                  program from US EPA (EPI v3.11) 
 
                  First Order Molecular Connectivity Index  :  5.913 
                  Non-Corrected Log Koc  :  3.7674 
                  Fragment Correction(s): 
                      *   Organic Acid  (-CO-OH)  : -1.7512 
                    2   Aliphatic Alcohol  (-C-OH)   : -3.0386 
 
                  Corrected Log Koc   : -1.0224 
                  Over Correction Adjustment to Lower Limit Log Koc  :  1.0000 
 
                  Estimated Koc:  10 
                  NOTE:     The Koc of this structure may be sensitive to pH! 
                  The estimated Koc represents a best-fit to the majority of 
                  experimental values;  however, the Koc may vary 
                  significantly with pH. 
Reliability:      (2)  valid with restrictions 
                  Accepted calculation method 
Flag:             Critical study for SIDS endpoint 
09-AUG-2004 
 
 
3.4 Mode of Degradation in Actual Use 
 
 
3.5 Biodegradation 
 
Type:             aerobic 
Inoculum:         other: secondary effluent of a municipal sewage plant 
                  (Breisgauer Bucht, 500000 population equivalent), 0.4 ml/l 
Concentration:    3 mg/l related to Test substance 
Contact time:     28 day(s) 
Degradation:      = 89 % after 28 day(s) 
Result:           readily biodegradable 
Kinetic:              3 day(s)    = 61.13 % 
                      7 day(s)    = 74.35 % 
                     14 day(s)    = 66.09 % 
                     21 day(s)    = 71.94 % 
                     28 day(s)    = 88.88 % 
Control Subst.:   Acetic acid, sodium salt 
Kinetic:               3 day(s)    = 67.15 % 
                      28 day(s)    = 80.93 % 
Deg. product:     not measured 
 
Method:           Directive 92/69/EEC, C.4-E 
  Year:           2001 
   GLP:           yes 
Test substance:   other TS 
 
Remark:           The 89% degradation indicated here relates to the 
                  Theoritical Oxygen Demand (ThOD). 
                  Data for the category: see details of study under sodium 
                  gluconate SIDS dossier. 
Test substance:   Sodium gluconate: 99.0-101.0% 
Reliability:      (1)  valid without restriction 
                  study conducted according to OECD guidelines, valid 
                  test,quality assurance and GLP certificates OECD SIDS    D- GLUCONIC ACID 
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Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                  (8) 
 
 
Type:             anaerobic 
Inoculum:         other: Digesting sludge of a municipal sewage plant 
                  (Breisgauer Bucht, 500000 population equivalent), 2.9 g total 
                  solids/l 
Concentration:    303 mg/l related to Test substance 
Contact time:     35 day(s) 
Degradation:      = 100 % after 35 day(s) 
Result:           readily biodegradable 
Kinetic:              1 day(s)    = 8 % 
                      8 day(s)    = 51 % 
                     15 day(s)    = 57 % 
                     22 day(s)    = 61 % 
                     35 day(s)    = 100 % 
Control Subst.:   Benzoic acid, sodium salt 
Kinetic:               8 day(s)    = 6 % 
                      35 day(s)    = 100 % 
Deg. product:     not measured 
 
Method:           other: DIN EN ISO 11734 
  Year:           2001 
   GLP:           yes 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under sodium 
                  gluconate SIDS dossier. 
Test substance:   sodium gluconate 
Reliability:      (1)  valid without restriction 
                  study conducted according to OECD guidelines, valid 
                  test,quality assurance and GLP certificates 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                  (9) 
 
 
3.6 BOD5, COD or BOD5/COD Ratio 
 
 
3.7 Bioaccumulation 
 
 
3.8 Additional Remarks OECD SIDS    D- GLUCONIC ACID 
4. ECOTOXICITY    ID: 526-95-4 
   DATE:  25.1.2006 
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AQUATIC ORGANISMS 
 
4.1 Acute/Prolonged Toxicity to Fish 
 
Type:             semistatic 
Species:          Oryzias latipes  (Fish, fresh water) 
Exposure period:  96 hour(s) 
Unit:             mg/l                   Analytical monitoring: yes 
NOEC:             > 100 - 
LC0:              > 100 - 
Limit Test:       yes 
 
Method:           OECD Guide-line 203  "Fish, Acute Toxicity Test" 
  Year:           2002 
   GLP:           yes 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under sodium 
                  gluconate SIDS dossier. 
Test substance:   sodium gluconate : 99.6% 
Reliability:      (1)  valid without restriction 
                  study conducted according to OECD guidelines, valid 
                  test,quality assurance and GLP certificates 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                 (14) 
 
 
4.2 Acute Toxicity to Aquatic Invertebrates 
 
Type:             static 
Species:          Daphnia magna  (Crustacea) 
Exposure period:  48 hour(s) 
Unit:             mg/l                   Analytical monitoring: yes 
NOEC:             > 1000 - 
EC100:            > 1000 - 
Limit Test:       yes 
 
Method:           OECD Guide-line 202 
  Year:           2002 
   GLP:           yes 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under sodium 
                  gluconate SIDS dossier. 
Test substance:   sodium gluconate : 99.6% 
Reliability:      (1)  valid without restriction 
                  study conducted according to OECD guidelines, valid 
                  test,quality assurance and GLP certificates 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                 (15) 
 
 
4.3 Toxicity to Aquatic Plants e.g. Algae 
 
Species:          Selenastrum capricornutum  (Algae) 
Endpoint:         growth rate 
Exposure period:  72 hour(s) 
Unit:             mg/l                   Analytical monitoring: yes OECD SIDS    D- GLUCONIC ACID 
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NOEC:             = 560 - 
EC50:             > 1000 - 
Limit Test:       yes 
 
Method:           OECD Guide-line 201  "Algae, Growth Inhibition Test" 
  Year:           2002 
   GLP:           yes 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under sodium 
                  gluconate SIDS dossier. 
Test substance:   sodium gluconate : 99.6% 
Reliability:      (1)  valid without restriction 
                  study conducted according to OECD guidelines, valid 
                  test,quality assurance and GLP certificates 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                 (16) 
 
 
4.4 Toxicity to Microorganisms e.g. Bacteria 
 
 
4.5 Chronic Toxicity to Aquatic Organisms 
 
4.5.1 Chronic Toxicity to Fish 
 
 
4.5.2 Chronic Toxicity to Aquatic Invertebrates 
 
 OECD SIDS    D- GLUCONIC ACID 
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TERRESTRIAL ORGANISMS 
 
4.6.1 Toxicity to Sediment Dwelling Organisms 
 
Species:          other 
 
 
Remark:           No data available but exposure in sediment expected to be 
                  extremely limited according to the Level III Fugacity Model 
                  program LEVEL3NT from US EPA (EPI v3.11). 
09-AUG-2004 
 
 
4.6.2 Toxicity to Terrestrial Plants 
 
 
Method:           other 
 
Remark:           No data available 
14-AUG-2003 
 
 
4.6.3 Toxicity to Soil Dwelling Organisms 
 
Type:             other 
 
Method:           other 
 
Remark:           no data available but due to the low intrinsic toxicity in 
                  aquatic organisms, it is reasonable to expect a similar low 
                  toxic impact on terrestrial organisms 
19-JAN-2004 
 
 
4.6.4 Toxicity to other Non-Mamm. Terrestrial Species 
 
 
4.7 Biological Effects Monitoring 
 
 
4.8 Biotransformation and Kinetics 
 
 
4.9 Additional Remarks OECD SIDS    D- GLUCONIC ACID 
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5.0 Toxicokinetics, Metabolism and Distribution 
 
 
5.1 Acute Toxicity 
 
 
5.1.1 Acute Oral Toxicity 
 
Type:             LDLo 
Species:          rat 
Strain:           Crj: CD(SD) 
Sex:              male/female 
No. of Animals:   10 
Vehicle:          no data 
Doses:            500, 1000, 2000 mg/kg 
Value:            > 2000 mg/kg bw 
 
Method:           other: no data 
  Year:           1995 
   GLP:           no data 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under sodium 
                  gluconate SIDS dossier. 
Test substance:   sodium gluconate 
Reliability:      (2)  valid with restrictions 
                  Short abstract not well documented but key study for initial 
                  assessment. 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                 (18) 
 
 
5.1.2 Acute Inhalation Toxicity 
 
 
5.1.3 Acute Dermal Toxicity 
 
 
5.1.4 Acute Toxicity, other Routes 
 
 
5.2 Corrosiveness and Irritation 
 
5.2.1 Skin Irritation 
 
Species:          rabbit 
Concentration:    50 % 
Exposure:         Occlusive 
Exposure Time:    24 hour(s) 
No. of Animals:   12 
Vehicle:          water 
Result:           not irritating 
EC classificat.:  not irritating 
 
Method:           other: Directive 79/831/EEC, B.4. "Acute toxicity" (skin 
                  irritation) 
  Year:           1984 
   GLP:           no data OECD SIDS    D- GLUCONIC ACID 
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Test substance:   as prescribed by 1.1 - 1.4 
 
Method:           Primary irritation of the skin was measured by a patch-test 
                  technique on the abraded and intact skin of albino rabbits. 
 
                  24 hours prior to applying the materials, the hair is 
                  removed from the backs of the animals with an electric 
                  clipper in such a way to avoid abrasions. 
 
                  An amount of 0.5 ml (or 0.5g in case of solids or semi 
                  solids) of the test substance is brought on the intact or 
                  abraded skin under a surgical patch measuring 1 inch x 1 
                  inch.  The patches are fixed on the application site by 
                  means of adhesive tape and the entire trunk of the rabbits 
                  is wrapped with an impervious material to maintain the 
                  patches in position and to retard evaporation of volatile 
                  substances. 6 rabbits are treated on the intact skin, the 
                  other 6 on the abraded skin (abrasions are minor icisions 
                  through the stratum corneum but not deep enough to disturb 
                  the derma or to produce bleeding). 
 
                  The exposure period was 4 hours and skin effects were 
                  examined at the end of the exposure period and then after 
                  24, 48 and 72 hours. 
 
                  The resulting skin reactions are evaluated by the method of 
                  Draize and CIVO-grading system. 
Result:           The test material caused very slight erythema in the 3 out 
                  of 6 rabbits.  After 72 hours, these effects had cleared up 
                  completely. 
 
 
                  Individual and average skin irritation scores of gluconic 
                  acid (50% in water) 
 
                  Rabbit no  Hours after patch removal 
                      1  24  48  72 
                  ------------------------------------------------- 
                  (A=erythema) 
                  (B=oedema)  A-B  A-B  A-B  A-B 
                  ------------------------------------------------- 
                  2059    1-0  0-0  0-0  0-0 
                  2060    1-0  1-0  1-0  0-0 
                  2061    1-0  0-0  0-0  0-0 
                  2062    0-0  0-0  0-0  0-0 
                  2063    0-0  0-0  0-0  0-0 
                  2064    0-0  0-0  0-0  0-0 
                  ------------------------------------------------- 
                  Average    0.5  0.2  0.2  0.0 
                  _________________________________________________ 
Test substance:   gluconic acid, 50% solution in water (pH of the test 
                  material: 1.8) 
Reliability:      (1)  valid without restriction 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                 (19) 
 
 
5.2.2 Eye Irritation OECD SIDS    D- GLUCONIC ACID 
5. TOXICITY    ID: 526-95-4 
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Species:          rabbit 
Concentration:    50 % 
Dose:             .1 ml 
Exposure Time:    4 hour(s) 
No. of Animals:   9 
Vehicle:          water 
Result:           not irritating 
EC classificat.:  not irritating 
 
Method:           Draize Test 
  Year:           1984 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Method:           For the in vivo eye irritation test, 9 New Zealand white 
                  albinos rabbits were used. 
 
                  The eyes of the animals are examined before testing and only 
                  those animals without observable eye defects are used. 0.1 
                  ml of the test substance is allowed to fall on the everted 
                  lower lid of one eye of each rabbit; the upper and lower eye 
                  lid are then carefully closed and subsequently held together 
                  for at least one second before releasing.  The other eye, 
                  untreated, serves as a control. 
 
                  Their eyes of 3 rabbits were not washed out after the 
                  instillation of the test substance. The eyes of the other 6 
                  animals are washed out with 20 ml lukewarm water after 2 
                  seconds (3 animals) or after 4 seconds (3 animals).  The 
                  eyes are examined at 1, 24, 48, 72 hours and 7 days after 
                  instillation of the test material or until the eye effects 
                  have cleared up completely.  Ocular reactions are scored 
                  with the Draize Method. 
 
                  The in vitro assessment of eye irritating properties of the 
                  test material was made in enucleated rabbit eyes, placed in 
                  superfusion chambers at 32°C.  The test material was applied 
                  to 4 eyes and the effects were observed with a Haag-Streit 
                  slit lamp biomicroscope, over a period of 4 hours following 
                  the application. 
Result:           Eye irritation (in vivo) 
                  ------------------------ 
                  The test material generally caused slight redness and slight 
                  swelling of the conjuctivae.  After 72 hours, these effects 
                  had cleared up. 
 
 
                  Individual scores awarded to the ocular lesions elicited by 
                  gluconic acid (50% in water) 
                  *********************************************************** 
                  After one hour: 
                  _______________ 
 
                  Rabbit /cornea      /Iris /Conjunctivae     /Discharge/ Total 
                  Number /opacity area/    /redness - chemosis/         / score 
                  -------/------------/----/------------------/--------/------- 
                  2044   / 0      0   / 0  / 2           1    /   0    /  6 OECD SIDS    D- GLUCONIC ACID 
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                  2100   / 0      0   / 1  / 1           1    /   1    /  11 
                  2101   / 0      0   / 0  / 1           1    /   0    /  4 
                  ************************************************************ 
 
                  After 24 hours: 
                  _______________ 
 
                  Rabbit /cornea      /Iris /Conjunctivae     /Discharge/ Total 
                  Number /opacity area/    /redness - chemosis/         / score 
                  -------/------------/----/------------------/--------/------- 
                  2044   / 0       0  / 0  / 1          1     /   0    /    4 
                  2100   / 0       0  / 0  / 1          1     /   0    /    4 
                  2101   / 0       0  / 0  / 1          0     /   0    /    2 
                  ************************************************************ 
 
                  After 48 hours: 
                  _______________ 
 
                  Rabbit /cornea      /Iris /Conjunctivae     /Discharge/ Total 
                  Number /opacity area/    /redness - chemosis/         / score 
                  -------/------------/----/------------------/--------/------- 
                  2044   / 0       0  / 0  / 1          1     /   0    /    4 
                  2100   / 0       0  / 0  / 1          1     /   0    /    4 
                  2101   / 0       0  / 0  / 1          0     /   0    /    2 
                  ************************************************************ 
 
                  After 72 hours: 
                  _______________ 
 
                  Rabbit /cornea      /Iris /Conjunctivae     /Discharge/ Total 
                  Number /opacity area/    /redness - chemosis/         / score 
                  -------/------------/----/------------------/--------/------- 
                  2044   / 0       0  / 0  / 0          0     /   0    /    0 
                  2100   / 0       0  / 0  / 0          0     /   0    /    0 
                  2101   / 0       0  / 0  / 0          0     /   0    /    0 
 
 
                  Eye irritation (in vitro) 
                  ------------------------- 
                  During the course of the 4 hours after treatment cornea 
                  swelling was 4% and slight permeability of the superficial 
                  epithelial cell layers of the cornea was observed.  These 
                  effects were not considered to be of any toxicological 
                  significance. 
Test substance:   gluconic acid, 50% solution in water (pH of the test 
                  material: 1.8) 
Reliability:      (1)  valid without restriction 
Flag:             Critical study for SIDS endpoint 
25-JAN-2006                                                                 (19) 
 
 
5.3 Sensitization 
 
 
5.4 Repeated Dose Toxicity 
 
Type:                    Sub-acute 
Species:                 rat                               Sex: male/female OECD SIDS    D- GLUCONIC ACID 
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Strain:                  Crj: CD(SD) 
Route of administration: gavage 
Exposure period:         4 weeks 
Frequency of treatment:  daily 
Doses:                   0, 500, 1000, 2000 mg/kg bw 
Control Group:           yes, concurrent no treatment 
NOAEL:                   = 1000 mg/kg bw 
NOAEL females :          = 2000 mg/kg bw 
 
Method:           other: no data 
  Year:           1995 
   GLP:           no data 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under sodium 
                  gluconate SIDS dossier 
Test substance:   sodium gluconate 
Reliability:      (2)  valid with restrictions 
                  Secondary litterature but described in sufficient detail ina 
                  recognised WHO report.  Acceptable for initial assessment. 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                 (17) 
 
 
Type:                    Sub-acute 
Species:                 rat                               Sex: 
Strain:                  no data 
Route of administration: oral feed 
Exposure period:         10 days 
Frequency of treatment:  daily 
Doses:                   400 mg/kg/day 
Control Group:           no data specified 
 
Method:           other: no data specified 
  Year:           1942 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Result:           No effect on the metabolic rate.  Also, sodium and magnesium 
                  gluconate were fed at a level of 450 mg/kg/day and the 
                  metabolic rate reduced.  However, the rate returned to 
                  normal when the gluconate feeding was discontinued. These 
                  results suggest that the observed effects were produced by 
                  the cations and not by the gluconate portion of the 
                  molecule. 
Test substance:   gluconic acid 
Reliability:      (3)  invalid 
                  secondary litterature 
14-NOV-2005                                                                  (1) 
 
Type:                    Sub-acute 
Species:                 human                             Sex: no data 
Route of administration: oral unspecified 
Exposure period:         3-6 days 
Frequency of treatment:  no data 
Doses:                   5-10 g/day 
Control Group:           no data specified 
 OECD SIDS    D- GLUCONIC ACID 
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Method:           other: no data specified 
  Year:           1941 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Result:           Oral administration  of gluconic acid at doses of 5-10 g/day 
                  for periods varying from 3 to 6 days to five volunteers 
                  induced no renal changes, i.e. no blood, protein, casts, or 
                  sugar was observed in the urine. 
Test substance:   gluconic acid 
Reliability:      (3)  invalid 
                  old study 
14-NOV-2005                                                                  (2) 
 
 
Type:                    Sub-acute 
Species:                 other: cats and dogs              Sex: no data 
Strain:                  no data 
Route of administration: gavage 
Exposure period:         14 days 
Frequency of treatment:  daily 
Doses:                   1 g gluconic acid (10% solution) 
Control Group:           no data specified 
 
Method:           other: not specified 
  Year:           1941 
   GLP:           no 
Test substance:   as prescribed by 1.1 - 1.4 
 
Method:           5 cats and 3 dogs received a daily dose of 1 g gluconic acid 
                  (10% solution) by stomach intubation for 14 days. 
Result:           No changes were observed in general appearance or in the 
                  urine of either species.  Several incidences of vomiting and 
                  diarrhoea were reported in 3 of the cats.  Gross examination 
                  of the lungs, heart, liver, kidneys, gastrointestinal tract, 
                  urinary bladder, ureter, and spleen of treated animals 
                  showed that they were normal.  No histological abnormalities 
                  were observed in the livers, lungs, or kidneys.  The blood 
                  pressure of cats given intravenous injections of gluconic 
                  acid and ammonium gluconate (500 mg/kg) fell temporarily but 
                  returned to normal within 5 minutes. 
Test substance:   gluconic acid 
Reliability:      (3)  invalid 
14-NOV-2005                                                                  (2) 
 
 
5.5 Genetic Toxicity 'in Vitro' 
 
Type:                    other: Saccharomyces Cerevisiae and Salmonella 
                         typhimurium reverse mutation assay 
System of testing:       bacterial and non bacterial 
Concentration:           bacteria: 0.006%, 0.0012 %,  0.0024 % and yeast: 1.25%, 
                         2.50% and 5.00% 
Cytotoxic Concentration: 50% survival in bacteria calculated was at 0.0024 % 
                         test substance and 5% for yeast 
Metabolic activation:    with and without 
Result:                  negative 
 OECD SIDS    D- GLUCONIC ACID 
5. TOXICITY    ID: 526-95-4 
   DATE:  25.1.2006 
 
 UNEP  PUBLICATIONS  65
Method:           OECD Guide-line 471 
  Year:           1975 
   GLP:           no data 
Test substance:   other TS 
 
Remark:           This study was conducted using 3 bacteria strains 
                  (salmonella typhimurium) and one yeast strain (saccharomyces 
                  cervisiae) rather than a fourth bacteria strain as 
                  indicators for this in vitro microbial assay with and 
                  without metabolic activation.  Therefore, the results of 
                  this report on bacteria and yeast are included in the same 
                  entry. 
 
                  Data for the category: see details of study under sodium 
                  gluconate SIDS dossier. 
Test substance:   sodium gluconate 
Reliability:      (2)  valid with restrictions 
                  OECD guideline  No. 471 followed except that the study was 
                  made on one yeast strain : saccharomyces cerevisiae, strain 
                  D4 and 3 bacteria strains: S. typhimurium TA1535, TA1537 and 
                  TA 1538. 
 
                  Positive controls different from the ones described in the 
                  OECD guideline No 471. 
 
                  The study was made only on 3 test concentrations. 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                 (13) 
 
 
5.6 Genetic Toxicity 'in Vivo' 
 
Type:             other: in vivo chromosomal aberration test with mouse bone 
                  marrow cells 
Species:          mouse                             Sex: male 
Strain:           C57BL 
Route of admin.:  oral feed 
Exposure period:  single dose and 4 days 
Doses:            single dose administration : 2.5, 5 and 10 g/kg. 
                  4 day repeated dose: 1.25 and 2.5 g/kg 
Result:           negative 
 
Method:           other: no data specified 
  Year:           1974 
   GLP:           no data 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under sodium 
                  gluconate SIDS dossier. 
Test substance:   sodium gluconate 
Reliability:      (2)  valid with restrictions 
                  translation of a report not fully documented but acceptable 
                  for initial assessment 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                 (21) 
 
 
5.7 Carcinogenicity OECD SIDS    D- GLUCONIC ACID 
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5.8.1 Toxicity to Fertility 
 
 
5.8.2 Developmental Toxicity/Teratogenicity 
 
Species:                   rat                               Sex: female 
Strain:                    Wistar 
Route of administration:   gavage 
Exposure period:           from day 6 to day 15 of gestation 
Frequency of treatment:    daily 
Duration of test:          10 days 
Doses:                     0, 5.94, 27.6, 128.0, 594.0 mg/kg 
Control Group:             yes, concurrent vehicle 
NOAEL Maternal Toxity:     > 594 mg/kg bw 
NOAEL Teratogenicity:      > 594 mg/kg bw 
Result:                    non teratogen 
 
Method:           other: no data specified 
  Year:           1973 
   GLP:           no data 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under 
                  glucono-delta-lactone SIDS dossier. 
Test substance:   Glucono-delta-lactone 
Reliability:      (1)  valid without restriction 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                  (4) 
 
Species:                   mouse                             Sex: female 
Strain:                    CD-1 
Route of administration:   gavage 
Exposure period:           from day 6 to day 15 of gestation 
Frequency of treatment:    daily 
Duration of test:          10 days 
Doses:                     0, 6.95, 32.5, 150, 695 mg/kg 
Control Group:             yes, concurrent vehicle 
NOAEL Maternal Toxity:     > 695 mg/kg bw 
NOAEL Teratogenicity:      > 695 mg/kg bw 
Result:                    non teratogen 
 
Method:           other: no data specified 
  Year:           1973 
   GLP:           no 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under 
                  glucono-delta-lactone SIDS dossier. 
Test substance:   Glucono-delta-lactone 
Reliability:      (1)  valid without restriction 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                  (4) 
 
 
 
Species:                   rabbit                            Sex: female OECD SIDS    D- GLUCONIC ACID 
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Strain:                    Dutch 
Route of administration:   gavage 
Exposure period:           from day 6 to 18 of gestation 
Frequency of treatment:    daily 
Duration of test:          13 days 
Doses:                     0, 7.80, 36.2, 168.5, 780.0 mg/kg 
Control Group:             yes, concurrent vehicle 
NOAEL Maternal Toxity:     > 780 mg/kg bw 
NOAEL Teratogenicity:      > 780 mg/kg bw 
Result:                    non teratogen 
 
Method:           other: no data specified 
  Year:           1973 
   GLP:           no 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under 
                  glucono-delta-lactone SIDS dossier. 
Test substance:   Glucono-delta-lactone 
Reliability:      (1)  valid without restriction 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                  (4) 
 
Species:                   hamster                           Sex: female 
Route of administration:   gavage 
Exposure period:           from day 6 to day 10 of gestation 
Frequency of treatment:    daily 
Duration of test:          5 days 
Doses:                     0, 5.60, 26.0, 121, 560 mg/kg 
Control Group:             yes, concurrent vehicle 
NOAEL Maternal Toxity:     > 560 mg/kg bw 
NOAEL Teratogenicity:      > 560 mg/kg bw 
Result:                    non teratogen 
 
Method:           other: no data specified 
  Year:           1973 
   GLP:           no 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under 
                  glucono-delta-lactone SIDS dossier. 
Test substance:   Glucono-delta-lactone 
Reliability:      (1)  valid without restriction 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                  (3) 
 
 
 
Species:                   rat                               Sex: female 
Strain:                    Sprague-Dawley 
Route of administration:   oral unspecified 
Exposure period:           from day 6 to day 15 of gestation 
Frequency of treatment:    daily 
Duration of test:          10 days 
Doses:                     1000 and 4000 mg/kg 
Control Group:             no data specified 
NOAEL Maternal Toxity:     > 4000 mg/kg bw 
NOAEL Teratogenicity:      > 4000 mg/kg bw OECD SIDS    D- GLUCONIC ACID 
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Result:                    non teratogen 
 
Method:           other: no data specified 
  Year:           1978 
   GLP:           no data 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under 
                  glucono-delta-lactone SIDS dossier. 
Test substance:   Glucono-delta-lactone 
Reliability:      (2)  valid with restrictions 
                  short abstract but acceptable for initial assessment 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                  (6) 
 
Species:                   mouse                             Sex: female 
Strain:                    ICR 
Route of administration:   oral unspecified 
Exposure period:           from day 6 to day 15 of gestation 
Frequency of treatment:    daily 
Duration of test:          10 days 
Doses:                     1000 and 4000 mg/kg 
Control Group:             no data specified 
NOAEL Maternal Toxity:     > 4000 mg/kg bw 
NOAEL Teratogenicity:      > 4000 mg/kg bw 
Result:                    non teratogen 
 
Method:           other: no data specified 
  Year:           1978 
   GLP:           no data 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under 
                  glucono-delta-lactone SIDS dossier. 
Test substance:   Glucono-delta-lactone 
Reliability:      (2)  valid with restrictions 
                  short abstract but acceptable for initial assessment 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                  (7) 
 
 
5.8.3 Toxicity to Reproduction, Other Studies 
 
 
5.9 Specific Investigations 
 
 
5.10 Exposure Experience 
 
 
5.11 Additional Remarks 
 
Type:             Excretion 
 
Remark:           Effect of gluconic acid on the urine of human subjects: 
 
                  Oral administration  of gluconic acid at doses of 5-10 g/day 
                  for periods varying from 3 to 6 days to five volunteers OECD SIDS    D- GLUCONIC ACID 
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                  induced no renal changes, i.e. no blood, protein, casts, or 
                  sugar was observed in the urine.  The results show that 
                  gluconic acid produces no signs of renal injury, judged in 
                  this way. 
 
                  Oral administrations of 10-30 g gluconic acid showed that 
                  the excretion varies from 7.7 to 15 % of the dose in the 24 
                  hours, the major part of the excretion taking place within 
                  the first few hours.  The concentration in urine at 10-30 g 
                  doses was extremely variable, ranging fro 0.03 to .4 %, 
                  usually, however, less than 0.5 % 
 
                  Effect of gluconic acid on the pH of the urine: 
 
                  10 - 50 g doses gluconic acid were given at one time to 10 
                  persons, 5 with and 5 without a urinary infection and marked 
                  variation of the average pH of the urine examined.  In 
                  normal urine, the pH usually decined.  In infected urine, a 
                  decline rarely occurred and the usual response was a rise of 
                  the pH.  A similar resistance of infected urine to 
                  acidification by intravenous injections of gluconic acid in 
                  human beings was reported by Bodon. (1936) 
Reliability:      (3)  invalid 
                  Secondary litterature. Old study, not well documented 
 
14-NOV-2005                                                                  (2) 
 
Type:             Metabolism 
 
Remark:           D-gluconic acid and its 1,5-lactone are important 
                  intermediates in carbohydrate metabolism.  These compounds 
                  serve two important functions: 
 
                  (1) they contribute to the synthesis of reduced 
                  nicotinamide-adenine dinucleotide phosphate (NADPH), which 
                  is required in the biosynthesis of fatty acids and steroids, 
                  and 
 
                  (2) they lead to the formation of ribose-5-phosphate, which 
                  is used in nucleic acid synthesis. 
Reliability:      (2)  valid with restrictions 
                  Data from Handbook or collection of data. 
 
14-NOV-2005                                                                 (23) 
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1.0.1 Applicant and Company Information 
 
Type:             lead organisation 
Name:             The Gluconic acid and its sodium, potassium and calcium salts 
                  and glucono-delta-lactone consortium 
Contact Person:   Jean-Philippe Montfort    Date: 02-APR-2003 
Street:           Rue Blanche 25 
Town:             1060 Brussels 
Country:          Belgium 
Phone:            +32 2 541 05 70 
Telefax:          + 32 2 541 05 80 
Email:            montfort@khlaw.be 
 
Remark:           Sponsor Country for this Category: Belgium; Co-sponsor 
                  country: Japan. 
12-DEC-2005 
 
Type:             manufacturer 
Name:             FUSO Chemical Co. Ltd 
Contact Person:   Ph.D. Shinichi Sugita     Date: 
Street:           Iwamoto-cho Toyo Building, 1-2 Iwamoto-cho 3-chome, Chiyoda-ku 
Town:             101 0032  Tokyo 
Country:          Japan 
Phone:            +81 3 5820 1611 
Telefax:          +81 3 5820 1634 
Email:            Shinichi.Sugita@fusokk.co.jp 
 
03-AUG-2004 
 
Type:             manufacturer 
Name:             Jungbunzlauer International AG 
Contact Person:   Raphaël Singer            Date: 17-APR-2003 
Street:           St. Alban-Vorstadt 90 
Town:             4002 Basel 
Country:          Switzerland 
Phone:            +41 61 295 51 25 
Telefax:          +41 61 295 52 66 
Email:            raphael.singer@jungbunzlauer.ch 
 
17-OCT-2003 
 
Type:             manufacturer 
Name:             Roquette Freres 
Contact Person:   Johnny Pallot             Date: 
Town:             62080 Lestrem Cedex 
Country:          France 
Phone:            +33 3 21 63 37 40 
Telefax:          +33 3 21 63 38 50 
Email:            JOHNNY.PALLOT@roquette.com 
 
31-JUL-2003 
 
 
Type:             manufacturer 
Name:             PURAC 
Contact Person:   Ton van Dongen            Date: 
Street:           PO BOX 21 
Town:             4200 AA Gorinchem OECD SIDS    D-GLUCONO-1,5-LACTONE 
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Country:          Netherlands 
Phone:            +31 183 695 730 
Telefax:          +31 183 695 603 
Email:            t.van.dongen@purac.com 
 
03-AUG-2004 
 
 
1.0.2 Location of Production Site, Importer or Formulator 
 
 
1.0.3 Identity of Recipients 
 
 
1.0.4 Details on Category/Template 
 
 
Remark:           Glucono-delta-lactone, gluconic acid and its sodium, calcium 
                  and potassium salts have been proposed in a category, as the 
                  salts of gluconic acid freely dissociate to the gluconate 
                  anion and the respective cation. 
 
                  Glucono-delta-lactone (GDL) is the inner ester of gluconic 
                  acid formed by the removal of water. 
 
                  When glucono-delta-lactone is used in aqueous solution, it 
                  is slowly hydrolysed until an equilibrium is reached between 
                  gluconic acid and its delta-lactone. 
12-AUG-2004 
 
 
1.1.0 Substance Identification 
 
IUPAC Name:       D-gluconic acid, .delta. -lactone 
Smiles Code:      O=C ( OC (C (O) C1O) CO) C1O 
Mol. Formula:     C6H10O6 
Mol. Weight:      178.14 
 
10-AUG-2004 
 
 
1.1.1 General Substance Information 
 
Purity type:      typical for marketed substance 
Substance type:   organic 
Physical status:  solid 
Purity:           ca. 99 - 101 % w/w 
Colour:           white 
Odour:            neutral 
 
Remark:           Glucono-delta-lactone (GDL) is the inner ester of gluconic 
                  acid formed by the removal of water.  GDL is commercially 
                  produced by an aerobic oxidising fermentation process to 
                  convert a carbohydrate source into gluconic acid.  After 
                  fermentation a blend of gluconic acid and GDL is separated 
                  by crystallisation. 
 
                          oxidation                   crystallisation OECD SIDS    D-GLUCONO-1,5-LACTONE 
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                  Glucose -----------> gluconic acid <================> GDL 
 
                          1/2 O2                       -H2O 
                  C6H12O6 -----------> C6H12O7     <================> C6H10O6 
                                                       +H2O 
10-NOV-2005                                                                 (21) 
 
 
1.1.2 Spectra 
 
 
1.2 Synonyms and Tradenames 
 
D(-)-Pentahydroxycaproic acid-1,5-lactone 
 
25-JUN-2003 
 
Glucono-1,5-lactone 
 
25-JUN-2003 
 
glucono-delta-lactone 
 
25-JUN-2003 
 
pentahydroxycaproic acid 1,5-lactone 
 
25-JUN-2003 
 
 
1.3 Impurities 
 
Purity type:      typical for marketed substance 
 
Remark:           For food applications the level of impurities complies with 
                  the restrictions laid down in the corresponding EU 
                  Directives. 
19-JAN-2004 
 
 
1.4 Additives 
 
 
Remark:           For all the chemicals of the category: no additives used 
10-NOV-2005 
 
 
1.5 Total Quantity 
 
Quantity:         ca. 10000 - 20000 tonnes produced in 2000 
 
Remark:           Estimation of the worldwide market. 
Flag:             confidential 
10-AUG-2004 
 
Quantity:         > 1000 tonnes produced in 1999 
 
Remark:           Estimated production capacity for glucono-delta-lactone in OECD SIDS    D-GLUCONO-1,5-LACTONE 
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                  Western Europe. 
Flag:             confidential 
10-NOV-2005                                                                 (29) 
 
 
1.6.1 Labelling 
 
 
Remark:           For all the chemicals in the category: proposal of Industry: 
                  no labelling required 
10-NOV-2005 
 
 
1.6.2 Classification 
 
Classified:       other, as in legislation 
 
Remark:           For all chemicals of the category: proposal of Industry: no 
                  classification required 
10-NOV-2005 
 
 
1.6.3 Packaging 
 
 
1.7 Use Pattern 
 
Type:             type 
Category:         Wide dispersive use 
 
Remark:           Data for the category: see sodium gluconate 
14-AUG-2003 
 
 
1.7.1 Detailed Use Pattern 
 
 
1.7.2 Methods of Manufacture 
 
 
1.8 Regulatory Measures 
 
 
1.8.1 Occupational Exposure Limit Values 
 
 
1.8.2 Acceptable Residues Levels 
 
 
1.8.3 Water Pollution 
 
 
1.8.4 Major Accident Hazards 
 
 
1.8.5 Air Pollution 
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1.8.6 Listings e.g. Chemical Inventories 
 
 
1.9.1 Degradation/Transformation Products 
 
 
1.9.2 Components 
 
 
1.10 Source of Exposure 
 
Source of exposure: other 
 
Remark:             Data for the category: see sodium gluconate 
14-AUG-2003 
 
 
1.11 Additional Remarks 
 
 
Remark:           In the European Parliament and Council Directive 95/2/EC 
                  glucono-delta-lactone is listed as a generally permitted 
                  food additive (E 575) and may be added to all foodstuffs, 
                  following the "quantum satis" principle, as long as no 
                  special regulations restrict the use. 
 
                  The US Food and Drug Administration (FDA) assigned 
                  glucono-delta-lactone the "generally recognised as safe" 
                  (GRAS) status and permitted its use in food  without 
                  limitation other than good manufacturing practice (21 CFR, 
                  §184.1318). 
10-AUG-2004 
 
1.12 Last Literature Search 
 
 
12-AUG-2004 
 
 
1.13 Reviews 
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2.1 Melting Point 
 
Decomposition:    yes at = 153 degree C 
 
Method:           other: no data specified 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Reliability:      (2)  valid with restrictions 
                  Data from Handbook or collection of data. 
Flag:             Critical study for SIDS endpoint 
12-AUG-2004                                                                 (30) 
 
Decomposition:    yes at = 153 degree C 
 
Method:           other: no data 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Reliability:      (4)  not assignable 
                  Data from an MSDS. No data on method used. 
Flag:             Critical study for SIDS endpoint 
12-AUG-2004                                                                  (4) 
 
Value:            ca. 153 degree C 
 
Method:           other: no data specified 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Reliability:      (4)  not assignable 
                  Data from an MSDS. No data on method used. 
Flag:             Critical study for SIDS endpoint 
12-AUG-2004                                                                 (22) 
 
Value:            ca. 153 degree C 
Decomposition:    yes at > 180 degree C 
 
Method:           other: no data specified 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Reliability:      (4)  not assignable 
                  Data from an MSDS. No data on method used. 
Flag:             Critical study for SIDS endpoint 
12-AUG-2004                                                                 (13) 
 
 
2.2 Boiling Point 
 
Value:            = 398.5 degree C 
 
Method:           other: calculated 
   GLP:           no 
Test substance:   as prescribed by 1.1 - 1.4 
 
Remark:           Estimated with MPBPWIN (v1.41) program from US EPA (EPI 
                  v3.11) OECD SIDS    D-GLUCONO-1,5-LACTONE 
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Reliability:      (2)  valid with restrictions 
                  Accepted calculation method 
Flag:             Critical study for SIDS endpoint 
10-AUG-2004 
 
 
2.3 Density 
 
Type:             relative density 
Value:            = 1.68 
 
Method:           other: no data 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Reliability:      (4)  not assignable 
                  Data from an MSDS. No data on method used. 
Flag:             Critical study for SIDS endpoint 
10-AUG-2004                                                                  (4) 
 
Type:             bulk density 
Value:            = 800 kg/m3 
 
Method:           other: no data 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Reliability:      (4)  not assignable 
                  Data from an MSDS. No data on method used. 
Flag:             Critical study for SIDS endpoint 
10-AUG-2004                                                                 (13) 
 
Type:             bulk density 
Value:            ca. 800 kg/m3 
 
Method:           other: no data 
   GLP:           no 
Test substance:   as prescribed by 1.1 - 1.4 
 
Reliability:      (4)  not assignable 
                  Data from an MSDS. No data on method used. 
Flag:             Critical study for SIDS endpoint 
10-AUG-2004                                                                 (22) 
 
 
2.3.1 Granulometry 
 
 
2.4 Vapour Pressure 
 
Value:            = .00000000241 hPa 
 
Method:           other (calculated) 
   GLP:           no 
Test substance:   as prescribed by 1.1 - 1.4 
 
Remark:           Estimated with MPBPVP (v1.41) program from US EPA (EPI 
                  v3.11): OECD SIDS    D-GLUCONO-1,5-LACTONE 
2. PHYSICO-CHEMICAL DATA    ID: 90-80-2 
   DATE:  25.1.2006 
 
 UNEP  PUBLICATIONS  80
 
                  Vapor Pressure Estimations (25 deg C): 
                    (Using BP: 398.51 deg C (estimated)) 
                    (Using MP: 153.00 deg C (user entered)) 
                      VP:  2.5E-010 mm Hg (Antoine Method) 
                      VP:  1.81E-009 mm Hg (Modified Grain Method) 
                      VP:  1E-006 mm Hg (Mackay Method) 
                    Selected VP:  1.81E-009 mm Hg = 2.41E-009 hPa (Modified 
                  Grain Method) 
Result:           Selected VP:  1.81E-009 mm Hg = 2.41E-009 hPa (Modified 
                  Grain Method) 
Reliability:      (2)  valid with restrictions 
                  Accepted calculation method 
Flag:             Critical study for SIDS endpoint 
10-AUG-2004 
 
 
2.5 Partition Coefficient 
 
Partition Coeff.: octanol-water 
log Pow:          = -1.98 
 
Method:           other (calculated) 
   GLP:           no 
 
Remark:           Estimated with Kowwin  (v1.67) program from US EPA (EPI 
                  v3.11) 
Reliability:      (2)  valid with restrictions 
                  Accepted calculation method 
Flag:             Critical study for SIDS endpoint 
10-AUG-2004 
 
 
2.6.1 Solubility in different media 
 
Solubility in:    Water 
Value:            = 590 g/l at 25 degree C 
 
Method:           other: no data 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Reliability:      (2)  valid with restrictions 
                  Data from Handbook or collection of data 
Flag:             Critical study for SIDS endpoint 
10-AUG-2004                                                                 (30) 
 
Solubility in:    other: alcohol 
Value:            ca. 10 g/l at 25 degree C 
 
Method:           other: no data specified 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Reliability:      (2)  valid with restrictions 
                  Data from Handbook or collection of data. 
Flag:             Critical study for SIDS endpoint 
12-AUG-2004                                                                 (30) OECD SIDS    D-GLUCONO-1,5-LACTONE 
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Solubility in:    Water 
Value:            ca. 500 g/l at 20 degree C 
pH       value:   = 4 
         Conc.:   1 vol% degree C 
 
 
Remark:           pH = 2.6 after 2 hours (equilibrium with gluconic acid of 
                  the 1% solution is reached after 2 hours) 
Reliability:      (4)  not assignable 
                  Data from an MSDS. No data on method used. 
Flag:             Critical study for SIDS endpoint 
10-AUG-2004                                                                 (13) 
 
Solubility in:    Water 
Value:            ca. 500 g/l at 20 degree C 
pH       value:   ca. 4 
         Conc.:   1 vol% degree C 
 
Method:           other: no data 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Remark:           pH: approximately 4 at 1%, approximately 2.6 after 2 hours 
Reliability:      (4)  not assignable 
                  Data from an MSDS. No data on method used. 
Flag:             Critical study for SIDS endpoint 
10-AUG-2004                                                                 (22) 
 
Solubility in:    Water 
Value:            = 590 g/l 
 
Method:           other: no data 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Reliability:      (4)  not assignable 
                  Data from an MSDS. No data on method used. 
Flag:             Critical study for SIDS endpoint 
10-AUG-2004                                                                  (4) 
 
Solubility in:    Water 
Value:            ca. 900 g/l at 20 degree C 
 
Method:           other: no data 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Reliability:      (2)  valid with restrictions 
                  Data from Handbook or collection of data 
Flag:             Critical study for SIDS endpoint 
12-AUG-2004                                                                 (32) 
 
 
2.6.2 Surface Tension 
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2.7 Flash Point 
 
 
2.8 Auto Flammability 
 
 
2.9 Flammability 
 
 
2.10 Explosive Properties 
 
 
2.11 Oxidizing Properties 
 
 
2.12 Dissociation Constant 
 
Acid-base Const.: pKA = 3.70 
 
Method:           other: no data 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Reliability:      (2)  valid with restrictions 
                  Data from Handbook or collection of data 
Flag:             Critical study for SIDS endpoint 
10-AUG-2004                                                                 (32) 
 
 
2.13 Viscosity 
 
 
2.14 Additional Remarks 
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3.1.1 Photodegradation 
 
Type:             air 
Deg. products:    not measured 
 
Method:           other (calculated): Estimated with AOP (v1.91) program from US 
                  EPA (EPI v3.11) 
   GLP:           no 
Test substance:   as prescribed by 1.1 - 1.4 
 
Remark:           Estimated with AOP (v1.91) program from US EPA (EPI v3.11) 
 
                  OVERALL OH Rate Constant =  32.4111 E-12 cm3/molecule-sec 
 
                  HALF-LIFE =     0.330 Days (12-hr day; 1.5E6 OH/cm3) 
                  HALF-LIFE =     3.960 Hrs 
Reliability:      (2)  valid with restrictions 
                  Accepted calculation method 
Flag:             Critical study for SIDS endpoint 
12-AUG-2004 
 
 
3.1.2 Stability in Water 
 
Type:             abiotic 
 
Method:           other: no data 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Remark:           When glucono-delta-lactone is used in aqueous solution, it 
                  is slowly hydrolysed until a balance is reached between 
                  gluconic acid and its delta-lactone. (see attached 
                  document). 
 
                  At an initial concentration of 10% glucono-delta-lactone, 
                  the equilibrium gluconate-lactone is 80/20. 
 
                  At 25°C, glucono-delta-lactone in solution in water at a 
                  concentration of w/w 0.75% has an equilibrium pH of 2.5-2.7. 
 
                  When an alkaline product is added, the equilibrium is upset 
                  and all the lactone is converted into acid. 
Attached doc.:    hydrolysis rate of GDL at pH 6 and 7 (see attached document) 
Reliability:      (4)  not assignable 
                  Data from commercial brochures. No data on method used. 
Flag:             Critical study for SIDS endpoint 
25-JAN-2006                                                             (5) (23) 
 
 
3.1.3 Stability in Soil 
 
 
3.2.1 Monitoring Data (Environment) 
 
 
3.2.2 Field Studies 
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3.3.1 Transport between Environmental Compartments 
 
Type:             fugacity model level III 
Media:            other 
Method:           other: calculated 
 
Remark:           Estimated with the Level III Fugacity Model program LEVEL3NT 
                  from US EPA (EPI v3.11) 
 
                  Chem Name   : D-Gluconic acid, .delta.-lactone 
                  Molecular Wt: 178.14 
                  Henry's LC  : 1.38e-009 atm-m3/mole (Henrywin program) 
                  Vapor Press : 1.81e-009 mm Hg  (Mpbpwin program) 
                  Liquid VP   : 3.34e-008 mm Hg  (super-cooled) 
                  Melting Pt  : 153 deg C (user-entered) 
                  Log Kow     : -1.98  (Kowwin program) 
                  Soil Koc    : 0.00429  (calc by model) 
                  ------------------------------------------------------ 
                            Mass Amount    Half-Life    Emissions 
                            (percent)        (hr)       (kg/hr) 
                  ------------------------------------------------------ 
                  Air       0.8             7.92         1000 
                  Water     46.8            208          1000 
                  Soil      52.3            208          1000 
                  Sediment  0.0698          832          0 
                  _______________________________________________________ 
 
                  ------------------------------------------------------------ 
                  -------- 
                            Fugacity    Reaction    Advection   Reaction 
                  Advection 
                            (atm)      (kg/hr)      (kg/hr)    (percent) 
                  (percent) 
                  ------------------------------------------------------------ 
                  -------- 
                  Air       2.59e-013    461         52.7        15.4 
                  1.76 
                  Water     1.19e-014    1.03e+003   308         34.2 
                  10.3 
                  Soil      4.95e-013    1.15e+003   0           38.3        0 
                  Sediment  8.91e-015    0.383       0.0092      0.0128 
                  0.000307 
                  ____________________________________________________________ 
                  ________ 
 
                  Persistence Time: 220 hr 
                  Reaction Time:    250 hr 
                  Advection Time:   1.83e+003 hr 
                  Percent Reacted:  88 
                  Percent Advected: 12 
                  Half-Lives (hr), (based upon Biowin (Ultimate) and Aopwin): 
                  Air:      7.92 
                  Water:    208.1 
                  Soil:     208.1 
                  Sediment: 832.3 
                  Biowin estimate: 3.586  (days-weeks  ) 
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                  Air:      100 
                  Water:    1000 
                  Sediment: 5e+004 
Reliability:      (2)  valid with restrictions 
                  Accepted calculation method 
Flag:             Critical study for SIDS endpoint 
10-AUG-2004 
 
3.3.2 Distribution 
 
Media:            air - biota - sediment(s) - soil - water 
Method:           other (calculation) 
 
Result:           Henry's law constant estimated with HENRY (v3.10) program 
                  from US EPA (EPI v3.11) 
 
                  HENRYs LAW CONSTANT at 25 deg C = 1.38E-009 atm-m3/mole 
 
                  ---------------------------------------------------------- 
                  Soil Adsorption Coefficient estimated with PCKOC (v1.66) 
                  program from US EPA (EPI v3.11) 
 
                  First Order Molecular Connectivity Index   :  5.575 
                  Non-Corrected Log Koc   :  3.5876 
                  Fragment Correction(s): 
                  2   Aliphatic Alcohol  (-C-OH)   : -3.0386 
                  1   Ester  (-C-CO-O-C-) or (HCO-O-C)  : -1.3089 
                  Corrected Log Koc  : -0.7599 
                  Over Correction Adjustment to Lower Limit Log Koc :  1.0000 
 
                  Estimated Koc:  10 
Reliability:      (2)  valid with restrictions 
                  Accepted calculation method 
Flag:             Critical study for SIDS endpoint 
10-AUG-2004 
 
 
3.4 Mode of Degradation in Actual Use 
 
 
3.5 Biodegradation 
 
Type:             aerobic 
Inoculum:         other: secondary effluent of a municipal sewage plant 
                  (Breisgauer Bucht, 500000 population equivalent), 0.4 ml/l 
Concentration:    3 mg/l related to Test substance 
Contact time:     28 day(s) 
Degradation:      = 89 % after 28 day(s) 
Result:           readily biodegradable 
Kinetic:              3 day(s)    = 61.13 % 
                      7 day(s)    = 74.35 % 
                     14 day(s)    = 66.09 % 
                     21 day(s)    = 71.94 % 
                     28 day(s)    = 88.88 % 
Control Subst.:   Acetic acid, sodium salt 
Kinetic:               3 day(s)    = 67.15 % 
                      28 day(s)    = 80.93 % 
Deg. product:     not measured OECD SIDS    D-GLUCONO-1,5-LACTONE 
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Method:           Directive 92/69/EEC, C.4-E 
  Year:           2001 
   GLP:           yes 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under  sodium 
                  gluconate SIDS dossier. 
                  The 89% degradation indicated here relates to the 
                  Theoritical Oxygen Demand (ThOD) 
Test substance:   Sodium gluconate: 99.0-101.0% 
Reliability:      (1)  valid without restriction 
                  study conducted according to OECD guidelines, valid 
                  test,quality assurance and GLP certificates 
Flag:             Critical study for SIDS endpoint 
10-NOV-2005                                                                 (11) 
 
Type:             anaerobic 
Inoculum:         other: Digesting sludge of a municipal sewage plant 
                  (Breisgauer Bucht, 500000 population equivalent), 2.9 g total 
                  solids/l 
Concentration:    303 mg/l related to Test substance 
Contact time:     35 day(s) 
Degradation:      = 100 % after 35 day(s) 
Result:           readily biodegradable 
Kinetic:              1 day(s)    = 8 % 
                      8 day(s)    = 51 % 
                     15 day(s)    = 57 % 
                     22 day(s)    = 61 % 
                     35 day(s)    = 100 % 
Control Subst.:   Benzoic acid, sodium salt 
Kinetic:               8 day(s)    = 6 % 
                      35 day(s)    = 100 % 
Deg. product:     not measured 
 
Method:           other: DIN EN ISO 11734 
  Year:           2001 
   GLP:           yes 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under  sodium 
                  gluconate SIDS dossier. 
Test substance:   Sodium gluconate 
Reliability:      (1)  valid without restriction 
                  study conducted according to OECD guidelines, valid 
                  test,quality assurance and GLP certificates 
Flag:             Critical study for SIDS endpoint 
10-NOV-2005                                                                 (12) 
 
 
3.6 BOD5, COD or BOD5/COD Ratio 
 
 
3.7 Bioaccumulation 
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AQUATIC ORGANISMS 
 
 
4.1 Acute/Prolonged Toxicity to Fish 
 
Type:             semistatic 
Species:          Oryzias latipes  (Fish, fresh water) 
Exposure period:  96 hour(s) 
Unit:             mg/l                   Analytical monitoring: yes 
NOEC:             > 100 - 
LC0:              > 100 - 
Limit Test:       yes 
 
Method:           OECD Guide-line 203  "Fish, Acute Toxicity Test" 
  Year:           2002 
   GLP:           yes 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under  sodium 
                  gluconate SIDS dossier. 
Test substance:   sodium gluconate : 99.6% 
Reliability:      (1)  valid without restriction 
                  study conducted according to OECD guidelines, valid 
                  test,quality assurance and GLP certificates 
Flag:             Critical study for SIDS endpoint 
10-NOV-2005                                                                 (16) 
 
Type:             other 
Species:          other: no data 
Exposure period:  48 hour(s) 
Unit:             mg/l                   Analytical monitoring: no data 
LC0:              = 250 - 
LC50:             = 360 - 
LC100:            = 400 - 
Limit Test:       no 
 
Method:           other:  DIN 38 412 L15 
  Year:           1992 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Result:           Due to the hydrolysis of the glucono-delta-lactone to 
                  gluconic acid, the pH was reduced and therefore the LC50 and 
                  LC100 observed are not related to the toxicity of the 
                  substance but rather due to the non physiologic  conditions 
                  (pH= 4). 
Test substance:   Glucono-delta-lactone 
Reliability:      (3)  invalid 
                  short abstract, no data on species, unphysiologic 
                  conditions, no OECD guidelines 
10-NOV-2005                                                                 (26) 
 
 
4.2 Acute Toxicity to Aquatic Invertebrates 
 
Type:             static 
Species:          Daphnia magna  (Crustacea) 
Exposure period:  48 hour(s) OECD SIDS    D-GLUCONO-1,5-LACTONE 
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Unit:             mg/l                   Analytical monitoring: yes 
NOEC:             > 1000 - 
EC100:            > 1000 - 
Limit Test:       yes 
 
Method:           OECD Guide-line 202 
  Year:           2002 
   GLP:           yes 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under sodium 
                  gluconate SIDS dossier. 
Test substance:   sodium gluconate : 99.6% 
Reliability:      (1)  valid without restriction 
                  study conducted according to OECD guidelines, valid 
                  test,quality assurance and GLP certificates 
Flag:             Critical study for SIDS endpoint 
10-NOV-2005                                                                 (17) 
 
Type:             static 
Species:          Daphnia magna  (Crustacea) 
Exposure period:  24 hour(s) 
Unit:             mg/l                   Analytical monitoring: no data 
EC50:             = 305 - 
Limit Test:       no 
 
Method:           other:  DIN 38 412 -L 30 
  Year:           1997 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Result:           At 200 mg/l, all daphnia kept their swimming capabilities. 
                  At 250 mg/l, 7 daphnia kept their swimming capabilities. 
                  At 333 mg/l, none of the daphnia kept their swimming 
                  capabilities. 
 
                  The EC calculated for glucono-delta-lactone was 305 mg/l. 
 
                  The report also refers to the GD value = dilution level 
                  where minimum 90% of the daphnia survived 
 
                   = > Due to the GD value = 5 (at 200 mg/l 100% daphnia 
                  survived); glucono-delta-lactone was considered to be weak 
                  toxic. 
Test condition:   Species: daphnia magna 
                  Biomass loading: 2 groups of  5 daphnias 
                  Test concentration : 1 g/l 
                  T°: 20°C 
                  PH: 3.17 
Test substance:   glucono-delta-lactone 
 
Reliability:      (3)  invalid 
                  short abstract, no OECD guidelines 
10-NOV-2005                                                                 (27) 
 
 
4.3 Toxicity to Aquatic Plants e.g. Algae 
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Species:          Selenastrum capricornutum  (Algae) 
Endpoint:         growth rate 
Exposure period:  72 hour(s) 
Unit:             mg/l                   Analytical monitoring: yes 
NOEC:             = 560 - 
EC50:             > 1000 - 
Limit Test:       yes 
 
Method:           OECD Guide-line 201  "Algae, Growth Inhibition Test" 
  Year:           2002 
   GLP:           yes 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under  sodium 
                  gluconate SIDS dossier. 
Test substance:   Sodium gluconate: 99.6% 
Reliability:      (1)  valid without restriction 
                  study conducted according to OECD guidelines, valid 
                  test,quality assurance and GLP certificates 
Flag:             Critical study for SIDS endpoint 
10-NOV-2005                                                                 (18) 
 
Species:          Scenedesmus subspicatus  (Algae) 
Endpoint:         biomass 
Exposure period:  72 hour(s) 
Unit:             mg/l                   Analytical monitoring: no data 
EC50:             > 1000 - 
Limit Test:       no 
 
Method:           other: DIN 38412 - L33 
  Year:           1997 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Result:           GA = smallest dilution where inhibition of biomass 
                  production is reduced by 20% = > GA= 2 
 
                  Dilution  Measured value  pH  % inhibition 
                  1    11.3    6.02  30 
                  2    13.4    6.46  -15* 
                  3    13.3      -36.7* 
 
                  * negative value = increase of the biomass production 
Test condition:   Incubation:  72 h 
                  T°: 23°C. 
                  Measurement of chlorophylle fluorescence: lambda = 450- 685 
                  nm 
                  Concentration of test: 1 g/l 
                  pH= 3.09 
Test substance:   Glucono-delta-lactone 
Reliability:      (3)  invalid 
                  short abstract, no OECD guidelines 
10-NOV-2005                                                                 (24) 
 
 
4.4 Toxicity to Microorganisms e.g. Bacteria 
 
Species:          Pseudomonas putida  (Bacteria) OECD SIDS    D-GLUCONO-1,5-LACTONE 
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Exposure period:  16 hour(s) 
Unit:             mg/l                   Analytical monitoring: no data 
EC0:              > 500 - 
 
Method:           other:  DIN 38 412 L8 
  Year:           1992 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Result:           0-500 mg/l: stimulation of growth 
                  > 500 mg/l: inhibition of growth due to the high 
                  concentration of glucono-delta-lactone that hydrolyses into 
                  the acid and reduces the pH (3.2-3.3). 
Test condition:   Exposure period: 16 h (+/- 1 h incubation) 
                  Temperature: 21°C 
                  Limit test: yes 
                  2 range of concentration tested: 
                  0-500 mg/l 
                  > 500 mg/l 
                  The pH was corrected to reach a value between 6 and 8. 
Test substance:   Glucono-delta-lactone 
Reliability:      (3)  invalid 
                  short abstract, no OECD guidelines 
10-NOV-2005                                                                 (25) 
 
 
4.5 Chronic Toxicity to Aquatic Organisms 
 
4.5.1 Chronic Toxicity to Fish 
 
 
4.5.2 Chronic Toxicity to Aquatic Invertebrates 
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TERRESTRIAL ORGANISMS 
 
 
4.6.1 Toxicity to Sediment Dwelling Organisms 
 
Species:          other 
 
 
Remark:           No data available but exposure in sediment expected to be 
                  extremely limited according to the Level III Fugacity Model 
                  program LEVEL3NT from US EPA (EPI v3.11). 
10-AUG-2004 
 
 
4.6.2 Toxicity to Terrestrial Plants 
 
 
Method:           other 
 
Remark:           no data available 
14-AUG-2003 
 
 
4.6.3 Toxicity to Soil Dwelling Organisms 
 
 
Method:           other 
 
Remark:           no data available but due to the low intrinsic toxicity in 
                  aquatic organisms, it is reasonable to expect a similar low 
                  toxic impact on terrestrial organisms. 
10-AUG-2004 
 
 
4.6.4 Toxicity to other Non-Mamm. Terrestrial Species 
 
 
4.7 Biological Effects Monitoring 
 
 
4.8 Biotransformation and Kinetics 
 
 
4.9 Additional Remarks 
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5.0 Toxicokinetics, Metabolism and Distribution 
 
In Vitro/in vivo:              In vivo 
Type:                          Absorption 
Species:                       rat 
 
 
 
Method:           other: no data specified 
  Year:           1979 
   GLP:           no 
Test substance:   as prescribed by 1.1 - 1.4 
 
Method:           Radioactivity was measured in the blood of normal and 
                  alloxan diabetic rats, after oral administration of 
                  [U-14C]gluconate and [U-14C]glucono-delta-lactone (0.8 
                  g/kg), respectively. 
 
                  Radioactivity was also measured in the intestinal contents 
                  and feces 5 h after ingestion of the radioactive materials. 
Result:           glucono-delta-lactone is absorbed more rapidly from the 
                  intestine than sodium gluconate.  A higher retention in 
                  tissues and a greater loss in urine was also observed after 
                  administration of the lactone.  Incorporation into liver 
                  glycogen is also higher from the lactone than from the 
                  gluconate, particularly in diabetic animals. 
 
                  Initial oxidation occurred after 7 h with the gluconate and 
                  4 h for the lactone.  The oxidative turnover of lactone and 
                  gluconate was significantly enhanced in diabetic animals. 
                  The better utilisation in diabetic metabolism is in part 
                  explainable by a rise of glycolitic intermediates in the 
                  liver, which are decreased in starvation and diabetes. 
Test substance:   glucono-delta-lactone 
Reliability:      (4)  not assignable 
                  Secondary literature 
14-NOV-2005                                                                 (28) 
 
 
5.1 Acute Toxicity 
 
 
5.1.1 Acute Oral Toxicity 
 
Type:             LDLo 
Species:          rat 
Strain:           Crj: CD(SD) 
Sex:              male/female 
No. of Animals:   10 
Vehicle:          no data 
Doses:            500, 1000, 2000 mg/kg 
Value:            > 2000 mg/kg bw 
 
Method:           other: no data 
  Year:           1995 
   GLP:           no data 
Test substance:   other TS 
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Test substance:   Sodium gluconate 
Reliability:      (2)  valid with restrictions 
                  Short abstract not well documented but key study for initial 
                  assessment. 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                 (19) 
 
Type:             LD50 
Species:          rat 
Strain:           no data 
Sex:              no data 
Vehicle:          no data 
Doses:            no data 
Value:            = 5940 mg/kg bw 
 
Method:           other: no data specified 
  Year:           1973 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Test substance:   glucono-delta-lactone 
Reliability:      (4)  not assignable 
                  These are only results reported in another review paper.  No 
                  other data are available 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                 (33) 
 
Type:             LD50 
Species:          mouse 
Strain:           no data 
Sex:              no data 
Vehicle:          no data 
Doses:            no data 
Value:            = 6800 mg/kg bw 
 
Method:           other: no data specified 
  Year:           1973 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Test substance:   glucono-delta-lactone 
Reliability:      (4)  not assignable 
                  These are only results reported in another review paper.  No 
                  other data are available. 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                 (33) 
 
Type:             LD50 
Species:          rabbit 
Strain:           no data 
Sex:              no data 
Vehicle:          no data 
Doses:            no data 
Value:            = 7850 mg/kg bw 
 
Method:           other: no data specified 
  Year:           1973 
   GLP:           no data OECD SIDS    D-GLUCONO-1,5-LACTONE 
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Test substance:   as prescribed by 1.1 - 1.4 
 
Test substance:   glucono-delta-lactone 
Reliability:      (4)  not assignable 
                  These are only results reported in another review paper.  No 
                  other data are available. 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                 (33) 
 
Type:             LD50 
Species:          hamster 
Strain:           no data 
Sex:              no data 
Vehicle:          no data 
Doses:            no data 
Value:            = 5600 mg/kg bw 
 
Method:           other: no data specified 
  Year:           1973 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Test substance:   glucono-delta-lactone 
Reliability:      (4)  not assignable 
                  These are only results reported in another review paper.  No 
                  other data are available. 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                 (33) 
 
 
5.1.2 Acute Inhalation Toxicity 
 
 
5.1.3 Acute Dermal Toxicity 
 
 
5.1.4 Acute Toxicity, other Routes 
 
 
5.2 Corrosiveness and Irritation 
 
 
5.2.1 Skin Irritation 
 
Species:          other: no data on glucono-delta-lactone. See gluconic acid 
 
 
10-AUG-2004 
 
 
5.2.2 Eye Irritation 
 
Species:          other: no data on glucono-delta-lactone. See gluconic acid 
 
 
10-AUG-2004 
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5.3 Sensitization 
 
 
5.4 Repeated Dose Toxicity 
 
Type:                    Sub-acute 
Species:                 rat                               Sex: male/female 
Strain:                  Crj: CD(SD) 
Route of administration: gavage 
Exposure period:         4 weeks 
Frequency of treatment:  daily 
Doses:                   0, 500, 1000, 2000 mg/kg bw 
Control Group:           yes, concurrent no treatment 
NOAEL:                   = 1000 mg/kg bw 
NOAEL :                  = 2000 mg/kg bw 
 
Method:           other: no data 
  Year:           1995 
   GLP:           no data 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under  sodium 
                  gluconate SIDS dossier. 
Test substance:   Sodium gluconate 
Reliability:      (2)  valid with restrictions 
                  Secondary litterature but described in sufficient detail in 
                  a recognised International Organisation report.  Acceptable 
                  for assessment. 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                 (20) 
 
Type:                    Chronic 
Species:                 rat                               Sex: male/female 
Strain:                  Sprague-Dawley 
Route of administration: oral unspecified 
Exposure period:         6 months 
Frequency of treatment:  no data 
Doses:                   250, 500, 1000, 2000 and 4000 mg/kg 
Control Group:           no data specified 
 
Method:           other: no data specified 
  Year:           1978 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Result:           In all dose groups, thickening of the stratified squamous 
                  epithelium was detected at the anterior stomach, 
                  particularly the transitional area continuous with the 
                  pyloric stomach, and the frequency and severity of this 
                  thickening increased with dose.  In high dose groups, 
                  submucosal inflammatory cell infiltration was also detected, 
                  but this change was not statistically significant.  The 
                  above changes seemed to represent irritation due to the 
                  drug. 
 
                  No other abnormalities likely to be associated with the drug 
                  were detected, and there was no death. 
Test condition:   10 males and 10 females tested. OECD SIDS    D-GLUCONO-1,5-LACTONE 
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                  During the period of treatment, observation of the general 
                  condition, measurement of body weight and food consumption 
                  and urinalysis were carried out. 
 
                   At the end of treatment, animals were sacrificed, and blood 
                  specimen were collected for hematological and chemical 
                  analyses. 
 
                  Major organs were observed grossly, weighed and examined 
                  histopathologically. 
Test substance:   glucono-delta-lactone 
Reliability:      (2)  valid with restrictions 
                  only abstract, no data on control group, GLP, method, 
                  frequency of exposure 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                  (7) 
 
Type:                    Chronic 
Species:                 rat                               Sex: male/female 
Strain:                  Wistar 
Route of administration: oral feed 
Exposure period:         24 months 
Frequency of treatment:  no data 
Doses:                   2.5 % (1240-1350 mg/kg bw) and 10% (4920-5760  mg/kg) 
                         doses (30 males and 30 females tested) 
Control Group:           no data specified 
 
Method:           other: no data 
  Year:           1978 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Result:           In test diet groups, no abnormalities were observed in the 
                  general condition throughout the period of testing, but 
                  weight gain tended to be slightly reduced since 2-3 months 
                  after the initiation of the test feeding in 10% GDL group. 
                  There was no statistically siginificant difference in the 
                  number of deaths 
                  and the time to death between the test diet and the control 
                  groups. 
 
                  Histopathological examination showed changes accompanying 
                  ageing were observed in all groups including the control, 
                  but no specific changes likely to be associated with the 
                  test diet were detected.  Tumor development occurred 
                  considerably frequently, but tumor induction by the drug was 
                  not detected. 
Test condition:   The rats were fed with pellets containing 2.5% and 10 % 
                  concentration of glucono-delta-lactone.  The total intake of 
                  the drug during testing was 1240-1350 mg/kg bw for the group 
                  receiving 2.5% GDL and 4920-5760 mg/kg bw for the group 
                  receiving 10 % in the pellets. 
Test substance:   glucono-delta-lactone 
Reliability:      (2)  valid with restrictions 
                  only abstract, no data on control group, GLP, frequency of 
                  exposure 
Flag:             Critical study for SIDS endpoint OECD SIDS    D-GLUCONO-1,5-LACTONE 
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14-NOV-2005                                                                  (6) 
 
Type:                    Chronic 
Species:                 rat                               Sex: male/female 
Strain:                  no data 
Route of administration: other: diet 
Exposure period:         26 weeks 
Doses:                   0 and 500 mg/kg bw 
Control Group:           no data specified 
NOAEL:                   > 500 mg/kg bw 
 
Method:           other: no data specified 
  Year:           1962 
   GLP:           no 
Test substance:   as prescribed by 1.1 - 1.4 
 
Result:           No reported adverse effects and no histopathological 
                  findings. 
Test substance:   glucono-delta-lactone 
Reliability:      (3)  invalid 
                  only secondary litterature + old study 
14-NOV-2005                                                                  (2) 
 
Type:                    Sub-acute 
Species:                 human                             Sex: no data 
Strain:                  no data 
Route of administration: oral feed 
Exposure period:         3-6 days 
Frequency of treatment:  daily 
Doses:                   80-170mg/kg/day 
Control Group:           no data specified 
 
Method:           other: no data specified 
  Year:           1941 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Method:           Oral doses of GDL (80-170mg/kg/day) were administered to 5 
                  healthy human subjects for 3-6 days. 
Result:           There was no sign of renal injury as judged by examining 
                  urine for protein, casts, blood cells, pus cells and sugar. 
Test substance:   glucono-delta-lactone 
Reliability:      (3)  invalid 
                  old study 
14-NOV-2005                                                                  (1) 
 
5.5 Genetic Toxicity 'in Vitro' 
 
Type:                    other: Saccharomyces Cerevisiae and Salmonella 
                         typhimurium 
System of testing:       bacterial and non bacterial 
Concentration:           bacteria: 0.25%, (2.5 µg/ml) and 0.50% (5 µg/ml) (0.50% 
                         plate test) and yeast: 1.25% (12.5 µg/ml) and 2.50% (25 
                         µg/ml) 
Cytotoxic Concentration: 50% survival in bacteria calculated was at 1% (10 
                         µg/ml) test substance and 5% (50 µg/ml) for yeast 
Metabolic activation:    with and without 
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Method:           OECD Guide-line 471 
  Year:           1974 
   GLP:           no 
Test substance:   as prescribed by 1.1 - 1.4 
 
Method:           A. Toxicity: 
 
                  The solubility, toxicity and doses for all chemicals were 
                  determined prior to screening. 
 
                  Each chemical was tested for survival against strains 
                  TA-1537 and D4 over a range of doses  to determine the 50% 
                  survival dose.  Bacteria were tested in phosphate buffer, pH 
                  7.4 for one hour at 37°c on a shaker. 
 
                  Yeasts were tested in phosphate buffer, pH 7.4 for 4 hours 
                  at 30°c on a shaker.  The 50% survival curve and the 1/4 and 
                  1/2 50% doses calculated.  If no toxicity was obtained for a 
                  chemical with a given strain, a maximum dose of 5% (w/v) was 
                  used. 
 
                  The doses calculated for the tests in buffer were applied to 
                  the activation tests.  The solubility of the test substance 
                  under treatment conditions  was measured and GDL is soluble 
                  in 0.067 M phosphate buffer, pH 7.4 (solvent used for this 
                  compound) 
 
 
                  --------------------------------------------- 
                  B. Plate tests 
 
                  Approximately 10 exp9 cells from a log phase culture of each 
                  strain were spread over the surface of a minimal plate, and 
                  a measured amount of the test chemical was placed in the 
                  center of the test plate. 
 
 
                  In activation tests, the test chemical was added to the 
                  cells, and an aliquot of the mixture was spread on the 
                  surface o fhte test plate. The reaction mixture (0.1 ml) 
                  plus tissue extract was then spotted on hte surface of the 
                  plate. 
 
                  The plates were incubated for 4 days at 37°C, and 
                  scored.  Positive and 
                  solvent controls were run with each assay. 
                  ------------------------------------------------ 
                  C.  Suspension tests 
 
                  1. Nonactivation 
 
                  Log phase bacteria and stationary phase yeast cultures were 
                  grown in complete broth, washed and resuspended in 0.9% 
                  saline to densities of  1 x 10 exp9 cells/ml and 5 x 10 exp7 
                  cells/ml respectively.  Tests were conducted in plastic 
                  tissue culture plates. Cells plus chemicals were added to 
                  the wells to give a final volume of 2 ml.  The solvent OECD SIDS    D-GLUCONO-1,5-LACTONE 
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                  replaced the test chemical in the negative controls. 
 
                  Treatment was at 30°C for 4 hours for yeast tests and at 
                  37°c for one hour for bacterial tests.  All flasks were 
                  shaken during treatment.  After treatments, the plates were 
                  set on ice.  Aliquots of cells were removed, diluted in 
                  sterile saline (4°c) and plated on the appropriate complete 
                  media.  Undiluted samples from flasks containing the 
                  bacteria were plated on minimal selective medium in 
                  reversion experiments.  Samples from a 1/10 dilution of 
                  treated cells were plated on the selected media for 
                  enumeration of gene conversion with strain D4. 
 
                  Bacterial plates were scored after incubation for 48 hours 
                  at 37°C.  The yeast plates were incubated at 30°C for 3-5 
                  days before scoring. 
 
                  2. Activation 
 
                  Bacteria and yeast cells were grown and prepared as 
                  described in the nonactivation tests except that the cell 
                  densities were increased approximately 5 x for working stock 
                  suspensions.  Measured amounts of the test and control 
                  chemicals plus 0.25 ml of the stock cell suspension were 
                  added to a 30 ml plastic tissue homogenate.  All flasks were 
                  incubated at 37°C with shaking. 
Remark:           This study was conducted using 3 bacteria strains 
                  (salmonella typhimurium) and one yeast strain (saccharomyces 
                  cervisiae) rather than a fourth bacteria strain as 
                  indicators for this in vitro microbial assay with and 
                  without metabolic activation.  Therefore, the results of 
                  this report on bacteria and yeast are included in the same 
                  entry. 
Result:           Glucono-delta-lactone was not genetically active, either 
                  directly or in the presence of organ homogenates, in any of 
                  the in vitro assays employed in this evaluation. 
Test condition: 
                  Strains  tested: 
 
                  Yeast: Saccharomyces Cerevisiae, Strain D4 
 
                  Bacteria: Salmonella typhimurium, strains: TA1535, TA1537, 
                  TA1538 
 
                  ------------------------------ 
                  Reaction mixture: 
 
                  Component:               Final concentration/ml 
                  TNP (sodium salt)               6 µM 
                  Isocitric acid                  49 µM 
                  Tris buffer, pH 7.4             28 µM 
                  MgCl2                           1.7 µM 
                  Isocitric dehydrogenase         6.3 units 
                  Tissue homogenate or cell fraction 
 
                  -------------------------------- 
                  Tissue homogenates and supernatants: 
 OECD SIDS    D-GLUCONO-1,5-LACTONE 
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                  The tissue homogenates and supernatants (9000 g) were 
                  prepared from tissues of mouse (ICR random bred adult 
                  males); rat (Sprague-Dawnley adult males) and monkey (Macaca 
                  mulatta adult males) 
                  --------------------------------- 
                  Positive controls in direct and activation assays: 
 
                  Non activation: 
 
                  Chemical                Solvent         Probable mutagenic 
                                                              specificity 
                     
                  Ethyl                   water or saline     base-pair 
                  methanesulfonate (EMS)                      substitution 
                  2-nitrofluorene  (NF)    dimethylsulfoxide   frameshift 
                  Quinacrine or           water or saline     frameshift 
                  quinacrinemustard (QM) 
                  *************************** 
                  Activation: 
 
                  Chemical                   Solvent       Probable mutagenic 
                                                               specificity 
                  Dimethylnitrosamine (DMN)  water or saline    base-pair 
                                                                substitution 
                  2-acetylaminofluorene (AAF) dimethylsulfoxide frameshift 
 
                  --------------------------------------------- 
                  Concentration of positive controls: 
 
                  Non activation: 
                  TA-1535  EMS 0.05ml/plate 
                  TA-1537 QM 0.25mg/plate 
                  TA-1538 NF 0.25 mg/plate 
 
                  Activation: 
                  TA-1535 DMN 25 µM/plate 
                  TA-1537 AAF  1.25 mg/plate 
                  TA-1538 AAF  1.25 µg 
 
Test substance:   glucono-delta-lactone 
Reliability:      (2)  valid with restrictions 
                  OECD guideline 471 requires that 5 strains of bacteria at 
                  least are tested: 4 strains of S. typhimurium (TA1535,TA1537 
                  or TA97 or TA97a, TA98, TA100) and E. Coli WP2 uvrAor E. 
                  Coli WP2uvrA (pKM101) or S.typhirmurium TA102. 
                  The study was made on one yeast strain : saccharomyces 
                  cerevisiae, strain D4 and 3 bacteria strains: S. 
                  typhimuriumTA1535, TA1537 and TA 1538 
 
 
                  Positive controls are different from the controls described 
                  in OECD guideline 471. 
 
 
 
                  At least 5 concentrations should be tested, the substance 
                  was only tested on 3 concentrations. 
Flag:             Critical study for SIDS endpoint OECD SIDS    D-GLUCONO-1,5-LACTONE 
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25-JAN-2006                                                                 (14) 
 
 
5.6 Genetic Toxicity 'in Vivo' 
 
Type:             other: in vivo chromosomal aberration test with mouse bone 
                  marrow cells 
Species:          mouse                             Sex: male 
Strain:           C57BL 
Route of admin.:  oral feed 
Exposure period:  single dose and 4 days 
Doses:            single dose administration : 2, 4 and 8 g/kg 
                  4 day repeated dose: 2 and 4 g/kg 
Result:           negative 
 
Method:           other: no data specified 
  Year:           1974 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Method:           After receiving the single dose and the repeated dose test 
                  substance, the animals were sacrified at 24 hours (single 
                  dose) and 27 hours after last administration (4-days 
                  repeated dose). 0.3 ml of 500 µg/ml colchicine was 
                  intraperitoneally injected to each mouse at one hour before 
                  sacrifice so that the metaphase cells could be observed. 
 
                  After the bone marrow cells were washed, treated and fixed 
                  with a fixing solution (1:3 acetic acid:ethanol solution), 
                  the cells were suspended and dripped on a slide glass and 
                  stained with Giemsa solution and examined. 
 
                  Examination: 
 
                  At least 200 metaphase cells per mouse were examined for the 
                  presence or absence of chromosomal aberrations (gaps, 
                  breaks, translocation, fragments, ring chromosomes and 
                  minutes chromosomes) 
Result:           Single dose administration: 
 
                  At 8 g/kg, all mice died. 
 
                  MMC induced chromosomal aberrations in at least 20% of bone 
                  marrow cells. 
 
                  GDL induced chromosomal aberrations in the 
                  cells at a frequency of about 0.5% comparable to the 
                  control. 
 
                  4-day repeated dose administration: 
 
                  MMC induced chromosomal aberrations at about 30% cells. 
 
                  The frequency of cells with chromosomal aberrations was 1 % 
                  or less in the test groups which is comparable to the 
                  control group. 
 
                  Induction of chromosomal aberration by GDL was OECD SIDS    D-GLUCONO-1,5-LACTONE 
5. TOXICITY    ID: 90-80-2 
   DATE:  25.1.2006 
 
 UNEP  PUBLICATIONS  102
                  not detected after in vivo single and repeated dose 
                  treatment. 
Test condition:   Animals: 
 
                  Male C57BL/6 mice aged 12 or 13 weeks 
 
                  Materials: 
 
                  Test substance: GDL dissolved with 0.9% 
                  physiological saline solution and orally administered at a 
                  dose of 1ml/mouse 
 
                  Positive control: MMC (mitomycin C) dissolved with 0.9% 
                  physiological saline solution and administered 
                  intraperitoneally at a dose of 0.5 ml/mouse 
 
                  ------------------------------------------------- 
                  Single dose administration : 
                  ------------------------------------------------- 
 
                  Control (physiological solution) : 
                  group 1 - 3 animals 
 
                  MMC:   
                  group 1 - 2 animals - 5 mg/kg (intraperitoneal) 
 
                  GDL : 
                  group 1 - 3 animals - 8 g/kg 
                  group 2 - 3 animals - 4 g/kg 
                  group 3 - 3 animals - 2 g/kg 
 
                  ------------------------------------------------ 
                  4-day repeated dose administration : 
 
                  ------------------------------------------------- 
 
 
                  Control (physiological solution) : 
                  group 1 - 2 animals 
 
                  MMC:   
                  group 1 - 2 animals - 5 mg/kg (single dose intraperitoneal) 
 
                  GDL : 
                  group 1 - 3 animals - 4 g/kg 
                  group 2 - 2 animals - 2 g/kg 
Test substance:   glucono-delta-lactone 
Reliability:      (2)  valid with restrictions 
                  Translation of a report.  No data on GLP, guidelines, 
                  conditions, mitotic index, but sufficient for initial 
                  assessment. 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                 (15) 
 
 
5.7 Carcinogenicity 
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5.8.1 Toxicity to Fertility 
 
 
5.8.2 Developmental Toxicity/Teratogenicity 
 
Species:                   rat                               Sex: female 
Strain:                    Wistar 
Route of administration:   gavage 
Exposure period:           from day 6 to day 15 of gestation 
Frequency of treatment:    daily 
Duration of test:          10 days 
Doses:                     0, 5.94, 27.6, 128.0, 594.0 mg/kg 
Control Group:             yes, concurrent vehicle 
NOAEL Maternal Toxity:     > 594 mg/kg bw 
NOAEL Teratogenicity:      > 594 mg/kg bw 
Result:                    non teratogen 
 
Method:           other: no data specified 
  Year:           1973 
   GLP:           no 
Test substance:   as prescribed by 1.1 - 1.4 
 
Result:           The administration of up to 594 mg/kg bw of GDL to pregnant 
                  rats for 10 consecutive days had no clearly 
                  discernible effect on nidation or on maternal or fetal 
                  survival.  The number of abnormalities seen in either soft 
                  or skeletal tissues of the test groups did not differ from 
                  the number occurring spontaneously in the sham-treated 
                  controls. 
 
Test condition:   Positive control: 250 mg/kg Aspirin 
 
                  Body weights  were recorded on days 0, 6, 11, 15 and 20 of 
                  gestation. On day 20, all dams were subjected to caesarean 
                  section and the numbers of implantation sites, resorption 
                  sites, and live and dead fetuses were recorded.Body weights 
                  of the live pups were also recorded.The urogenital tract of 
                  each dam was examined in detail for anatomical normality. 
                  All the fetuses were examined grossly for the presence of 
                  external congenital abnormalities. 1/3 of the fetuses of 
                  each litter underwent detailed visceral examinations 
                  employing the Wilson technique. The remaining 2/3 were 
                  cleared in KOH, stained with alizarin red S dye and examined 
                  for skeletal defects. 
Test substance:   glucono-delta-lactone 
Reliability:      (1)  valid without restriction 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                  (3) 
 
Species:                   mouse                             Sex: female 
Strain:                    CD-1 
Route of administration:   gavage 
Exposure period:           from day 6 to day 15 of gestation 
Frequency of treatment:    daily 
Duration of test:          10 days 
Doses:                     0, 6.95, 32.5, 150, 695 mg/kg 
Control Group:             yes, concurrent vehicle OECD SIDS    D-GLUCONO-1,5-LACTONE 
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NOAEL Maternal Toxity:     > 695 mg/kg bw 
NOAEL Teratogenicity:      > 695 mg/kg bw 
Result:                    non teratogen 
 
Method:           other: no data specified 
  Year:           1973 
   GLP:           no 
Test substance:   as prescribed by 1.1 - 1.4 
 
Result:           The administration of up to 695 mg/kg bw of GDL to 
                  pregnant mice for 10 consecutive days had no clearly 
                  discernibleeffect on nidation or on maternal or fetal 
                  survival.  The number of abnormalities seen in either soft 
                  or skeletal tissues of the test groups did not differ from 
                  the number occurring spontaneously in the sham-treated 
                  controls. 
Test condition:   Positive control: 150 mg/kg Aspirin 
 
                  Body weights were recorded on days 0, 6, 11, 15 and 17 
                  ofgestation.On day 17, all dams were subjected to caesarean 
                  section and the numbers of implantation sites, resorption 
                  sites, andlive and dead fetuses were recorded.Body weights 
                  of the live pups were also recorded.The urogenital tract of 
                  each dam was examined in detail foranatomical normality.All 
                  the fetuses were examined grossly for the presence 
                  ofexternal congenital abnormalities.1/3 of the fetuses of 
                  each litter underwent detailedvisceral examinations 
                  employing the Wilson technique.The remaining 2/3 were 
                  cleared in KOH, stained with alizarinred S dye and examined 
                  for skeletal defects. 
Test substance:   glucono-delta-lactone 
Reliability:      (1)  valid without restriction 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                  (3) 
 
Species:                   rabbit                            Sex: female 
Strain:                    Dutch 
Route of administration:   gavage 
Exposure period:           from day 6 to 18 of gestation 
Frequency of treatment:    daily 
Duration of test:          13 days 
Doses:                     0, 7.80, 36.2, 168.5, 780.0 mg/kg 
Control Group:             yes, concurrent vehicle 
NOAEL Maternal Toxity:     > 780 mg/kg bw 
NOAEL Teratogenicity:      > 780 mg/kg bw 
Result:                    non teratogen 
 
Method:           other: no data specified 
  Year:           1973 
   GLP:           no 
Test substance:   as prescribed by 1.1 - 1.4 
 
Result:           The administration of up to 780 mg/kg bw of GDL to pregnant 
                  rabbits for 13 consecutive days had no clearly discernible 
                  effect on nidation or on maternal or fetal survival. 
                  Thenumber of abnormalities seen in either soft or 
                  skeletal tissues of the test groups did not differ from the 
                  number occurring spontaneously in the sham-treated controls. OECD SIDS    D-GLUCONO-1,5-LACTONE 
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Test condition:   Positive control: 2.5 mg/kg 6-aminonicotinamide dosed on 
                  day 9. 
 
                  On day 0, each doe was given an injection of 0.4 ml 
                  of human chorionic gonadotropin (400 IU) via the marginal 
                  ear vein.  3 hours later, each doe was inseminated 
                  artificially with 0.3 ml of diluted semen using 
                  approximately 20 x 10exp6 motile sperm.  Beginning on day 6 
                  until day 18, the females were dosed by oral intubation. 
                  Body weights were recorded on days 0, 6, 12, 18 and 29 of 
                  gestation. On day 29, all does were subjected to caesarean 
                  section andthe numbers of corpora lutea, implantation sites, 
                  resorption sites, and live and dead fetuses were recorded. 
                  Body weights of the live pups were also recorded. The 
                  urogenital tract of each animal was examined in detail for 
                  normality.All the fetuses were examined grossly for the 
                  presence of external congenital 
                  abnormalities.The live fetuses of each litter were placed in 
                  an incubator for 4 hours for evaluation of neonatal 
                  survival.  All surviving pups were sacrificed and examined 
                  for visceral abnormalities. All fetuses were then cleared in 
                  KOH, stained with alizarin red S dye and examined for 
                  skeletal defects. 
Test substance:   glucono-delta-lactone 
Reliability:      (1)  valid without restriction 
 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                  (3) 
 
Species:                   hamster                           Sex: female 
Strain:                    no data 
Route of administration:   gavage 
Exposure period:           from day 6 to day 10 of gestation 
Frequency of treatment:    daily 
Duration of test:          5 days 
Doses:                     0, 5.60, 26.0, 121, 560 mg/kg 
Control Group:             yes, concurrent vehicle 
NOAEL Maternal Toxity:     > 560 mg/kg bw 
NOAEL Teratogenicity:      > 560 mg/kg bw 
Result:                    non teratogen 
 
Method:           other: no data specified 
  Year:           1973 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Result:           The administration of up to 560 mg/kg bw of GDL to 
                  pregnant hamsters for 5 consecutive days had no clearly 
                  discernible effect on nidation or on maternal or fetal 
                  survival.  The number of abnormalities seen in either soft 
                  or skeletal tissues of the test groups did not differ from 
                  the number occurring spontaneously in the sham-treated 
                  controls. 
Test condition:   Positive control: 50 mg/kg Aspirin 
 
                  Body weights were recorded on days 0, 6, 8, 10 and 14 of 
                  gestation. On day 14, all animals were subjected to 
                  caesarean section and the numbers of implantation sites, OECD SIDS    D-GLUCONO-1,5-LACTONE 
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                  resorption sites, and live and dead fetuses were 
                  recorded.Body weights of the live pups were also recorded. 
                  The urogenital tract of each dam was examined 
                  in detail for anatomical normality. All the fetuses were 
                  examined grossly for the presence of external congenital 
                  defects. 1/3 of the fetuses of each litter underwent 
                  detailed visceral examinations employing the Wilson 
                  technique. The remaining 2/3 were cleared in KOH, stained 
                  with alizarin red S dye and examined for skeletal defects. 
Test substance:   glucono-delta-lactone 
Reliability:      (1)  valid without restriction 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                  (3) 
 
 
Species:                   rat                               Sex: female 
Strain:                    Sprague-Dawley 
Route of administration:   oral unspecified 
Exposure period:           from day 6 to day 15 of gestation 
Frequency of treatment:    daily 
Duration of test:          10 days 
Doses:                     1000 and 4000 mg/kg 
Control Group:             no data specified 
NOAEL Maternal Toxity:     > 4000 mg/kg bw 
NOAEL Teratogenicity:      > 4000 mg/kg bw 
Result:                    non teratogen 
 
Method:           other: no data specified 
  Year:           1978 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Result:           During pregnancy, no abnormalities were observed in 
                  the general condition, body weight change or food 
                  consumption in any of the dose groups, nor were the deaths. 
                  In observation of dams after laparotomy, no abnormalities 
                  were detected in the number of implantations, dead fetuses, 
                  live offspring or mean body weight of offspring, nor was 
                  there any influence of the drug on the external appearance, 
                  organs, or skeletons of the fetuses. Observation of the dams 
                  allowed to deliver spontaneously, protraction of the 
                  duration of pregnancy or abnormalities at birth were not 
                  observed, nor any influence of the drug detected in the 
                  mortality rate, body weight gain, behavior,external 
                  appearance or visceral abnormalities of the offspring during 
                  the period of nursing. 
Test condition:   GDL was administered orally to female nulliparous rats for 
                  10 days and the fetuses were observed by laparotomy on 
                  pregnancy day 21.  Several dams in each group were 
                  allowed to deliver spontaneously, and the offspring were 
                  observed until postnatal day 21. 
Test substance:   glucono-delta-lactone 
Reliability:      (2)  valid with restrictions 
                  Short abstract but acceptable for initial assessment 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                  (9) 
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Species:                   mouse                             Sex: female 
Strain:                    ICR 
Route of administration:   oral unspecified 
Exposure period:           from day 6 to day 15 of gestation 
Frequency of treatment:    daily 
Duration of test:          10 days 
Doses:                     1000 and 4000 mg/kg 
Control Group:             no data specified 
NOAEL Maternal Toxity:     > 4000 mg/kg bw 
NOAEL Teratogenicity:      > 4000 mg/kg bw 
Result:                    non teratogen 
 
Method:           other: no data specified 
  Year:           1978 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Result:           During pregnancy, no abnormalities were observed in 
                  the general condition, body weight change or food 
                  consumption in any of the dose groups, nor were the deaths. 
                  In observation of dams after laparotomy, no abnormalities 
                  were detected in the number of implantations, dead fetuses, 
                  live offspring or mean body weight of offspring, nor was 
                  there any influence of the drug on the external 
                  appearance,organs, or skeletons of the fetuses. Observation 
                  of the dams allowed to deliver spontaneously, protraction of 
                  the duration of pregnancy or abnormalities atbirth were not 
                  observed, nor any influence of the drug detected in the 
                  mortality rate, body weight gain, behavior,external 
                  appearance or visceral abnormalities of the offspring during 
                  the period of nursing. 
Test condition:   GDL was administered orally to female nulliparous mice for10 
                  days and the fetuses were observed by laparotomy on damson 
                  pregnancy day 18.  Several dams in each group wereallowed to 
                  deliver spontaneously, and the offspring wereobserved until 
                  postnatal day 21. 
Test substance:   glucono-delta-lactone 
Reliability:      (2)  valid with restrictions 
                  Short abstract but acceptable for initial assessment 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                  (8) 
 
 
5.8.3 Toxicity to Reproduction, Other Studies 
 
 
5.9 Specific Investigations 
 
 
5.10 Exposure Experience 
 
 
5.11 Additional Remarks 
 
Type:             Biochemical or cellular interactions 
 
Remark:           GDL was reported to inhibit competitively mannosidase and 
                  glucosidase isolated from rat epididymis and limpet tissue OECD SIDS    D-GLUCONO-1,5-LACTONE 
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                  (Levvy et al. 1964).  These findings were confirmed using 
                  acid alpha-glucosidase from rabbits (Palmer, 1971). 
 
                  GDL is a non-competitive inhibitor of polysaccharide 
                  phosphorylase in in vitro assays (Tu et al., 1971) 
Reliability:      (3)  invalid 
                  only secondary litterature 
 
07-JUN-2003                                                                 (31) 
 
Type:             Excretion 
 
Remark:           16 persons (7 with urologic conditions) received doses of 5 
                  g glucono-delta-lactone every 2 hours up to total doses of 
                  15-25g daily for 2 days usually followed by a 2-day control 
                  period, then 10-25 g doses every 2 hours up to total doses 
                  of 20-50 g for an additional day. 
 
                  No consistent changes in the pH of the urine were 
                  detectable.  However, diarrhea was observed in 11 of the 16 
                  patients.  No other adverse effects were reported. 
Reliability:      (3)  invalid 
                  Secondary litterature 
 
14-NOV-2005                                                                 (10) 
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1.0.1 Applicant and Company Information 
 
Type:             lead organisation 
Name:             The Gluconic acid and its sodium, potassium and calcium salts 
                  and glucono-delta-lactone consortium 
Contact Person:   Jean-Philippe Montfort    Date: 02-APR-2003 
Street:           Rue Blanche 25 
Town:             1060 Brussels 
Country:          Belgium 
Phone:            +32 2 541 05 70 
Telefax:          + 32 2 541 05 80 
Email:            montfort@khlaw.be 
 
Remark:           Sponsor Country for this Category: Belgium; Co-sponsor 
                  country: Japan. 
12-DEC-2005 
 
Type:             manufacturer 
Name:             FUSO Chemical Co. Ltd 
Contact Person:   Ph.D. Shinichi Sugita     Date: 
Street:           Iwamoto-cho Toyo Building, 1-2 Iwamoto-cho 3-chome, Chiyoda-ku 
Town:             101 0032  Tokyo 
Country:          Japan 
Phone:            +81 3 5820 1611 
Telefax:          +81 3 5820 1634 
Email:            Shinichi.Sugita@fusokk.co.jp 
 
03-AUG-2004 
 
Type:             manufacturer 
Name:             Jungbunzlauer International AG 
Contact Person:   Raphaël Singer            Date: 17-APR-2003 
Street:           St. Alban-Vorstadt 90 
Town:             4002 Basel 
Country:          Switzerland 
Phone:            +41 61 295 51 25 
Telefax:          +41 61 295 52 66 
Email:            raphael.singer@jungbunzlauer.ch 
 
17-OCT-2003 
 
Type:             manufacturer 
Name:             Roquette Freres 
Contact Person:   Johnny Pallot             Date: 
Town:             62080 Lestrem Cedex 
Country:          France 
Phone:            +33 3 21 63 37 40 
Telefax:          +33 3 21 63 38 50 
Email:            JOHNNY.PALLOT@roquette.com 
 
31-JUL-2003 
 
Type:             manufacturer 
Name:             PURAC 
Contact Person:   Ton van Dongen            Date: 
Street:           PO BOX 21 
Town:             4200 AA Gorinchem 
Country:          Netherlands OECD SIDS    SODIUM GLUCONATE 
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Phone:            +31 183 695 730 
Telefax:          +31 183 695 603 
Email:            t.van.dongen@purac.com 
 
03-AUG-2004 
 
 
1.0.2 Location of Production Site, Importer or Formulator 
 
 
1.0.3 Identity of Recipients 
 
 
1.0.4 Details on Category/Template 
 
 
Remark:           Glucono-delta-lactone, gluconic acid and its sodium, calcium 
                  and potassium salts have been proposed in a category, as the 
                  salts of gluconic acid freely dissociate to the gluconate 
                  anion and the respective cation. 
 
                  Glucono-delta-lactone (GDL) is the inner ester of gluconic 
                  acid formed by the removal of water. 
 
                  When glucono-delta-lactone is used in aqueous solution, it 
                  is slowly hydrolysed until an equilibrium is reached between 
                  gluconic acid and its delta-lactone. 
12-AUG-2004 
 
 
1.1.0 Substance Identification 
 
IUPAC Name:       sodium gluconate 
Smiles Code:      [Na]OC (=O) C (O) C (O) C (O) C(O) CO 
Mol. Formula:     C6H11NaO7 
Mol. Weight:      218.14 
Petrol Class:     other: N/A 
 
Attached doc.:    sodium gluconate.bmp 
03-AUG-2004 
 
 
1.1.1 General Substance Information 
 
Purity type:      typical for marketed substance 
Substance type:   organic 
Physical status:  solid 
Purity:           ca. 98 - 102 % w/w 
Colour:           white/ off white 
Odour:            none 
 
Remark:           Sodium gluconate is the sodium salt of gluconic acid.  It 
                  forms stable chelates with iron, aluminium, calcium, zinc 
                  and other heavy metals, especially in alkaline solution.  It 
                  possesses good sequestering activity in cleaning baths and 
                  is highly stable, even in concentrated alkaline solutions. 
03-AUG-2004 
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1.1.2 Spectra 
 
 
1.2 Synonyms and Tradenames 
 
D-Gluconic acid, monosodium salt 
 
02-MAY-2003 
 
sodium pentahydroxy-capronate 
 
17-APR-2003 
 
 
1.3 Impurities 
 
Purity type:      typical for marketed substance 
 
Remark:           For food applications the level of impurities complies with 
                  the restrictions laid down in the corresponding EU 
                  Directives. 
19-JAN-2004 
 
 
1.4 Additives 
 
 
Remark:           For all the chemicals of the category: no additives used 
10-NOV-2005 
 
 
1.5 Total Quantity 
 
Quantity:         ca. 50000 - 70000 tonnes produced in 2000 
 
Remark:           Estimation of the worldwide market per year. There is no 
                  production in Belgium. 
Flag:             confidential 
03-AUG-2004 
 
Quantity:         > 32000 tonnes produced in 1999 
 
Remark:           Estimated production capacities for gluconates in Western 
                  Europe. 
10-NOV-2005                                                                 (40) 
 
Quantity:         = - 5500 tonnes produced in 1998 
 
Remark:           Japanese production of gluconic acid and salts (sodium salt 
                  basis) 
10-NOV-2005                                                                 (39) 
 
 
1.6.1 Labelling 
 
 
Remark:           For all the chemicals in the category: proposal of Industry: OECD SIDS    SODIUM GLUCONATE 
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                  no labelling required 
10-NOV-2005 
 
 
1.6.2 Classification 
 
Classified:       other, as in legislation 
 
Remark:           For all chemicals of the category: proposal of Industry: no 
                  classification required 
10-NOV-2005 
 
 
1.6.3 Packaging 
 
 
1.7 Use Pattern 
 
Type:             type 
Category:         Non dispersive use 
 
Remark:           The listed uses cover all the members of the category. 
 
                  The main non dispersive applications are industrial 
                  cleaning, metal surface treatment, textile bleach stabiliser 
                  and aluminium processing.For potential volumes, see under 
                  1.10 Source of exposure. 
03-AUG-2004 
 
Type:             type 
Category:         Wide dispersive use 
 
Remark:           The wide dispersive applications are chelating agents in 
                  cement set retarding, institutional and household cleaning, 
                  personal care, pharmaceuticals and foodstuffs. For potential 
                  volumes, see under 1.10 Source of exposure 
03-AUG-2004 
 
 
1.7.1 Detailed Use Pattern 
 
 
1.7.2 Methods of Manufacture 
 
 
1.8 Regulatory Measures 
 
 
1.8.1 Occupational Exposure Limit Values 
 
 
1.8.2 Acceptable Residues Levels 
 
 
1.8.3 Water Pollution 
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1.8.4 Major Accident Hazards 
 
 
1.8.5 Air Pollution 
 
 
1.8.6 Listings e.g. Chemical Inventories 
 
 
1.9.1 Degradation/Transformation Products 
 
 
1.9.2 Components 
 
 
1.10 Source of Exposure 
 
Source of exposure: Human: exposure by production 
Exposure to the:    Substance 
 
Remark:             Gluconic acid is produced by a fermentation process using 
                    dextrose as a raw material. After the fermentation process 
                    the product is separated from the rest of the broth by 
                    filtration, followed by demineralization and discoloration. 
                    After a concentration step the material is then crystallized 
                    to obtain glucono-delta-lactone on one side and the run off 
                    on the other side. Separation happens in a centrifuge. The 
                    run off material is gluconic acid. It can be sold as such or 
                    transformed into sodium gluconate by neutralization with 
                    sodium hydroxide. 
 
                    All these operations are carried out in closed equipment. At 
                    this stage no human contact is possible but in case of some 
                    maintenance work or sample analysis done in the laboratory. 
                    Maintenance operators who have to be in touch with the 
                    product wear the usual safety equipment: protective clothes, 
                    gloves and goggles. In the control laboratory operators wear 
                    the general safety equipment: gloves and goggles. 
Source:             Roquette Frères 
Reliability:        (4)  not assignable 
Flag:               Critical study for SIDS endpoint 
05-AUG-2004 
 
Source of exposure: Human: exposure of the operator by intended use 
Exposure to the:    Substance 
 
Remark:             Sodium gluconate is sold as a liquid aqueous solution as 
                    well as in a powder crystalline form. 
 
                    The liquid aqueous solution is being used mainly in concrete 
                    and mortar admixtures. Liquid sodium gluconate manufacturers 
                    sell the material in large quantities to concrete admixture 
                    producers. The material is shipped in bulk containers to 
                    their facilities, where it is unloaded into a storage tank. 
                    From there it is pumped into a mixer where other chemicals 
                    are also added. The mixture is filed into containers or 
                    drums in order to be supplied to concrete and mortar 
                    producers. OECD SIDS    SODIUM GLUCONATE 
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                    Workers are not in contact with sodium gluconate during the 
                    unloading and the mixing operations, since both operations 
                    are done in completely closed systems. Companies involved in 
                    the production of this type of mixtures are aware of the 
                    risks related to chemicals and their handling. Therefore 
                    workers as well as laboratory operators have to wear safety 
                    equipment in order to avoid skin or eye contact: protective 
                    clothes, gloves and goggles. 
 
                    Crystalline sodium gluconate is sold in bags or big bags. It 
                    has to be dissolved into water before further use. Some dust 
                    may be formed at this stage during the cracking of the paper 
                    bags or the emptying of the big bags into the hopper before 
                    dissolution. The product is mainly used in industrial 
                    detergent formulations and metal surface treatment 
                    preparations. In both cases it functions as a sequestering 
                    or chelating agent after blending with other chemicals . 
                    Companies making those preparations in large production 
                    units are used to use chemicals and therefore have already 
                    in place efficient safety procedures, including the use of 
                    protective clothes, gloves, masks and goggles by workers and 
                    laboratory operators who could be in contact with the 
                    material. 
 
                    Gluconic acid is also used in detergent formulations. Since 
                    it shows an acidic function although weak, it has to be 
                    handled as an acid. Companies involved in preparing 
                    detergent formulations are aware of the risks linked with 
                    handling this type of material. Therefore all the necessary 
                    measures are taken in order to avoid any skin or eye 
                    contact, as described in the previous paragraph. 
 
                    Glucono-delta-lactone also called GDL is the lactone form of 
                    the gluconic acid. Because of its higher price it is mainly 
                    used in food applications as a slowly released acid. It is 
                    shipped and handled in bags or big bags. Because it is only 
                    converted into acid by a very slow hydrolysis process, it 
                    does not show as such any acidic function. It can be handled 
                    by using the usual safety measures taken on any 
                    food-manufacturing site: hygienic clothes and gloves. 
                    Western European and Japanese consumption of sodium 
                    gluconate chelating agents in metal surface treatment 
                    applications in 1998 (tonnes/year): 
 
                    EU: 5100 
                    JP: 900 
 
                    Western European and Japanese consumption of sodium 
                    gluconate chelating agents as industrial cleaners in 1998 
                    (tonnes/year): 
 
                    EU : 5100 
                    JP : 600 
 
                    Western european and Japanese consumption of sodium 
                    gluconate chelating agents in other applications in 1998 
                    (ie, textile bleach stabiliser, aluminium processing) OECD SIDS    SODIUM GLUCONATE 
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                    (tonnes/year): 
 
                    EU: 1700 
                    JP: 900 
 
                    Western European and Japanese consumption of sodium 
                    gluconate chelating agents as cement set retarder 
                    (tonnes/year): 
 
                    EU : 5100 
                    JP : 7600 
Source:             Roquette Frères 
Reliability:        (4)  not assignable 
Flag:               Critical study for SIDS endpoint 
05-AUG-2004 
 
Source of exposure: Human: exposure of the consumer/bystander 
Exposure to the:    Substance 
 
Remark:             Exposure of consumers in the dispersive uses of gluconates 
                    is expected to be extremely limited because gluconates are 
                    most of the time only additives, not main ingredients in the 
                    products where they are used. 
 
                    Typical dosages: 
 
                    -sodium gluconate in concrete: 0.1-0.2% based on cement 
                    weight 
                    -sodium gluconate in institutional and household cleaners: 
                    <5% based on formulation weight 
                    -sodium gluconate in personal care products: <1% based on 
                    formulation weight. 
 
                    - glucono-delta-lactone in foodstuffs: <3% in dairy and 
                    bakery products, 
                     <1% in meat and seafood products and other food 
                    applications 
 
                    The daily exposure of consumers to gluconates is lower than 
                    the daily production of gluconate from endogenous sources. 
 
                    Furthermore, gluconic acid and glucono-delta-lactone are 
                    also present naturally at a level up to 1% in wine, honey 
                    and other foods and drinks like kombucha. 
Source:             Jungbunzlauer International AG 
Reliability:        (4)  not assignable 
Flag:               Critical study for SIDS endpoint 
05-AUG-2004 
 
Source of exposure: other: human 
Exposure to the:    Substance 
 
Remark:             Gluconate is a metabolite of glucose oxidation in mammals. 
                    The activity is greatest in the liver, adipose tissue, 
                    adrenal cortex, thyroid, erythrocyte, testis and the 
                    lactating mammary gland. 
 
                    In these tissues, as much as 20 % of the glucose may be OECD SIDS    SODIUM GLUCONATE 
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                    metabolized through this route. In contrast, the 
                    phosphogluconate pathway is little utilised in muscle 
                    tissue.  Gluconate formation increases during active 
                    lipogenesis and carbohydrate intake and decreases during 
                    starvation or periods of inanition. 
 
                    A rough estimate of the daily production of gluconate can be 
                    calculated by assuming approximately 10 % of the glucose 
                    utilized by the body to be metabolized through this 
                    alternative pathway: An individual receiving 2800 kcal per 
                    day from an average diet, would oxidize about 275 g of 
                    glucose.  Approximately 25 to 30 g of this amount would be 
                    oxidized through the phosphogluconate pathway to yield 
                    roughly the same amount of gluconate. Thus, the daily 
                    production of gluconate from endogenous sources is about 450 
                    mg/kg for a 60 kg person.  The body can easily cope with 
                    this load since only a small amount of 6-phosphogluconate is 
                    found in the liver (approximately 10 mg/kg).  This reflects 
                    the efficiency of the liver in the conversion of gluconate. 
Reliability:        (2)  valid with restrictions 
                    Secondary literature. Abstract of a report from a recognised 
                    institution 
Flag:               Critical study for SIDS endpoint 
10-NOV-2005                                                                 (19) 
 
Source of exposure: Environment: exposure from production 
Exposure to the:    Substance 
 
Remark:             Environmental exposure during production is very limited. 
                    Material lost or spilled during manufacturing is collected 
                    and sent to the wastewater treatment plant, where it is 
                    completely degraded. 
Source:             Roquette Frères 
Reliability:        (4)  not assignable 
Flag:               Critical study for SIDS endpoint 
05-AUG-2004 
 
Source of exposure: Environment: exposure from intended use 
Exposure to the:    Substance 
 
Remark:             In the application as a sequestering agent in the building 
                    industry (concrete and mortar), the gluconate ion reacts 
                    with calcium ions present in the cement to form an insoluble 
                    and impermeable layer of calcium gluconate. Therefore, the 
                    gluconate is bound within the microcrystalline fibers of 
                    cement and is not free for any environmental pollution. 
 
                    When used in detergent formulations, sodium gluconate or 
                    gluconic acid are valuable as complexing agent for di- or 
                    trivalent metal cations in alkaline industrial cleaning 
                    solutions. Since they are washed out with clean water during 
                    the cleaning process, they necessarily flow into the 
                    wastewater treatment plant of the site, where the bacteria 
                    will transform the easily biodegradable gluconate ion. 
 
                    In metal surface treatment sodium gluconate is an effective 
                    sequestering agent in alkaline solutions where it chelates 
                    earth metal such as calcium and magnesium ions. In this case OECD SIDS    SODIUM GLUCONATE 
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                    as in the detergent application the product finally flows 
                    into the wastewater treatment plant of the user's site for 
                    further biotransformation. 
 
                    In food applications glucono-delta-lactone is added in a 
                    crystalline or powder form to the other food components such 
                    as meet or milk or soja at levels below 5 %w/w. There is no 
                    need for an environmental evaluation in this case since the 
                    final food is anyway ingested. 
Source:             Roquette Frères 
Reliability:        (4)  not assignable 
Flag:               Critical study for SIDS endpoint 
05-AUG-2004 
 
 
1.11 Additional Remarks 
 
Memo:             Regulatory status 
 
Remark:           In the European Parliament and Council Directive 95/2/EC 
                  sodium gluconate is listed as a generally permitted food 
                  additive (E 576) and may be added to all foodstuffs, 
                  following the "quantum satis" principle, as long as no 
                  special regulations restrict the use. 
 
                  The US Food and Drug Administration (FDA) assigned sodium 
                  gluconate the "generally recognised as safe" (GRAS) status 
                  and permitted its use in food as a sequestrant without 
                  limitation other than good manufacturing practice (21 CFR, 
                  §182.6757). 
14-AUG-2003 
 
1.12 Last Literature Search 
 
 
1.13 Reviews 
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2.1 Melting Point 
 
Value:            = 205 - 209 degree C 
 
Method:           other: no data 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Reliability:      (2)  valid with restrictions 
                  Data from Handbook or collection of data 
Flag:             Critical study for SIDS endpoint 
05-AUG-2004                                                                 (11) 
 
Value:            ca. 170 - 175 degree C 
Decomposition:    yes at ca. 196 - 198 degree C 
 
Method:           other: no data 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Reliability:      (4)  not assignable 
                  Data from an MSDS. No data on method used. 
Flag:             Critical study for SIDS endpoint 
05-AUG-2004                                                                 (17) 
 
Decomposition:    yes at >= 210 degree C 
 
Method:           other: no data 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Remark:           Decomposes before melting 
Reliability:      (4)  not assignable 
                  Data from an MSDS. No data on method used. 
Flag:             Critical study for SIDS endpoint 
05-AUG-2004                                                                  (8) 
 
 
2.2 Boiling Point 
 
Value:            = 613.1 degree C 
 
Method:           other: calculated 
   GLP:           no 
Test substance:   as prescribed by 1.1 - 1.4 
 
Remark:           Estimated with MPBPWIN (v1.41) program from US EPA (EPI 
                  v3.11) 
Reliability:      (2)  valid with restrictions 
                  Accepted calculation method 
Flag:             Critical study for SIDS endpoint 
09-AUG-2004 
 
 
2.3 Density 
 
Type:             density 
Value:            = 1.789 g/cm³ OECD SIDS    SODIUM GLUCONATE 
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Method:           other: no data 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Reliability:      (4)  not assignable 
                  Data from an MSDS. No data on method used. 
Flag:             Critical study for SIDS endpoint 
05-AUG-2004                                                                  (8) 
 
Type:             bulk density 
Value:            ca. 850 kg/m3 
 
Method:           other: no data 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Reliability:      (4)  not assignable 
                  Data from an MSDS. No data on method used. 
05-AUG-2004                                                                 (32) 
 
Type:             bulk density 
Value:            ca. 850 kg/m3 
 
Method:           other: no data 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Reliability:      (4)  not assignable 
                  Data from an MSDS. No data on method used. 
05-AUG-2004                                                                 (17) 
 
 
2.3.1 Granulometry 
 
 
2.4 Vapour Pressure 
 
Value:            = 0 hPa at 25 degree C 
 
Method:           other (calculated) 
   GLP:           no 
Test substance:   as prescribed by 1.1 - 1.4 
 
Remark:           Estimated with MPBPVP (v1.41) program from US EPA (EPI 
                  v3.11): 
 
                  Vapour pressure estimations (25°C, using estimated boiling 
                  point: 613.05°C and entered melting point = 210.00°C) 
 
                  VP: 1.18E-022 mm Hg (Antoine Method) 
                  VP: 3.4E-017 mm Hg (Modified Grain Method) 
                  VP: 1.05E-012 mm Hg (Mackay Method) 
Result:           Selected VP: 3.4E-017 mm Hg =4.53e-017 hPa (Modified Grain 
                  Method) 
Reliability:      (2)  valid with restrictions 
                  Accepted calculation method 
Flag:             Critical study for SIDS endpoint OECD SIDS    SODIUM GLUCONATE 
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03-AUG-2004 
 
 
2.5 Partition Coefficient 
 
Partition Coeff.: octanol-water 
log Pow:          = -5.99 
 
Method:           other (calculated) 
   GLP:           no 
 
Remark:           Estimated with Kowwin (v1.67) Program from US EPA (EPI 
                  v3.11) 
Reliability:      (2)  valid with restrictions 
                  Accepted calculation method 
Flag:             Critical study for SIDS endpoint 
03-AUG-2004 
 
 
2.6.1 Solubility in different media 
 
Solubility in:    Water 
Value:            = 590000 mg/l at 25 degree C 
pH       value:   = 6.5 - 7.5 
         Conc.:   10 vol% at 25 degree C 
Descr.:           very soluble (> 10000 mg/L) 
 
Method:           other: no data 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
Stable:           yes 
 
Reliability:      (2)  valid with restrictions 
                  Data from Handbook or collection of data 
Flag:             Critical study for SIDS endpoint 
12-AUG-2004                                                                 (41) 
 
Solubility in:    Water 
Value:            = 590 g/l at 25 degree C 
 
Method:           other: no data 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Reliability:      (4)  not assignable 
                  Data from an MSDS. No data on method used. 
05-AUG-2004                                                                  (8) 
 
Solubility in:    Water 
Value:            = 600 g/l at 20 degree C 
pH       value:   = 6.5 - 7.5 
         Conc.:   10 vol% degree C 
 
Method:           other: no data 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
Stable:           yes 
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Reliability:      (4)  not assignable 
                  Data from an MSDS. No data on method used. 
05-AUG-2004                                                                 (17) 
 
Solubility in:    Water 
Value:            ca. 600 g/l at 25 degree C 
pH       value:   = 6.5 - 7.5 
         Conc.:   10 vol% degree C 
 
Method:           other: no data 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
Stable:           yes 
 
Reliability:      (4)  not assignable 
                  Data from an MSDS. No data on method used. 
05-AUG-2004                                                                 (32) 
 
Solubility in:    other: alcohol 
Value:            < .1 mg/l at 20 degree C 
Descr.:           insoluble (< 0.1 mg/L) 
 
Method:           other: no data 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Reliability:      (4)  not assignable 
                  Data from an MSDS. No data on method used. 
05-AUG-2004                                                                 (18) 
 
Solubility in:    other: ether 
Value:            < .1 mg/l 
Descr.:           insoluble (< 0.1 mg/L) 
 
 
Reliability:      (4)  not assignable 
                  Data from an MSDS. No data on method used. 
05-AUG-2004                                                                  (9) 
 
 
2.6.2 Surface Tension 
 
 
2.7 Flash Point 
 
 
2.8 Auto Flammability 
 
Value:            > 200 degree C 
 
 
Remark:           ROQUETTE MSDS : 400 °C (GG - CLOUD) 
Source:           Jungbunzlauer International AG MSDS 
Reliability:      (3)  invalid 
02-MAY-2003 
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2.10 Explosive Properties 
 
 
2.11 Oxidizing Properties 
 
 
2.12 Dissociation Constant 
 
Acid-base Const.: pKa= 3.70 
 
Method:           other: no data 
   GLP:           no data 
Test substance:   other TS 
 
Remark:           The dissociation in water is expected to be complete as the 
                  pKa values of gluconic acid found in literature range from 
                  3.5 to 3.8. 
Test substance:   gluconic acid 
Reliability:      (2)  valid with restrictions 
                  Data from Handbook or collection of data. 
 
Flag:             Critical study for SIDS endpoint 
12-AUG-2004                                                                 (42) 
 
 
2.13 Viscosity 
 
 
2.14 Additional Remarks 
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3.1.1 Photodegradation 
 
Type:             air 
 
Method:           other (calculated): Estimated with AOP (v1.91) program from US 
                  EPA (EPI v3.11) 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Remark:           Estimated with AOP (v1.91) program from US EPA (EPI v3.11) 
 
                  OVERALL OH Rate Constant =  38.1277 E-12 cm3/molecule-sec 
 
                  HALF-LIFE = 0.281 Days (12-hr day; 1.5E6 OH/cm3) 
 
                  HALF-LIFE = 3.366 Hrs 
Reliability:      (2)  valid with restrictions 
                  Accepted calculation method 
Flag:             Critical study for SIDS endpoint 
12-AUG-2004 
 
 
3.1.2 Stability in Water 
 
Type:             abiotic 
 
Method:           other: no data 
   GLP:           no data 
Test substance:   other TS 
 
Remark:           The dissociation in water is expected to be complete as the 
                  pKa values of gluconic acid found in literature range from 
                  3.5 to 3.8 
Test substance:   gluconic acid 
Reliability:      (2)  valid with restrictions 
                  Data from Handbook or collection of data 
Flag:             Critical study for SIDS endpoint 
10-NOV-2005                                                                 (42) 
 
 
3.1.3 Stability in Soil 
 
 
3.2.1 Monitoring Data (Environment) 
 
 
3.2.2 Field Studies 
 
 
3.3.1 Transport between Environmental Compartments 
 
Type:             fugacity model level III 
Media:            other 
Method:           other: calculated 
 
Remark:           Estimated with the Level III Fugacity Model program LEVEL3NT 
                  from US EPA (EPI v3.11) 
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                    Mass Amount (%)  Half-Life (hr)  Emissions (kg/hr) 
                  ---------------------------------------------------------- 
                  Air  1.2    6.73    1000 
                  Water 49.8    208    1000 
                  Soil  48.9    208    1000 
                  Sediment0.0743    832    0 
                  ___________________________________________________________ 
 
                    Fugacity  Reaction   Advection   Reaction Advection 
                    (atm)   (kg/hr)     (kg/hr)    (%)      (%) 
                  ----------------------------------------------------------- 
                  Air   2e-020    720         70  24  2.33 
                  Water 3.17e-018   968         291  32.3  9.69 
                  Soil  1.15e-016   951         0    31.7  0 
                  Sed.  2.36e-018   0.361       0.00867  0.012 0.000289 
                  ___________________________________________________________ 
 
                  Persistence Time: 195 hr 
                  Reaction Time: 221 hr 
                  Advection Time: 1.62e+003 hr 
                  % Reacted: 88 
                  % Advected: 12 
 
                  Half-Lives (hr), (based upon Biowin (Ultimate) and Aopwin): 
                  Air: 6.732 
                  Water: 208.1 
                  Soil: 208.1 
                  Sediment: 832.3 
                  Biowin estimate: 3.517 (days-weeks) 
 
                  Advection Times (hr): 
                  Air: 100 
                  Water: 1000 
                  Sediment: 5e+004 
Reliability:      (2)  valid with restrictions 
                  Accepted calculation method 
Flag:             Critical study for SIDS endpoint 
12-AUG-2004 
 
 
3.3.2 Distribution 
 
Media:            air - biota - sediment(s) - soil - water 
Method:           other (calculation) 
 
Remark:           Henry's law constant estimated with HENRY (v3.10) program 
                  from US EPA (EPI v3.11) 
 
                  HENRYs LAW CONSTANT at 25 deg C = 4.76E-013 atm-m3/mole 
                  ---------------------------------------------------------- 
                  Soil Adsorption Coefficient estimated with PCKOC (v1.66) 
                  program from US EPA (EPI v3.11) 
 
                  NOTE: THE METAL (Na, Li or K) HAS BEEN REMOVED TO ALLOW 
                  ESTIMATION! 
                  First Order Molecular Connectivity Index : 5.913 OECD SIDS    SODIUM GLUCONATE 
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                  Non-Corrected Log Koc : 3.7674 
                  Fragment Correction(s): 
                  * Organic Acid  (-CO-OH) : -1.7512 
                  2 Aliphatic Alcohol (-C-OH) : -3.0386 
                  Corrected Log Koc : -1.0224 
                  Over Correction Adjustment to Lower Limit Log Koc: 1.0000 
 
                  Estimated Koc: 10 
 
                  NOTE: 
                  The Koc of this structure may be sensitive to pH! The 
                  estimated Koc represents a best-fit to the majority of 
                  experimental values; however, the Koc may vary significantly 
                  with pH. 
Reliability:      (2)  valid with restrictions 
                  Accepted calculation method 
Flag:             Critical study for SIDS endpoint 
05-AUG-2004 
 
 
3.4 Mode of Degradation in Actual Use 
 
 
3.5 Biodegradation 
 
Type:             aerobic 
Inoculum:         other: secondary effluent of a municipal sewage plant 
                  (Breisgauer Bucht, 500000 population equivalent), 0.4 ml/l 
Concentration:    3 mg/l related to Test substance 
Contact time:     28 day(s) 
Degradation:      = 89 % after 28 day(s) 
Result:           readily biodegradable 
Kinetic:              3 day(s)    = 61.13 % 
                      7 day(s)    = 74.35 % 
                     14 day(s)    = 66.09 % 
                     21 day(s)    = 71.94 % 
                     28 day(s)    = 88.88 % 
Control Subst.:   Acetic acid, sodium salt 
Kinetic:               3 day(s)    = 67.15 % 
                      28 day(s)    = 80.93 % 
Deg. product:     not measured 
 
Method:           Directive 92/69/EEC, C.4-E 
  Year:           2001 
   GLP:           yes 
Test substance:   as prescribed by 1.1 - 1.4 
 
Method:           The bottles were kept in the dark for 28 days. 
 
                  T° remained between 20-20.5°C. 
 
                  On days 3, 7, 10, 14, 21 and 28, at least duplicate bottles 
                  were removed for determination of dissolved oxygen and pH. 
                  If the oxygen concentration of duplicate bottles differed 
                  more than 0.4 mg/l, a third bottle was measured to make 
                  sure. 
 
                  At the end of test, dissolved oxygen concentration in all OECD SIDS    SODIUM GLUCONATE 
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                  remaining bottles was measured. 
Remark:           The 89% degradation indicated here relates to the 
                  Theoritical Oxygen Demand (ThOD) 
Result:           Blanks: 
 
                  Maximum deviation between parallels = 8.9% 
                  Oxygen consumption after 28 days = 0.79-1.18 mg/l. 
                  pH : 7.2 at the beginning and 6.7 at the end of the test. 
                  ---------------------------------- 
                  Sodium gluconate: 
 
                  Maximum deviation between parallels = 4.6% at day 3. 
                  Biological degradation : 61% of ThOD after 3 days and 
                  maximum degradation = 89% of the ThOD at day 28. 
                  pH : 7.2 at the beginning and 6.7 at the end of the test. 
                  Oxygen concentration during test never felt below 5.9 mg/l 
 
                  ---------------------------------------- 
                  Reference item (sodium acetate): 
 
                  Maximum deviation between parallels = 3.8% at day 14. 
                  Biological degradation : 67% after 3 days 
                  pH : 7.2 at the beginning and 6.7 at the end of the test. 
Test condition:   Verification of identity: 
 
                  TOC of the test item was compared to TOC of sodium 
                  D-gluconate from Aldrich (Cat N° 18,633-3, lot 50824 
                  50323012).  The results matched. 
 
                  Inoculum: the inoculum was used on the day of collection. 
 
                  Stock solutions: according to OECD 301D 
 
                  Mineral medium: 20 ml of each stock solutions A-D were added 
                  to 10 litres deionised water and made up to 20 litres.  The 
                  medium was areated for 30 minutes and held in darkness for 
                  24 h (t° 20°C-20.5°C). 
 
                  Test item :  16 test bottles (concentration = 3 mg/l.) with 
                  0.4 ml/l inoculum were filled bubble-free and incubated in 
                  the dark at 20°C. 
 
                  Reference item:  reference item bottles containing sodium 
                  acetate stock solution (concentration= 4 mg/l) with 0.4 ml/l 
                  inoculum were also filled  and incubated in the dark at 
                  20°C. 
 
                  A blank was also prepared without any stock solution. 
Test substance:   Sodium gluconate: 99.0-101.0% 
Reliability:      (1)  valid without restriction 
                  study conducted according to OECD guidelines, valid test, 
                  quality assurance and GLP certificates 
Flag:             Critical study for SIDS endpoint 
10-NOV-2005                                                                 (13) 
 
Type:             anaerobic 
Inoculum:         other: Digesting sludge of a municipal sewage plant 
                  (Breisgauer Bucht, 500000 population equivalent), 2.9 g total OECD SIDS    SODIUM GLUCONATE 
3. ENVIRONMENTAL FATE AND PATHWAYS  ID: 527-07-1 
   DATE:  25.01.2006 
 
 UNEP  PUBLICATIONS  131
                  solids/l 
Concentration:    303 mg/l related to Test substance 
Contact time:     35 day(s) 
Degradation:      = 100 % after 35 day(s) 
Result:           readily biodegradable 
Kinetic:              1 day(s)    = 8 % 
                      8 day(s)    = 51 % 
                     15 day(s)    = 57 % 
                     22 day(s)    = 61 % 
                     35 day(s)    = 100 % 
Control Subst.:   Benzoic acid, sodium salt 
Kinetic:               8 day(s)    = 6 % 
                      35 day(s)    = 100 % 
Deg. product:     not measured 
 
Method:           other: DIN EN ISO 11734 
  Year:           2001 
   GLP:           yes 
Test substance:   as prescribed by 1.1 - 1.4 
 
Method:           Washed digested sludge containing very low amounts of 
                  inorganic carbon (IC), is diluted to 1-3 g/l total solids 
                  concentration and incubated in the absence of oxygen at 35 
                  +/- 2 °C in sealed vessels with the test item at a 
                  concentration of 20-200 mg/l total organic carbon (TOC) for 
                  35 days. 
 
                  The increase in headspace pressure in the test vessels 
                  resulting from the production of carbon dioxide and methane 
                  is measured. 
 
                  A considerable amount of CO2 will be dissolved in water or 
                  transformed to hydrogen carbonate or carbonate under the 
                  conditions of the test.  This IC is measured at the end of 
                  the test.  The amount of microbiologically produced biogas 
                  carbon is calculated from the net biogas production and the 
                  net DIC formation in excess over blank values. 
Remark:           At day 35, the average degradation percentage is 66% but the 
                  value shown includes the dissolved inorganic carbon (DIC). 
Result:           Test item: 
                  The percentage biodegradation is calculated from the total 
                  carbon transformed to biogas and DIC and the measured or 
                  calculated amount of carbon added as test item. 
 
                  The test item was degraded to 50% by day 8 and to 66% by day 
                  35.  The summing up of the net-mass carbon in the liquor 
                  shows that the test item is completely anaerobically 
                  degraded after 35 days. 
                  The pH at the end of the test was 6.8 in every bottle. 
 
                  Bottles with blanks showed a pH of 7.1-7.2. 
                  ------------------------------------------ 
 
                  Reference (sodium benzoate) 
                  The degradation of the reference item took some time to get 
                  started.  Between days 18 and 22 this lag-phase was over and 
                  the curve reached 67% by day 35.  After considering the DIC 
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                  degraded completely in 35 days. 
 
                  The pH at the end of the test was 6.8 in every bottle. 
Test condition:   T° range: 34.7°C-35.4°C 
 
                  The inoculum was kept for 24 h at 35°C before use. 
 
                  Test item: 0.121 g/400ml 
 
                  Reference item: sodium benzoate (0.069 g/400 ml) 
 
                  Blanks: 3 additional test bottles were prepared with 10 ml 
                  deionised water. 
Test substance:   sodium gluconate 
Reliability:      (1)  valid without restriction 
                  study conducted according to OECD guidelines, valid test, 
                  quality assurance and GLP certificates 
Flag:             Critical study for SIDS endpoint 
10-NOV-2005                                                                 (14) 
 
 
3.6 BOD5, COD or BOD5/COD Ratio 
 
 
3.7 Bioaccumulation 
 
 
3.8 Additional Remarks 
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AQUATIC ORGANISMS 
 
4.1 Acute/Prolonged Toxicity to Fish 
 
Type:             semistatic 
Species:          Oryzias latipes  (Fish, fresh water) 
Exposure period:  96 hour(s) 
Unit:             mg/l                   Analytical monitoring: yes 
NOEC:             > 100 - 
LC0:              > 100 - 
Limit Test:       yes 
 
Method:           OECD Guide-line 203  "Fish, Acute Toxicity Test" 
  Year:           2002 
   GLP:           yes 
Test substance:   as prescribed by 1.1 - 1.4 
 
Result:           Measured concentrations of the test substance were within 
                  +/- 20% of the nominal concentrations.  Results were based 
                  on the nominal concentrations. 
 
                  No toxicological symptoms nor any death were observed at 100 
                  mg/l (limit test). 
Test condition:   A range finding test (5 fish/vessel/concentration) was 
                  conducted before the definitive test (only 2 concentrations 
                  were set based on toxicological data) and determined the 
                  concentration range in the definitive test: 0 and 100 mg/l 
                  (limit test) 
 
                  Biomass loading: 10 fish/concentration 
 
                  T°: 24 +/- 1°C 
 
                  Dissolved oxygen concentrations were over 60% of the 
                  saturation value (8.25 mg/l/24.0°C) 
 
                  pH : min: 7.1 - max : 7.6 
 
                  Light: fluorescent light. 16 hours light/8 hours dark 
 
                  Analytical method: HPLC 
Test substance:   sodium gluconate : 99.6% 
Reliability:      (1)  valid without restriction 
                  study conducted according to OECD guidelines, valid test, 
                  quality assurance and GLP certificates 
Flag:             Critical study for SIDS endpoint 
10-NOV-2005                                                                 (22) 
 
Type:             other: no data 
Species:          other: no data 
Exposure period:  48 hour(s) 
Unit:             mg/l                   Analytical monitoring: 
LC0:              = 10000 - 
LC50:             > 10000 - 
LC100:            = 50000 - 
 
Method:           other: DIN 38 412 L15 
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   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Result:           The potential toxicity observed here ( LC100 = 50 000) is 
                  due to the high concentration of the substance that changed 
                  the test conditions. 
Reliability:      (3)  invalid 
                  Report not complete. No data on species. Unphysiological 
                  conditions and not conform to OECD guidelines 
10-NOV-2005                                                                 (33) 
 
 
4.2 Acute Toxicity to Aquatic Invertebrates 
 
Type:             static 
Species:          Daphnia magna  (Crustacea) 
Exposure period:  48 hour(s) 
Unit:             mg/l                   Analytical monitoring: yes 
NOEC:             > 1000 - 
EC100:            > 1000 - 
Limit Test:       yes 
 
Method:           OECD Guide-line 202 
  Year:           2002 
   GLP:           yes 
Test substance:   as prescribed by 1.1 - 1.4 
 
Result:           Measured concentrations of the test substance in the test 
                  solution were within +/- 20% of the nominal concentration in 
                  all concentrations.  Results were based on the nominal 
                  concentrations: 
 
 
                  EC(50) 0-24 hours: > 1000 mg/l 
                  NOEC 0-24 hours: > 1000 mg/l 
                  EC100 0-24 hours: > 1000 mg/l 
 
                  EC(50) 0-48 hours: > 1000 mg/l 
                  NOEC 0-48 hours: > 1000 mg/l 
                  EC100 0-48 hours: > 1000 mg/l 
Test condition:   Species: 
 
                  Daphnia magna from the National Institute for Environmental 
                  Studies, Japan. 
 
                  Growth step: female juvenile (less than 24 hours) 
 
                  Biomass loading: 20 daphnids/concentration (5 
                  daphnids/vessel) 
 
                  T°: 20 +/- 1°C 
 
                  Light: fluorescent light, 16 hours light (below 800 lux)/8 
                  hours dark 
 
                  Analytical method: HPLC 
 
                  Dissolved oxygen concentration: >= 60% of the saturation OECD SIDS    SODIUM GLUCONATE 
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                  Dilution water (Elendt M4) recommended by OECD guidelines 
                  for testing of chemicals No. 211 was used. 
 
                  A range-finding test (2 vessels/concentration, 10 
                  daphnids/concentration) was conducted before the definitive 
                  test and enabled the nominal concentrations of the 
                  definitive test : 0 and 1000 mg/l (limit test) 
Test substance:   sodium gluconate : 99.6% 
Reliability:      (1)  valid without restriction 
                  study conducted according to OECD guidelines, valid test, 
                  quality assurance and GLP certificates 
Flag:             confidential, Critical study for SIDS endpoint 
10-NOV-2005                                                                 (23) 
 
Type:             static 
Species:          Daphnia magna  (Crustacea) 
Exposure period:  48 hour(s) 
Unit:             mg/l                   Analytical monitoring: yes 
EC0:              > 1000 - 
Limit Test:       yes 
 
Method:           OECD Guide-line 202 
  Year:           2001 
   GLP:           yes 
Test substance:   as prescribed by 1.1 - 1.4 
 
Method:           study conducted in accordance to OECD guideline 202. 
 
                  A limit test with 1000 mg/l was conducted: a solution of 
                  100.5 mg in 100 ml or 1005 mg/l was prepared and distributed 
                  to 4 beakers. pH and 
                  oxygen concentration were measured and 5 daphnia were put 
                  into each beaker. 
 
                  Controls: 4 beakers with 20 ml dilution water + 5 daphnia 
                  each. 
 
                  The vessels were held for 48 h in an incubator at 20°C in 
                  complete darkness. 
 
                  After 24 and 48 h, the swimming capability of the daphnia 
                  was observed.  An animal not swimming within 15 seconds 
                  after gently moving the beaker was considered immobile. 
                  After 48 h, the oxygen concentration and the pH was 
                  measured. 
 
                  The stability of the investigated concentration of sodium 
                  D-gluconate during testing was also examined via enzymatic 
                  analysis.  The test concentration did not decrease during 
                  the test period. 
Result: 
                  At 1000 mg/l, all daphnia kept their swimming capability. 
 
                  EC0 (24 h) > 1000 mg/l 
                  EC0 (48 h) > 1000 mg 
Test condition:   Test organisms: 
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                  German Federal Environmental Agency, department V 3.2. 
 
                  Quality Assurance takes place in regular intervals using a 
                  concentration range of Potassium dichromate.  Last quality 
                  check was January 2001 and EC50 was between 1.16and 2.32 
                  mg/l (required: 0.6-2.4 mg/l). 
 
                  For testing, daphnia of the age of 2-23 h were used.  Before 
                  using, the new young Daphnia were held at 20°C for 2 hours 
                  to ensure that none of them was younger than 2 h. 
 
                  Verification of identity : TOC of the test item was compared 
                  to TOC of  sodium D-gluconate from Aldrich (Cat N° 18,633-3, 
                  Lot 50824 50323012).  The results matched. 
 
                  pH difference between beginning and end of test = 0.2 units. 
 
                  Oxygen concentration was 95% of the start concentration. 
 
                  T° in the incubator was stable at 20°C during the test 
                  period. 
Test substance:   sodium gluconate: 99.0-101.0% 
Reliability:      (1)  valid without restriction 
                  study conducted according to OECD guidelines, valid test, 
                  quality assurance and GLP certificates 
Flag:             Critical study for SIDS endpoint 
10-NOV-2005                                                                 (15) 
 
Type:             static 
Species:          Daphnia magna  (Crustacea) 
Exposure period:  24 hour(s) 
Unit:             mg/l                   Analytical monitoring: no data 
EC0:              > 1000 - 
 
Method:           other: DIN 38 412 -L 30 
  Year:           1997 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Result:           At 1000 mg/l, all daphnia kept their swimming capability. 
 
                  EC0 (24 h) > 1000 mg/l 
Test condition:   Species: daphnia magna 
                  Biomass loading: 2 groups of  5 daphnias 
                  Test concentration: 1 gr/l 
                  T°: 20°C 
                  pH: 6.54 
Reliability:      (3)  invalid 
                  Abstract, no data on purity of substance, test conditions. 
                  not compliant with OECD guidelines. 
10-NOV-2005                                                                 (36) 
 
 
4.3 Toxicity to Aquatic Plants e.g. Algae 
 
Species:          Selenastrum capricornutum  (Algae) 
Endpoint:         growth rate 
Exposure period:  72 hour(s) OECD SIDS    SODIUM GLUCONATE 
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Unit:             mg/l                   Analytical monitoring: yes 
NOEC:             = 560 - 
EC50:             > 1000 - 
Limit Test:       yes 
 
Method:           OECD Guide-line 201  "Algae, Growth Inhibition Test" 
  Year:           2002 
   GLP:           yes 
Test substance:   as prescribed by 1.1 - 1.4 
 
Result:           Results were based on the nominal concentrations (measured 
                  concentrations were +/-20% of the nominal concentrations) 
 
 
 
                  Cell growth inhibition at 1000 mg/l = 25.4 % 
 
                  Growth rate inhibition (24-48 h) at 1000 mg/l = 7.6% 
 
                  Growth rate inhibition (24-72 h) at 1000 mg/l = 9.0 % 
 
 
                  50% growth inhibition concentration by comparison of areas 
                  under the growth curves: 
 
                  EbC50 (O-72 h): > 1000 mg/l 
                  NOECb (0-72 h): 560 mg/l 
                  ---------------------------------------------------- 
                  50% growth inhibition concentration by comparison of growth 
                  rates: 
 
                  ErC50 (24-48 h): > 1000 mg/l. 
                  ErC50 (24-72 h): > 1000 mg/l. 
                  NOECr (24-72h) : 560 mg/l 
                  NOECr (24-48h) : 560 mg/l 
 
                  Color of the test solutions were observed with naked eye and 
                  the cell shapes of algae were observed through the 
                  microscope.  The test solutions were green at 24 hours after 
                  the start of exposure.  Afterwards, the color of the test 
                  solutions showed a tendency to get more greenish with the 
                  passage of time. 
 
                  No unusual cell shapes of algae and no agglutination were 
                  observed at the end of exposure and the algae looked normal 
                  compared to the control. 
Test condition:   Test concentrations (nominal): control, 100, 180, 320, 560, 
                  1000 mg/l. 
 
                  A range-finding test was conducted before the definitive 
                  test to enable the above-mentioned concentration range in 
                  the definitive test. 
 
 
                  Measured concentrations of the test substance in the test 
                  solutions at the beginning of exposure were +/-20 % of the 
                  nominal concentrations. 
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                  Biomass loading: 1 x 10 Exp4 cells/ml 
 
                  T° range: 23+/- 2°C 
 
 
                  Illumination: 4000 lux - continuous(+/- 20% at the surface 
                  of the test solutions) 
 
                  Exposure procedure: static 
 
                  Analytical method: HPLC 
Test substance:   sodium gluconate: 99.6% 
Reliability:      (1)  valid without restriction 
                  study conducted according to OECD guidelines, valid test, 
                  quality assurance and GLP certificates. 
Flag:             Critical study for SIDS endpoint 
10-NOV-2005                                                                 (24) 
 
Species:          other algae: Desmodesmus subspicatus CHODAT (strain No 86.81 
                  SAG) 
Endpoint:         growth rate 
Exposure period:  72 hour(s) 
Unit:             mg/l                   Analytical monitoring: yes 
NOEC:             = 100 - 
EC50:             > 100 - 
Limit Test:       yes 
 
Method:           OECD Guide-line 201  "Algae, Growth Inhibition Test" 
  Year:           2001 
   GLP:           yes 
Test substance:   as prescribed by 1.1 - 1.4 
 
Method:           Study conducted in accordance to OECD guideline 201. 
 
                  However, for test 2, the procedure has been modified by 
                  covering the test vessels with glass petri dishes to prevent 
                  contamination by micro-organisms. 
 
                  The flasks were incubated in a water bath for 3 days and 
                  illuminated with 4 parallel set universal white fluorescent 
                  tubes of approximately 65 cm above the level of the tested 
                  media. 
 
                  Min/max t° was recorded on a daily basis. 
 
                  After 24, 48 and 72 hours, cell concentration was determined 
                  using a microscope with a counter chamber (8 fields 
                  counted). 
 
 
 
                  The stability of the investigated concentration of sodium 
                  D-gluconate during testing was also examined via enzymatic 
                  analysis.  A decrease of the test concentration in test 1 
                  was observed. 
Result:           test 1 : 1000 mg/l 
                  not valid -  a decrease of the test item concentration was 
                  observed and therefore the test could not meet the stability OECD SIDS    SODIUM GLUCONATE 
4. ECOTOXICITY    ID: 527-07-1 
   DATE:  25.01.2006 
 
 UNEP  PUBLICATIONS  139
                  requirements. 
 
                  Cell growth inhibition : 85% 
                  Average specific growth rate inhibition: 55% 
                  --------------------- 
 
                  test 2 : 100 mg/l and 1000 mg/l 
 
                  Cell growth inhibition : no inhibition at 100 mg/l 
                         70% inhibition at 1000 mg/l 
 
                  Average specific growth rate inhibition: no inhibition at 
                  100 mg/l 
                            42% inhibition at 1000 mg/l 
                  ---------------------------------------- 
 
                  Cell concentration increase in controls: factor 65.9 after 
                  72 h 
Test condition:   T° range: 
 
                  Test 1: 22.7-24.8°C 
                  test 2: 23.4-27.9°C 
 
                  Illumination: 8900-9300 lux. 
 
                  pH maximal difference between 0 and 72 hours: 0.3 
 
                  Sample preparation: stock solution in redistilled water. 
 
                  Verification of identity : TOC of the test item was compared 
                  to TOC of  sodium D-gluconate from Aldrich (Cat N° 18,633-3, 
                  Lot 50824 50323012).  the results matched. 
 
                  3 days before starting the tests, algae samples were 
                  transferred to Erlenmeyer flasks under sterile conditions. 
                  The stock solutions were also sterilised. 
 
                  Inoculum concentration: 10 x 10E4 algae/ml 
 
                  ----------------------------------------------- 
 
                  Test 1 = limit test: 
 
                  1000 mg/l (pH of stock solution = 7) 
                  3 flasks with test item and 6 flasks without test item were 
                  prepared. 
 
 
                  Test 2 
 
                  All the media used were sterilised.  Flasks, graduated 
                  cylinders and pipettes were also sterilised before using. 
 
                  2 concentrations test: 100 mg/l and 1000 mg/l (pH of stock 
                  solution = 7) 
                  3 flasks with 100 mg/l, 3 flasks with 1000 mg/l and 6 flasks 
                  without test item. 
Test substance:   Sodium gluconate: 99.0-101.0% OECD SIDS    SODIUM GLUCONATE 
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Reliability:      (1)  valid without restriction 
                  The substance has only been tested at 100 and 1000 mg/l 
                  because this test has been made on the basis of an older 
                  test according to a German norm. The inhibition level was 
                  thus expectable and the test concentrations limited to 100 
                  and 1000 mg/l. 
Flag:             Critical study for SIDS endpoint 
10-NOV-2005                                                                 (16) 
 
Species:          Scenedesmus subspicatus  (Algae) 
Endpoint:         biomass 
Exposure period:  72 hour(s) 
Unit:             mg/l                   Analytical monitoring: no data 
EC10:             > 1000 - 
 
Method:           other: DIN 38412 - L33 
  Year:           1997 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Result:           GA = smallest dilution where inhibition of biomass 
                  production is reduced by 20% = > GA= 1 
 
                  Dilution  Measured value  % inhibition 
                  1    16.1      3.0 
                  2    17.4      -4.8* 
                  3    19.3      -16.3* 
 
                  * negative value = increase of the biomass production 
Test condition:   Incubation:  72 h 
                  T°: 23°C. 
                  Measurement of chlorophylle fluorescence: lambda= 450- 685 
                  nm 
                  Concentration of test: 1 g/l 
                  PH= 5.84 
Reliability:      (3)  invalid 
                  Abstract, not compliant with OECD guidelines 
10-NOV-2005                                                                 (34) 
 
 
4.4 Toxicity to Microorganisms e.g. Bacteria 
 
Species:          Pseudomonas putida  (Bacteria) 
Exposure period:  16 hour(s) 
Unit:             mg/l                   Analytical monitoring: no data 
EC0:              > 5000 - 
 
Method:           other:  DIN 38 412 L8 
  Year:           1992 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Result:           0-40 mg/l: no effect 
                  80-5000 mg/l: stimulation of growth 
                  > 5000 mg/l: no stimulation of growth but not toxic 
Test condition:   Exposure period: 16 h (+/- 1 h incubation) 
                  Temperature: 21°C 
                  Limit test: yes OECD SIDS    SODIUM GLUCONATE 
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                  3 range of concentration tested: 
                  0-40 mg/l 
                  80-5000 mg/l 
                  > 5000 mg/l 
Test substance:   sodium gluconate 
Reliability:      (3)  invalid 
 
                  Abstract, not compliant with OECD guidelines 
10-NOV-2005                                                                 (35) 
 
 
4.5 Chronic Toxicity to Aquatic Organisms 
 
4.5.1 Chronic Toxicity to Fish 
 
 
4.5.2 Chronic Toxicity to Aquatic Invertebrates 
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TERRESTRIAL ORGANISMS 
 
4.6.1 Toxicity to Sediment Dwelling Organisms 
 
Species:          other 
 
 
Remark:           No data available but exposure in sediment expected to be 
                  extremely limited according to the Level III Fugacity Model 
                  program LEVEL3NT from US EPA (EPI v3.11) 
31-JUL-2003 
 
 
4.6.2 Toxicity to Terrestrial Plants 
 
 
Method:           other 
 
Remark:           No data available. 
14-AUG-2003 
 
 
4.6.3 Toxicity to Soil Dwelling Organisms 
 
 
Method:           other 
 
Remark:           no data available but due to the low intrinsic toxicity in 
                  aquatic organisms, it is reasonable to expect a similar low 
                  toxic impact on terrestrial organisms 
19-JAN-2004 
 
 
4.6.4 Toxicity to other Non-Mamm. Terrestrial Species 
 
 
4.7 Biological Effects Monitoring 
 
 
4.8 Biotransformation and Kinetics 
 
 
4.9 Additional Remarks 
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5.0 Toxicokinetics, Metabolism and Distribution 
 
In Vitro/in vivo:              In vivo 
Type:                          Absorption 
Species:                       rat 
Doses, males:                  no data 
Doses, females:                no data 
Vehicle:                       no data 
Route of administration:       oral unspecified 
Exposure time:                 5 hour(s) 
 
 
 
Test substance:   as prescribed by 1.1 - 1.4 
 
Method:           Radioactivity was measured in the blood of normal and 
                  alloxan diabetic rats, after oral administration of 
                  [U-14C]gluconate and [U-14C]glucono-delta-lactone, 
                  respectively. 
 
                  Radioactivity was also measured in the intestinal contents 
                  and feces 5 h after ingestion of the radioactive materials. 
Result:           glucono-delta-lactone is absorbed more rapidly from the 
                  intestine than sodium gluconate.  A higher retention in 
                  tissues and a greater loss in urine was also observed after 
                  administration of the lactone.  Incorporation into liver 
                  glycogen is also higher from the lactone than from the 
                  gluconate, particularly in diabetic animals. 
 
                  Initial oxidation occurred after 7 h with the gluconate and 
                  4 h for the lactone.  The oxidative turnover of lactone and 
                  gluconate was significantly enhanced in diabetic animals. 
                  The better utilisation in diabetic metabolism is in part 
                  explainable by a rise of glycolitic intermediates in the 
                  liver, which are decreased in starvation and diabetes. 
Test substance:   sodium gluconate 
Reliability:      (4)  not assignable 
                  Secondary litterature 
10-NOV-2005                                                                 (38) 
 
In Vitro/in vivo:              In vivo 
Type:                          Excretion 
Species:                       other: no data 
Doses, males:                  no data 
Doses, females:                no data 
Vehicle:                       no data 
Route of administration:       i.p. 
 
 
 
Method:           other: no data 
  Year:           1962 
   GLP:           no 
Test substance:   as prescribed by 1.1 - 1.4 
 
Result:           A significant portion (60-85%) of parenterally administered 
                  gluconate is excreted unchanged in the urine.  However, 
                  gluconate is readly catabolized (Wang et al., 1962) or OECD SIDS    SODIUM GLUCONATE 
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                  utilized for glucose synthesis, mainly from CO2 derived from 
                  carbon 1 and from glucogenic compounds derived from carbons 
                  2 through 6 of the gluconate (Stetten and stetten, 1950; 
                  Stetten and Topper, 1953).  Renal excretion of gluconate 
                  appears to be by tubular secretion (Herken et al., 1975) 
Reliability:      (3)  invalid 
                  Short abstract, secondary litterature, no data on test 
                  conditions, species, method used. 
10-NOV-2005                                                                 (20) 
 
 
5.1 Acute Toxicity 
 
 
5.1.1 Acute Oral Toxicity 
 
Type:             LDLo 
Species:          rat 
Strain:           Crj: CD(SD) 
Sex:              male/female 
No. of Animals:   10 
Vehicle:          no data 
Doses:            500, 1000, 2000 mg/kg 
Value:            > 2000 mg/kg bw 
 
Method:           other: no data 
  Year:           1995 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Result:           No death in males or females in any of the dose groups, 
                  minimum lethal dose estimated > 2000 mg/kg 
 
                  One female passed loose stools in 1000 mg/kg dose group, and 
                  all males and females passed loose or diarrheal in 2000 mg/g 
                  dose group but all animals recovered on the next day. 
 
                  Body weight: 
                  All males and females in all dose groups showed similar 
                  time-course changes in body weight. 
 
                  Autopsy: 
                  no abnormalities detected 
Test substance:   sodium gluconate 
Reliability:      (2)  valid with restrictions 
                  Short abstract not well documented but key study for initial 
                  assessment 
Flag:             Critical study for SIDS endpoint 
10-NOV-2005                                                                 (25) 
 
Type:             LDLo 
Species:          dog 
Strain:           Beagle 
Sex:              male/female 
No. of Animals:   2 
Vehicle:          no data 
Doses:            1000 and 2000 mg/kg 
Value:            > 2000 mg/kg bw OECD SIDS    SODIUM GLUCONATE 
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Method:           other: no data 
  Year:           1995 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Result:           No deaths were observed in 1000 or 2000 mg/kg dose groups. 
 
                  No changes likely to be associated with the test article 
                  were detected in observation of the general condition, body 
                  weight, food intake, hematological test, blood chemistry 
                  analysis, autopsy or weighing of organs. 
 
                  No toxicity was shown at the single dose of 2000 mg/kg 
                  (maximum dose that could be administered by gavage to beagle 
                  dogs) 
Test substance:   sodium gluconate 
Reliability:      (2)  valid with restrictions 
                  Short abstract not well documented but can be a key study 
                  for initial assessment. 
Flag:             Critical study for SIDS endpoint 
10-NOV-2005                                                                 (30) 
 
 
5.1.2 Acute Inhalation Toxicity 
 
 
5.1.3 Acute Dermal Toxicity 
 
 
5.1.4 Acute Toxicity, other Routes 
 
Type:             LDLo 
Species:          rabbit 
Strain:           no data 
Sex:              no data 
No. of Animals:   1 
Vehicle:          water 
Doses:            3270, 4360, 6540, 7194, 7630, 7848, 8720 
Route of admin.:  i.v. 
Value:            = 7630 mg/kg bw 
 
Method:           no data 
  Year:           1939 
   GLP:           no 
Test substance:   as prescribed by 1.1 - 1.4 
 
Result:           At the non lethal doses, no particular symptoms are observed 
                  except a reduction of the temperature of 2.5°C at the end of 
                  injection (3270 m/kg bw) and at higher non lethal doses can 
                  reach 3°C. 
 
                  Diffuse shaking and slight muscular contractions were also 
                  observed at the non lethal doses which stopped when the 
                  injection is interrupted. 
 
                  At the highest non lethal dose (7194 mg/kg bw), a growing 
                  weakness of the animal was observed (difficulty to stand on OECD SIDS    SODIUM GLUCONATE 
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                  its legs) during injection and it disappeared progressively 
                  after the injection. 
 
                  At the lethal doses, no serious observed cardiological 
                  effects were detected. A high reduction of the body t° was 
                  noted (up to 5.8°C), a higher number of the respiratory acts 
                  (not for dose 7848 mg/kg bw). Muscular contraction and high 
                  weakness. 
 
                  Respiration and heart rythms progressively slowered and 
                  death occurred at 15 to 24 hours after injection. 
 
                  Autopsy and histological examinations only revealed slight 
                  congestion in all organs.  The author explains that death is 
                  probably related to the depresive effect of the test 
                  substance on the activity of central nervous system. 
Test substance:   sodium gluconate 
Reliability:      (4)  not assignable 
                  Short abstract, secondary litterature, old study. 
10-NOV-2005                                                                 (10) 
 
 
5.2 Corrosiveness and Irritation 
 
5.2.1 Skin Irritation 
 
Species:          other: no data on sodium gluconate. See gluconic acid 
 
 
06-AUG-2004 
 
 
5.2.2 Eye Irritation 
 
Species:          other: no data for sodium gluconate. See gluconic acid 
 
 
06-AUG-2004 
 
 
5.3 Sensitization 
 
 
5.4 Repeated Dose Toxicity 
 
Type:                    Sub-acute 
Species:                 rat                               Sex: male/female 
Strain:                  Crj: CD(SD) 
Route of administration: gavage 
Exposure period:         4 weeks 
Frequency of treatment:  daily 
Doses:                   0, 500, 1000, 2000 mg/kg bw 
Control Group:           yes, concurrent no treatment 
NOAEL:                   = 1000 mg/kg bw 
NOAEL females :          = 2000 mg/kg bw 
 
Method:           other: no data 
  Year:           1995 OECD SIDS    SODIUM GLUCONATE 
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   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Result: 
                  No death or clinical signs of abnormality were observed in 
                  any of the groups. 
 
                  Histopathological examination showed a thickening of the 
                  limiting of the border of the stomach in 5/12 males at 2000 
                  mg/kg bw per day. No toxic changes associated with the test 
                  article were detected. 
 
                  As the limiting ridge is a tissue specific to rodents, this 
                  lesion is not toxicologically significant for humans. Other 
                  lesions occurred incidentally and were not related to 
                  treatment. 
 
                  The qualitative urinary analysis showed increased 
                  prevalences of urinary ketone bodies, urobilogen and 
                  phosphate sedimentation and increased urinary protein 
                  concentrations in all treated animals justified by 
                  interference in the assay. 
 
                  The non-toxic dose was estimated to be 1000 mg/kg/day for 
                  males and 2000 mg/kg/day for femal 
Test condition: 
                  Animals : 12 males and 12 females - 6 weeks of age 
 
                  Route : gavage of sodium gluconate in water at a volume of 
                  1ml/100g bw 
 
                  Satellite groups of 4 rats of each sex were included to 
                  determine the plasma concentration of sodium gluconate. 
 
                  Body weights and food consumption were measured on day 1 and 
                  every third or fourth day of the study. 
 
                  Ophthalmological examinations were performed on all animals 
                  at the start of the study and on 6 rats of each sex per 
                  group at week 4. 
 
                  Haematological and clinical chemical parameters were 
                  measured at the end of treatment on blood collected from 
                  fasted surviving rats on all animals at necropsy. 
 
                  Qualitative and quantitative urinary examinations (urinary 
                  pH, protein, ketones and glucose content) were performed on 
                  6 rats of each sex from each group at the end of treatment 
                  and water intake was measured over 24 hours. 
 
                  The weights of the brain, pituitary, thyroids, salivary 
                  glands, thymus, heart, lungs, liver, spleen, kidneys, 
                  adrenals, testes, prostate, seminal vesicles, ovaries, and 
                  uterus were recorded. 
 
                  Detailed histopathological examinations were performed on 
                  cerebrum, heart, lung, cecum, liver, kidney, testis, 
                  epididymis, prostate and eye on all control animals and OECD SIDS    SODIUM GLUCONATE 
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                  those receiving 2000 mg/kg bw per day and on all gross 
                  lesion 
Test substance:   sodium gluconate 
Reliability:      (2)  valid with restrictions 
                  Secondary litterature but described in sufficient detail in 
                  a recognised WHO report.  Acceptable for assessment. 
Flag:             Critical study for SIDS endpoint 
10-NOV-2005                                                                 (26) 
 
Type:                    Sub-acute 
Species:                 rat                               Sex: male/female 
Strain:                  Crj: CD(SD) 
Route of administration: oral feed 
Exposure period:         28 days 
Frequency of treatment:  daily 
Doses:                   0, 1000, 2000, 4100 mg/kg bw for males (and 0, 1000, 
                         2000, 4400 mg/kg bw females) 
Control Group:           other: 1.35% w/w NaCl (equivalent to the sodium 
                         concentration of the group receiving 5% sodium 
                         gluconate) 
NOAEL:                   = 4100 mg/kg bw 
 
Method:           other: no data 
  Year:           1997 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Remark:           The JECFA committee (Joint FAO/WHO Expert Committee on Food 
                  Additives) who has evaluated this report concluded that this 
                  study is not suitable for identifying a NOAEL because of the 
                  small group sizes and the positive findings in the 
                  qualitative analysis. 
Result:           No death occurred during the study period.  No changes  in 
                  the general condition, body weight or food and water intake, 
                  were observed in the animals over the study period.  No 
                  revisions were observed in the investigated ophthalmologic 
                  tests, urinalysis, heamatology  and blood chemistry over the 
                  study period.  In addition, histopathological examination 
                  indicated no adverse effects as a result of the treatment 
                  regime. 
 
                  Statistically significant differences in some urinary 
                  parameters (no specific data in the report) were reported in 
                  animals receiving 2.5 or 5% sodium gluconate when compared 
                  with those on basal diet; however, these differences were 
                  comparable to those observed in the NaCl control group and 
                  appeared to be related to the high sodium concentration of 
                  the sodium gluconate. 
 
                  Qualitative measurements of urinary protein showed 
                  significantly increased concentrations in females at 
                  2.5 and 5% sodium gluconate when compared with those on 
                  basal diet. Males at 5% showed a tendency for increased 
                  urinary protein concentrations, while the concentrations 
                  in males at 2.5% were not affected. The author reported that 
                  the increases in urinary protein were due to assay 
                  interference, however, the report does not provide detailed 
                  information. OECD SIDS    SODIUM GLUCONATE 
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                  Qualitative measurements of urinary ketone bodies also 
                  showed increases in males at 2.5% sodium gluconate. 
 
 
                  The authors concluded that the NOAEL was 5% 
                  (equal to 4100 mg/kg bw per day).  The JECFA committee who 
                  evaluated this report  has considered that effects shown in 
                  the qualitative urine analyses are related to the high 
                  sodium intake arising from the sodium gluconate. 
Source:           Glucono-delta-Lactone and the Calcium, Magnesium, Potassium 
                  and Sodium Salts of Gluconic acid, in Safety Evaluation of 
                  Certain Food Additives, WHO Food Additives Series 42, 
                  prepared by the 51st meeting of the Joint FAO/WHO Expert 
                  Committee on Food Additives, World Health Organisation, 
                  Geneva, 1999 (absorption, distribution and excretion, acute 
                  toxicity, short-term toxicity, long-term toxicity, 
                  reproductive and developmental toxicity, genotoxicity, 
                  observations in humans, 24 references). 
Test condition:   Animals : Sprague-Dawley SPF rats [Crj:CD (SD)] in groups of 
                  10 males and 10 females 
 
                  Oral feed: 0, 1.25, 2.5, 5 % w/w or 0, 1000, 2000, 4100 
                  mg/kg bw for males (and 0, 1000, 2000, 4400 mg/kg bw 
                  females) sodium gluconate and 1.35 %w/w sodium chloride 
                  (equivalent to the sodium content of diet containing 5% 
                  sodium gluconate) in order to differentiate the potential 
                  effects of high doses of sodium intake. 
 
                  Body weights and food consumption were measured on day 1 and 
                  every third or fourth day of the study.  food-efficiency was 
                  calculated from the body-weight gain and food consumption. 
                  Ophthalmological examinations were performed on all animals 
                  at the start of the study and on 6 rats of each sex per 
                  group at week 4. 
 
                  Haematological and clinical chemical examinations were 
                  performed on all animals at necropsy. 
 
                  Qualitative and quantitative urinary examinations (urinary 
                  pH, protein, ketones and glucose content) were performed at 
                  the end of treatment and water intake was measured over 24 
                  h.  The weights of the brain, pituitary, thyroids, salivary 
                  glands, thymus, heart, lungs, liver, spleen, kidneys, 
                  adrenals, testes, prostate, seminal vesicles, ovaries, and 
                  uterus were recorded.  Detailed histopathological 
                  examinations were performed on cerebrum, heart, lung, cecum, 
                  liver, kidney, testis, epididymis, prostate and eye from all 
                  animals at 0% and 5 % sodium gluconate and the NaCl control 
                  group and on all gross lesions. 
Test substance:   sodium gluconate 
Reliability:      (2)  valid with restrictions 
                  Secondary litterature but described in sufficient detail in 
                  a recognised WHO report.  Acceptable for assessment. 
Flag:             Critical study for SIDS endpoint 
10-NOV-2005                                                                 (27) 
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Species:                 dog                               Sex: male/female 
Strain:                  Beagle 
Route of administration: oral unspecified 
Exposure period:         4 weeks 
Frequency of treatment:  no data 
Doses:                   0, 500, 1000, 2000 mg/kg 
Control Group:           yes 
NOAEL:                   = 500 mg/kg 
 
Method:           other: no data 
  Year:           1995 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Result:           None of the animals died during the period of treatment in 
                  any dose group. 
 
                  Statistically significant increased frequency of vomiting 
                  and passage of loose or watery stools in 1000 and 2000 mg/kg 
                  dose groups was observed, as compared to controls. 
 
                  No significantly toxicologically changes were detected in 
                  the body weight, food intake, water intake, urinalysis, 
                  hematologic test, blood chemistry analysis, ophthalmologic 
                  test, electrocardiography, autopsy and organ weight or in 
                  histopathological examination. 
 
                  The non-toxic dose under the conditions of this testing was 
                  therefore estimated to be 500 mg/kg/day.  However, the 
                  toxicological effects observed (vomiting, passage of loose 
                  or watery stools) were considered extremely slight since 
                  other tests didn't show the same changes. 
Test condition: 
                  Animals : groups of 4 males and 4 females 
                  Route : oral unspecified 
 
 
                  Observation on the general conditions of the animals was 
                  noted daily before and after dosing during treatment. 
 
 
                  Ophthalmological examinations were performed on all animals 
                  1 week before dosing and at the third week of the study. 
 
                  Qualitative and quantitative urinary examinations (urinary 
                  pH, protein and glucose) were performed on weeks 2 and 1 
                  before dosing and on weeks 2 and 4 during the study. 
 
                  Haematological and clinical chemical parameters were 
                  measured at the end of treatment on blood collected from 
                  fasted surviving rats on all animals at necropsy. 
 
                  The weights of the brain, pituitary, thyroids, salivary 
                  glands, thymus, heart, lungs, liver, spleen, kidneys, 
                  adrenals, testes, prostate, seminal vesicles, ovaries, and 
                  uterus were recorded. 
 
                  Detailed histopathological examinations were performed on OECD SIDS    SODIUM GLUCONATE 
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                  the cerebrum, cerebellum, medulla oblongata, spinal cord, 
                  sciatic nerve, aorta,heart, larynx, trachea, lung, tongue, 
                  esophagus, stomach, duodenum, jejunum, ileum, cecum, colon, 
                  rectum, submandibular gland, sublingual gland, parotid 
                  gland, liver, gallbladder, pancreas, pituitary, thyroid, 
                  parathyroid, adrenal, thymus, spleen, submandibular lymph 
                  node, mesenteric lymph node, kidney, urinary bladder, 
                  testis, epididymis, prostate, mammary gland, skin, eye, 
                  optic nerve, lacrimal gland, bone marrow of sternum and 
                  femur and femoral muscl 
Test substance:   sodium gluconate 
Reliability:      (2)  valid with restrictions 
                  Abstract not sufficiently detailed but could be acceptable 
                  for an initial assessment. 
Flag:             Critical study for SIDS endpoint 
10-NOV-2005                                                                 (29) 
 
Type:                    Sub-acute 
Species:                 dog                               Sex: no data 
Strain:                  Beagle 
Route of administration: oral feed 
Exposure period:         1 week 
Frequency of treatment:  daily 
Doses:                   1500 mg/kg 
Control Group:           yes 
 
Method:           other: no data 
  Year:           1997 
   GLP:           no 
Test substance:   as prescribed by 1.1 - 1.4 
 
Method:           Sodium gluconate was administered to beagle dogs (3 animals 
                  per group) in dosage 
                  of 0 and 1500 mg/kg as an additive to food or in capsules 
                  for 1 week. 
 
                  Vomiting and fecal properties were compared between two 
                  methods of administration and confirmed. 
 
                  As a reference article, 405 mg/kg of sodium chloride (NaCl) 
                  was administered likewise. 
Result:           None of the animals died during the period of observation in 
                  any dose group. 
 
                  Passage of loose stools only was detected in the sodium 
                  gluconate diet group,and vomiting and loose stools were 
                  detected in the capsule group.  Only vomiting was detected 
                  in the NaCl containing diet group and the capsule group. 
                  The above findings suggested that vomiting was caused by 
                  physical stimulation by massive administration of the test 
                  article in capsules or caused by sodium chloride in the test 
                  substance.  Loose stools seemed to be related to homeostatic 
                  adjustment to increased osmolarity following administration 
                  of a solution of the test article. 
Test substance:   sodium gluconate 
Reliability:      (3)  invalid 
                  Short abstract on a comparison of 2 methods of 
                  administration of sodium gluconate. OECD SIDS    SODIUM GLUCONATE 
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10-NOV-2005                                                                 (28) 
 
Type:                    Sub-acute 
Species:                 rat                               Sex: no data 
Strain:                  no data 
Route of administration: oral feed 
Exposure period:         10 days 
Frequency of treatment:  daily 
Doses:                   450 mg/kg/day 
Control Group:           no data specified 
 
Method:           other: no data 
  Year:           1942 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Result:           metabolic rate reduced.  However, the rate returned to 
                  normal when the gluconate feeding was discontinued.  Also, 
                  gluconic acid fed at approximately 400 mg/kg per day had no 
                  effect on the metabolic rate.  These results suggest that 
                  the observed effects were produced by the cations and not by 
                  the gluconate portion of the molecule. 
Source:           Evaluation of the Health Aspects of Sodium, Potassium, 
                  Magnesium and Zinc Gluconates as Food Ingredients, SCOGS-78, 
                  prepared for Bureau of Foods, Food and Drug Administration, 
                  Department of Health, Education, and Welfare, Washington 
                  D.C., Contract No. FDA 233-75-2004, Life Science Research 
                  Office, Federation of American Societies for Experimental 
                  Biology, 9650 Rockville Pike Bethesda, Maryland, 1978 
                  (absorption and methabolism, acute toxicity, short-term 
                  studies, teratogenicity, mutagenicity, 26 references). 
Test substance:   sodium gluconate 
Reliability:      (4)  not assignable 
                  Short abstract, secondary litterature, old study, no data on 
                  sample size 
10-NOV-2005                                                                  (1) 
 
5.5 Genetic Toxicity 'in Vitro' 
 
Type:                    other: Saccharomyces Cerevisiae and Salmonella 
                         typhimurium reverse mutation assay 
System of testing:       bacterial and non bacterial 
Concentration:           bacteria: 0.006%, 0.0012 %,  0.0024 % and yeast: 1.25%, 
                         2.50% and 5.00% 
Cytotoxic Concentration: 50% survival in bacteria calculated was at 0.0024 % 
                         test substance and 5% for yeast 
Metabolic activation:    with and without 
Result:                  negative 
 
Method:           OECD Guide-line 471 
  Year:           1975 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Method:           A. Toxicity: 
 
                  The solubility, toxicity and doses for all chemicals were 
                  determined prior to screening. OECD SIDS    SODIUM GLUCONATE 
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                  Each chemical was tested on the strains over a range of 
                  doses (10, 1.0, 0.1, 0.01, 0.001 %) to determine the 
                  concentration that lead to 50% survival.  Bacteria were 
                  tested in phosphate buffer, pH 7.4 for one hour at 37°c on a 
                  shaker.  Yeasts were tested in phosphate buffer, pH 7.4 for 
                  4 hours at 30°c on a shaker.  The 50% survival curve and the 
                  1/4 and 1/2 50% doses calculated.  If no toxicity was 
                  obtained for a chemical with a given strain, a maximum dose 
                  of 5% (w/v) was used. 
 
                  The doses calculated for the tests in buffer were applied to 
                  the activation tests.  The solubility of the test substance 
                  under treatment conditions  was measured and  sodium 
                  gluconate is insoluble in dimethylsulfoxide (DMSO) 
 
 
                  --------------------------------------------- 
                  B. Plate tests (overlay method) 
 
                  Approximately 10 exp9 cells from a log phase culture of each 
                  strain were added to test tubes containing 2.0 ml of molten 
                  agar supplemented with biotin and a trace of histidine.  For 
                  nonactivation tests, the 3 dose levels of the test compound 
                  were added to the tubes and poured over the surfaces of 
                  selective agar plates. 
 
                  In activation tests, the 9000 x g tissue supernatant and 
                  required cofactors (core reaction mixture) were added to the 
                  overlay tubes. 3 dose levels of the test chemical were added 
                  to the tubes, which were mixed and content poured over the 
                  surface of a minimal agar (selective medium) plate and 
                  allowed to solidify. 
 
                  The plates were incubated for 48 to 72 hours at 37°C, and 
                  scored for colonies growing on each plate.  Positive and 
                  solvent controls were run with each assay. 
                  ------------------------------------------------------- 
                  C.  Suspension tests 
 
                  1. Nonactivation 
 
                  Log phase bacteria and stationary phase yeast cultures were 
                  grown in complete broth, washed and resuspended in 0.9% 
                  saline to densities of  1 x 10 exp9 cells/ml and 5 x 10 exp7 
                  cells/ml respectively.  Tests were conducted in plastic 
                  tissue culture plates. Cells plus chemicals were added to 
                  the wells to give a final volume of 1.5 ml.  The solvent 
                  replaced the test chemical in the negative controls. 
                  Treatment was at 30°C for 4 hours for yeast tests and at 
                  37°c for one hour for bacterial tests.  All flasks were 
                  shaken during treatment.  After treatments, the plates were 
                  set on ice.  Aliquots of cells were removed, diluted in 
                  sterile saline (4°c) and plated on the appropriate complete 
                  media.  Undiluted samples from flasks containing the 
                  bacteria were plated on minimal selective medium in 
                  reversion experiments.  Samples from a 1/10 dilution of 
                  treated cells were plated on the selected media for OECD SIDS    SODIUM GLUCONATE 
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                  enumeration of gene conversion with strain D4. 
 
                  Bacterial plates were scored after incubation for 48 hours 
                  at 37°C.  The yeast plates were incubated at 30°C for 3-5 
                  days before scoring. 
 
                  2. Activation 
 
                  Bacteria and yeast cells were grown and prepared as 
                  described in the nonactivation tests.  Measured amounts of 
                  the test and control chemicals plus 0.25 ml of the 
                  stock-cell suspension were added to wells of the Linbro 
                  plate containing the appropriate tissue fraction and 
                  reaction mixture.  All flasks (bacteria and yeast) were 
                  incubated at 37°c in an oxygen atmosphere with shaking.  The 
                  treatment times, dilutions, plating procedure and scoring of 
                  the plates were the same as described for non activation 
                  tests. 
Remark:           This study was conducted using 3 bacteria strains 
                  (salmonella typhimurium) and one yeast strain (saccharomyces 
                  cervisiae) rather than a fourth bacteria strain as 
                  indicators for this in vitro microbial assay with and 
                  without metabolic activation.  Therefore, the results of 
                  this report on bacteria and yeast are included in the same 
                  entry. 
Result:           A. Salmonella typhimurium: 
 
                  1. Plate tests: negative 
 
                  2. Nonactivation suspension tests: negative 
 
                  3. Activation suspension tests: negative (the 0.0024% dose 
                  with TA-1538 using mouse lung tissue fraction and the doses 
                  with TA-1537 usring rat lung tissue fraction were repeated 
                  because of low population counts. 
                  -------------------------------------------------- 
 
                  B. Saccharomyces cerevisiae 
 
                  1. Non-activation suspension tests: negative (the 2.50% dose 
                  was repeated because of a low mutant plate count. 
 
                  2. Activation suspension tests: negative 
 
 
                  Conclusion: 
 
                  The test compound sodium gluconate did not exhibit genetic 
                  activity in any of the assays employed in study. 
Test condition:   Strains tested: 
 
                  Yeast: Saccharomyces Cerevisiae, Strain D4 
 
                  Bacteria: Salmonella typhimurium, strains: TA1535, TA1537, 
                  TA1538 
 
                  ------------------------------ 
                  Reaction mixture: OECD SIDS    SODIUM GLUCONATE 
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                  Component:               Final concentration/ml 
                  TNP (sodium salt)               6 µM 
                  Isocitric acid                  49 µM 
                  Tris buffer, pH 7.4             28 µM 
                  MgCl2                          1.7 µM 
                  Homogenate fraction 
                  equivalent to 25 mg 
                  of wet tissue 
                  -------------------------------- 
                  Tissue homogenates and supernatants: 
 
                  The tissue homogenates and supernatants (9000 g) were 
                  prepared from tissues of mouse (ICR random bred adult 
                  males); rat (Sprague-Dawnley adult males) and monkey (Macaca 
                  mulatta adult males) 
                  --------------------------------- 
                  Positive controls in direct and activation assays: 
 
                  Non activation: 
 
                  Chemical                Solvent         Probable mutagenic 
                                                          specificity 
                  Ethyl 
                  methanesulfonate (EMS)  water or saline     base-pair 
                                                              substitution 
                  2-nitrofluorene  (NF)    dimethylsulfoxide   frameshift 
                  Quinacrine mustard (QM) water or saline     frameshift 
 
                  *************************** 
                  Activation: 
 
                  Chemical                    Solvent      Probable mutagenic 
                                                                specificity 
                  Dimethylnitrosamine (DMN)   water or saline   base-pair 
                                                                substitution 
                  2-acetylaminofluorene (AAF) dimethylsulfoxide frameshift 
                  8-Aminoquinoline (AMQ)      dimethylsulfoxide frameshift 
 
                  Concentration of positive controls: 
 
                  Non activation: 
                  TA-1535  EMS 10µl/plate 
                  TA-1537 QM 20 µg/plate 
                  TA-1538 NF 100 µg/plate 
 
                  Activation: 
                  TA-1535 ANTH (DMN ?) 100 µM/plate 
                  TA-1537 AMQ  100 µg/plate 
                  TA-1538 AAF  100 µg/plate 
 
 
                  No information is reported on the positive control origin 
                  and criteria used for determining the positive result. 
Test substance:   sodium gluconate: no data on purity of substance 
Reliability:      (2)  valid with restrictions 
                  OECD guideline  No. 471 followed except that the study 
                  was made on one yeast strain : saccharomyces OECD SIDS    SODIUM GLUCONATE 
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                  cerevisiae, strain D4 and 3 bacteria strains: S. typhimurium 
                  TA1535, TA1537 and TA 1538 
 
                  Positive controls different from the ones described in the 
                  OECD guideline No 471 
 
                  The study was made only on 3 test concentrations. 
Flag:             Critical study for SIDS endpoint 
25-JAN-2006                                                                 (21) 
 
5.6 Genetic Toxicity 'in Vivo' 
 
Type:             other: in vivo chromosomal aberration test with mouse bone 
                  marrow cells 
Species:          mouse                             Sex: male 
Strain:           C57BL 
Route of admin.:  oral feed 
Exposure period:  single dose and 4 days 
Doses:            single dose administration : 2.5, 5 and 10 g/kg 
                  4 day repeated dose: 1.25 and 2.5 g/kg 
Result:           negative 
 
Method:           other: no data specified 
  Year:           1974 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Method:           After receiving the single dose and the repeated dose test 
                  substance, the animals were sacrified at 24 hours (single 
                  dose) and 27 hours after last administration (4-days 
                  repeated dose). 0.3 ml of 500 µg/ml colchicine was 
                  intraperitoneally injected to each mouse at one hour before 
                  sacrifice so that the metaphase cells could be observed. 
 
                  After the bone marrow cells were washed, treated and fixed 
                  with a fixing solution (1:3 acetic acid:ethanol solution), 
                  the cells were suspended and dripped on a slide glass and 
                  stained with Giemsa solution and examined. 
 
                  Examination: 
 
                  At least 200 metaphase cells per mouse were examined for the 
                  presence or absence of chromosomal aberrations (gaps, 
                  breaks, translocation, fragments, ring chromosomes and 
                  minutes chromosome) 
Result:           Single dose administration: 
 
                  At 10 and 5 g/kg, all mice died. 
 
                  At 2.5 g/kg, observation could be made only on 2 
                  animals(preparation of the chromosome specimen failed). 
 
                  MMC induced chromosomal aberrations in at least 20% of bone 
                  marrow cells. 
 
                  Sodium gluconate induced chromosomal aberrations in the 
                  cells at a frequency of about 0.5% is comparable to the 
                  control. (1 gap and 1 minute chromosome for 283 cells). OECD SIDS    SODIUM GLUCONATE 
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                  ******************************************************* 
                  4-day repeated dose administration: 
 
                  At 1.25 and 2.5 g/kg, one mouse died in each group. 
 
                  MMC induced chromosomal aberrations at about 30% cells. 
 
                  The frequency of cells with chromosomal aberrations was 0.5% 
                  in the test groups which is comparable to the control group. 
 
 
                  Conclusion: Induction of chromosomal aberration by sodium 
                  gluconate was not detected after in vivo single and repeated 
                  dose 
                  treatment. 
Test condition:   Animals: 
 
                  Male C57BL/6 mice aged 12 or 13 weeks 
 
                  Materials: 
 
                  Test substance: sodium gluconate dissolved with 0.9% 
                  physiological saline solution and orally administered at a 
                  dose of 1ml/mouse 
 
                  Positive control: MMC (mitomycin C) dissolved with 0.9% 
                  physiological saline solution and administered 
                  intraperitoneally at a dose of 0.5 ml/mouse 
 
                  ------------------------------------------------- 
                  Single dose administration : 
                  ------------------------------------------------- 
 
                  Control (physiological solution) : 
                  group 1 - 3 animals 
 
                  MMC:   
                  group 1 - 2 animals - 5 mg/kg (intraperitoneal) 
 
                  Sodium gluconate : 
                  group 1 - 3 animals - 10 g/kg 
                  group 2 - 3 animals - 5 g/kg 
                  group 3 - 3 animals - 2.5 g/kg 
 
                  ------------------------------------------------ 
                  4-day repeated dose administration : 
                  ------------------------------------------------- 
 
 
                  Control (physiological solution) : 
                  group 1 - 2 animals 
 
                  MMC:   
                  group 1 - 2 animals - 5 mg/kg (single dose intraperitoneal) 
 
                  Sodium gluconate : 
                  group 1 - 3 animals - 2.5 g/kg 
                  group 2 - 2 animals - 1.25 g/kg OECD SIDS    SODIUM GLUCONATE 
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Test substance:   sodium gluconate: no data on purity of the substance 
Reliability:      (2)  valid with restrictions 
                  Translation of a report not fully documented but sufficient 
                  for initial assessment 
 
Flag:             Critical study for SIDS endpoint 
10-NOV-2005                                                                 (37) 
 
 
5.7 Carcinogenicity 
 
 
5.8.1 Toxicity to Fertility 
 
 
5.8.2 Developmental Toxicity/Teratogenicity 
 
Species:                   rat                               Sex: female 
Strain:                    Wistar 
Route of administration:   gavage 
Exposure period:           from day 6 to day 15 of gestation 
Frequency of treatment:    daily 
Duration of test:          10 days 
Doses:                     0, 5.94, 27.6, 128.0, 594.0 mg/kg 
Control Group:             yes, concurrent vehicle 
NOAEL Maternal Toxity:     > 594 mg/kg bw 
NOAEL Teratogenicity:      > 594 mg/kg bw 
Result:                    non teratogen 
 
Method:           other: no data specified 
  Year:           1973 
   GLP:           no 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under 
                  glucono-delta-lactone SIDS dossier. 
Test substance:   Glucono-delta-lactone 
Reliability:      (1)  valid without restriction 
Flag:             Critical study for SIDS endpoint 
10-NOV-2005                                                                  (4) 
 
Species:                   mouse                             Sex: female 
Strain:                    CD-1 
Route of administration:   gavage 
Exposure period:           from day 6 to day 15 of gestation 
Frequency of treatment:    daily 
Duration of test:          10 days 
Doses:                     0, 6.95, 32.5, 150, 695 mg/kg 
Control Group:             yes, concurrent vehicle 
NOAEL Maternal Toxity:     > 695 mg/kg bw 
NOAEL Teratogenicity:      > 695 mg/kg bw 
Result:                    non teratogen 
 
Method:           other: no data specified 
  Year:           1973 
   GLP:           no 
Test substance:   other TS 
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Remark:           Data for the category: see details of study under 
                  glucono-delta-lactone SIDS dossier. 
Test substance:   Glucono-delta-lactone 
Reliability:      (1)  valid without restriction 
Flag:             Critical study for SIDS endpoint 
10-NOV-2005                                                                  (4) 
 
Species:                   rabbit                            Sex: female 
Strain:                    Dutch 
Route of administration:   gavage 
Exposure period:           from day 6 to 18 of gestation 
Frequency of treatment:    daily 
Duration of test:          13 days 
Doses:                     0, 7.80, 36.2, 168.5, 780.0 mg/kg 
Control Group:             yes, concurrent vehicle 
NOAEL Maternal Toxity:     > 780 mg/kg bw 
NOAEL Teratogenicity:      > 780 mg/kg bw 
Result:                    non teratogen 
 
Method:           other: no data specified 
  Year:           1973 
   GLP:           no 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under 
                  glucono-delta-lactone SIDS dossier. 
Test substance:   Glucono-delta-lactone 
Reliability:      (1)  valid without restriction 
Flag:             Critical study for SIDS endpoint 
10-NOV-2005                                                                  (5) 
 
 
Species:                   hamster                           Sex: female 
Route of administration:   gavage 
Exposure period:           from day 6 to day 10 of gestation 
Frequency of treatment:    Daily 
Duration of test:          5 days 
Doses:                     0, 5.60, 26.0, 121, 560 mg/kg 
Control Group:             yes, concurrent vehicle 
NOAEL Maternal Toxity:     > 560 mg/kg bw 
NOAEL Teratogenicity:      > 560 mg/kg bw 
Result:                    non teratogen 
 
Method:           other: no data specified 
  Year:           1973 
   GLP:           no 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under 
                  glucono-delta-lactone SIDS dossier. 
Test substance:   Glucono-delta-lactone 
Reliability:      (1)  valid without restriction 
Flag:             Critical study for SIDS endpoint 
10-NOV-2005                                                                  (4) 
 
Species:                   rat                               Sex: female 
Strain:                    Sprague-Dawley 
Route of administration:   oral unspecified OECD SIDS    SODIUM GLUCONATE 
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Exposure period:           from day 6 to day 15 of gestation 
Frequency of treatment:    daily 
Duration of test:          10 days 
Doses:                     1000 and 4000 mg/kg 
Control Group:             no data specified 
NOAEL Maternal Toxity:     > 4000 mg/kg bw 
NOAEL Teratogenicity:      > 4000 mg/kg bw 
Result:                    Non teratogen 
 
Method:           other: No data specified 
  Year:           1978 
   GLP:           no data 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under 
                  glucono-delta-lactone SIDS dossier. 
Test substance:   Glucono-delta-lactone 
Reliability:      (2)  valid with restrictions 
                  short abstract but acceptable for initial assessment 
Flag:             Critical study for SIDS endpoint 
10-NOV-2005                                                                  (6) 
 
Species:                   mouse                             Sex: female 
Strain:                    ICR 
Route of administration:   oral unspecified 
Exposure period:           from day 6 to day 15 of gestation 
Frequency of treatment:    daily 
Duration of test:          10 days 
Doses:                     1000 and 4000 mg/kg 
Control Group:             no data specified 
NOAEL Maternal Toxity:     > 4000 mg/kg bw 
NOAEL Teratogenicity:      > 4000 mg/kg bw 
Result:                    non teratogen 
 
Method:           other: no data specified 
  Year:           1978 
   GLP:           no data 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under 
                  glucono-delta-lactone SIDS dossier. 
Test substance:   Glucono-delta-lactone 
Reliability:      (2)  valid with restrictions 
                  short abstract but acceptable for initial assessment 
Flag:             Critical study for SIDS endpoint 
10-NOV-2005                                                                  (7) 
 
 
5.8.3 Toxicity to Reproduction, Other Studies 
 
 
5.9 Specific Investigations 
 
 
5.10 Exposure Experience 
 
Type of experience:  Human - Exposure through Food 
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Remark:              On the basis of a re-evaluation of data previously 
                     considered by JECFA and new data on the short-term toxicity 
                     of sodium gluconate, the Committee extended the previous 
                     ADI 
                     'not specified' for glucono-delta-lactone to a group ADI 
                     for 
                     glucono-delta-lactone and the calcium, magnesium, 
                     potassium, 
                     and sodium salts of gluconic acid. 
01-AUG-2003                                                                 (43) 
 
Type of experience:  Human - Exposure through Food 
 
Remark:              Gluconic acid and its salts have been used in various 
                     applications in the food industry.  As a sequestrant, 
                     sodium 
                     gluconate finds broad application in cleaning solutions for 
                     the food industry.  Also, sodium gluconate has been used in 
                     indirect application in washing solutions for eggs, 
                     denuding 
                     tripe, and for preventing the staining of the exteriors of 
                     canned goods by cooling and retort water.  Sodium and 
                     calcium gluconate have been utilized as a partial 
                     replacement for sodium chloride in sausage products.  The 
                     emulsifying and water binding properties of the sausage as 
                     well as the nutritional properties were improved. 
 
                     Over the past ten years, there has been considerable 
                     research conducted in Japan using sodium gluconate to 
                     complement sodium chloride in the extraction of proteins 
                     from fish muscle.  Surimi, which had excellent whiteness 
                     and 
                     good elasticity, was produced by replacing the phosphates 
                     in 
                     the process with sodium gluconate. 
 
                     A process to improve meat tenderness was developed by 
                     scientists at the US Meat Animal Research Center.  The 
                     calcium activated Tenderization process uses post-mortem 
                     injected calcium to activate the calpain tenderizing 
                     enzymes.  While the original work used calcium chloride, 
                     more recent tests showed a calcium gluconate compound 
                     equally effective. 
 
                     Sodium and potassium gluconate have a unique impact on 
                     taste 
                     perception.  The gluconates perform a debitterant function 
                     when used with artificial sweeteners, i.e. saccharine, 
                     cyclamates and aspartame. 
 
                     Sodium gluconate is sometimes used as an ingredient in 
                     sugar 
                     replacement packets and diet beverages. The artificial 
                     sweetener, Aspartame, when used alone has a defect in that 
                     its sweeteness is slightly delayed in onset and tends to 
                     remain longer on the tongue.  The gustatory quality of 
                     aspartame is improved to be more like sucrose with the 
                     addition of sodium gluconate. OECD SIDS    SODIUM GLUCONATE 
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                     Potassium gluconate has been shown to suppress the 
                     sweeteness of hydrolized lactose without producing 
                     bitterness or off-flavors. 
 
                     Fujisawa Pharmaceutical Company, has conducted research on 
                     the reduction of sodium in foods.  Fujisawa scientists have 
                     developed a "low sodium" type product that combines sodium 
                     chloride with potassium gluconate.  Extensive tests have 
                     shown its functionality in various food products. 
14-AUG-2003                                                                 (12) 
 
Type of experience:  Human - Medical Data 
 
Remark:              Sodium gluconate is also used in pharmaceutical injection 
                     solutions in concentrations up to 55 g/l. 
 
                     Company      Product    Sodium gluconate 
                               Content 
                     ---------------------------------------------------- 
                     Abbott 
                     Laboratories  Normosol R Inj    5.02 g/l 
                         Normosol R W 5%   5.02 g/l 
                         dextrose Inj     
                     Baxter    Plasmalyte 148    5.02 g/l 
                         Plasmalyte 148     5.02 g/l 
                         in 5% dextrose inj   
                     B. Braun 
                      Medical Isolyte S    5.00 g/l 
                         Isolyte S     5.00 g/l 
                         with 5% dextrose inj 
                         Isolyte S pH 7.4  5.00 g/l 
                         Hyperlyte    43.6 g/l 
                     Pharmaceutical 
                     Partners 
                      of Canada  Lypholyte - Liq IV  55 g/l 
 
                     http://www.hc-sc.gc.ca/hpb/drugs-dpd/ 
10-NOV-2005                                                                  (2) 
 
 
5.11 Additional Remarks 
 
Type:             other 
 
Remark:           Opinion of the SCF in Reports of the Scientific Committee 
                  for Food, Twenty-fifth series (1991), First series of food 
                  additives of various technological functions (opinion 
                  expressed on 18 May 1990) 
 
                  Gluconate and glucono-delta-lactone: 
 
                  Consideration of these substances may be based on the 
                  metabolic evidence as intermediates of normal glucose 
                  metabolism in mammalian species. There is considerable 
                  experience with gluconates in man and animals. A single 
                  long-term test at one dose level showed no evidence of 
                  carcinogenicity for the lactone. Teratogenic tests have OECD SIDS    SODIUM GLUCONATE 
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                  shown no abnormalities in 4 species. In view of their role 
                  in the glucose metabolism in mammals the Committee agrees 
                  with the group ADI not specified established by JECFA 
 
10-NOV-2005                                                                 (31) 
 
Type:             other 
 
Remark:           Opinion of the Select Committee on GRAS substances: 
 
                  Gluconates are useful as nutritional supplements since their 
                  high solubility allows relatively rapid absorption of the 
                  cations. Evidence suggests that any possible toxicity is a 
                  function of the cation rather than of the gluconate portion 
                  of these substances. Thus, the acute toxic responses to the 
                  various gluconate salts are comparable with other salts of 
                  the same metals and long-term toxicities seem related to the 
                  tissue deposition of these metals. These observations could 
                  have been anticipated because gluconic acid is a normal 
                  metabolic product of glucose. The amount of gluconic acid 
                  produced endogenously is many times greater than the largest 
                  amounts likely to be consumed from food. Because the 
                  toxicological activities of these gluconates appear to be a 
                  function of their cationic components, safe and acceptable 
                  levels in foods are limited only by the nature of the 
                  specific cations. Based on the foregoing, the Select 
                  Committee concludes that there is no evidence in the 
                  available information on sodium gluconate, potassium 
                  gluconate, magnesium gluconate and zinc gluconate that 
                  demonstrates or suggests reasonable grounds to suspect a 
                  hazard to the public when they are used at levels that are 
                  now current or that might reasonably be expected in the 
                  future. 
 
17-OCT-2003                                                                  (3) 
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1.0.1 Applicant and Company Information 
 
Type:             lead organisation 
Name:             The Gluconic acid and its sodium, potassium and calcium salts 
                  and glucono-delta-lactone consortium 
Contact Person:   Jean-Philippe Montfort    Date: 02-APR-2003 
Street:           Rue Blanche 25 
Town:             1060 Brussels 
Country:          Belgium 
Phone:            +32 2 541 05 70 
Telefax:          + 32 2 541 05 80 
Email:            montfort@khlaw.be 
 
Remark:           Sponsor Country for this Category: Belgium; Co-sponsor 
                  country: Japan. 
12-DEC-2005 
 
Type:             manufacturer 
Name:             FUSO Chemical Co. Ltd 
Contact Person:   Ph.D. Shinichi Sugita     Date: 
Street:           Iwamoto-cho Toyo Building, 1-2 Iwamoto-cho 3-chome, Chiyoda-ku 
Town:             101 0032  Tokyo 
Country:          Japan 
Phone:            +81 3 5820 1611 
Telefax:          +81 3 5820 1634 
Email:            Shinichi.Sugita@fusokk.co.jp 
 
03-AUG-2004 
 
Type:             manufacturer 
Name:             Jungbunzlauer International AG 
Contact Person:   Raphaël Singer            Date: 17-APR-2003 
Street:           St. Alban-Vorstadt 90 
Town:             4002 Basel 
Country:          Switzerland 
Phone:            +41 61 295 51 25 
Telefax:          +41 61 295 52 66 
Email:            raphael.singer@jungbunzlauer.ch 
 
17-OCT-2003 
 
Type:             manufacturer 
Name:             Roquette Freres 
Contact Person:   Johnny Pallot             Date: 
Town:             62080 Lestrem Cedex 
Country:          France 
Phone:            +33 3 21 63 37 40 
Telefax:          +33 3 21 63 38 50 
Email:            JOHNNY.PALLOT@roquette.com 
 
31-JUL-2003 
 
Type:             manufacturer 
Name:             PURAC 
Contact Person:   Ton van Dongen            Date: 
Street:           PO BOX 21 
Town:             4200 AA Gorinchem 
Country:          Netherlands OECD SIDS    CALCIUM GLUCONATE 
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Phone:            +31 183 695 730 
Telefax:          +31 183 695 603 
Email:            t.van.dongen@purac.com 
 
03-AUG-2004 
 
 
1.0.2 Location of Production Site, Importer or Formulator 
 
 
1.0.3 Identity of Recipients 
 
 
1.0.4 Details on Category/Template 
 
 
Remark:           Glucono-delta-lactone, gluconic acid and its sodium, calcium 
                  and potassium salts have been proposed in a category, as the 
                  salts of gluconic acid freely dissociate to the gluconate 
                  anion and the respective cation. 
 
                  Glucono-delta-lactone (GDL) is the inner ester of gluconic 
                  acid formed by the removal of water. 
 
                  When glucono-delta-lactone is used in aqueous solution, it 
                  is slowly hydrolysed until an equilibrium is reached between 
                  gluconic acid and its delta-lactone. 
12-AUG-2004 
 
 
1.1.0 Substance Identification 
 
IUPAC Name:       calcium-di- 2,3,4,5,6 - pentahydroxy hexanoate anhydrous 
Smiles Code:      [Ca](OC(=O)C(O)C(O)C(O)C(O)CO)OC(=O)C(O)C(O)C(O)C(O)CO 
Mol. Formula:     C12H22O14Ca 
Mol. Weight:      430.4 
 
20-OCT-2003 
 
IUPAC Name:       calcium-di- 2,3,4,5,6 - pentahydroxy hexanoate monohydrate 
Mol. Formula:     C12H22O14Ca.H2O 
Mol. Weight:      448.4 
 
Remark:           CAS No for calcium gluconate monhydrate is 18016-24-5. 
12-AUG-2004 
 
 
1.1.1 General Substance Information 
 
Purity type:      typical for marketed substance 
Substance type:   organic 
Physical status:  solid 
Purity:           ca. 98 - 104 % w/w 
Colour:           white/off-white 
Odour:            none 
 
Remark:           Calcium gluconate is the calcium salt of gluconic acid, 
                  which is obtained from glucose (dextrose) by fermentation. OECD SIDS    CALCIUM GLUCONATE 
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                  Gluconic acid is produced naturally as a main metabolism 
                  product via the decomposition of glucose in foods such as 
                  wine or honey. 
09-AUG-2004 
 
 
1.1.2 Spectra 
 
 
1.2 Synonyms and Tradenames 
 
calcium gluconate 
 
11-JUN-2003 
 
mono calcium di-D(-)-pentahydroxycapronate 
 
11-JUN-2003 
 
 
1.3 Impurities 
 
Purity type:      typical for marketed substance 
 
Remark:           For food and/or medical applications the level of impurities 
                  complies with the restrictions laid down in the 
                  corresponding EU Directives. 
15-JAN-2004 
 
 
1.4 Additives 
 
 
Remark:           For all the chemicals of the category: no additives used 
10-NOV-2005 
 
 
1.5 Total Quantity 
 
Quantity:         ca. 4000 - 6000 tonnes produced in 2000 
 
09-AUG-2004 
 
 
1.6.1 Labelling 
 
 
Remark:           For all the chemicals in the category: proposal of Industry: 
                  no labelling required 
10-NOV-2005 
 
 
1.6.2 Classification 
 
Classified:       other, as in legislation 
 
Remark:           For all chemicals of the category: proposal of Industry: no 
                  classification required OECD SIDS    CALCIUM GLUCONATE 
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10-NOV-2005 
 
 
1.6.3 Packaging 
 
 
1.7 Use Pattern 
 
Type:             type 
Category:         Wide dispersive use 
 
Remark:           Data for the category: see sodium gluconate 
14-AUG-2003 
 
 
1.7.1 Detailed Use Pattern 
 
 
1.7.2 Methods of Manufacture 
 
 
1.8 Regulatory Measures 
 
 
1.8.1 Occupational Exposure Limit Values 
 
 
1.8.2 Acceptable Residues Levels 
 
 
1.8.3 Water Pollution 
 
 
1.8.4 Major Accident Hazards 
 
 
1.8.5 Air Pollution 
 
 
1.8.6 Listings e.g. Chemical Inventories 
 
 
1.9.1 Degradation/Transformation Products 
 
 
1.9.2 Components 
 
 
1.10 Source of Exposure 
 
Source of exposure: other 
 
Remark:             Data for the category: see sodium gluconate 
14-AUG-2003 
 
 
1.11 Additional Remarks 
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Memo:             Regulatory status 
 
Remark:           In the European Parliament and Council Directive 95/2/EC, 
                  calcium gluconate is listed as a generally permitted food 
                  additive (E578) and may be added to all foodstuffs, 
                  following the "quantum satis" principle, as long as no 
                  special regulations restrict the use. 
 
                  the US Food and Drug Administration (FDA) assigned calcium 
                  gluconate the "generally recognised as safe" (GRAS) status 
                  and permitted its use in food without limitation other than 
                  good manufacturing practice. 
14-AUG-2003 
 
1.12 Last Literature Search 
 
 
1.13 Reviews 
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2.1 Melting Point 
 
Value:            = 120 degree C 
 
Method:           other: no data 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Test substance:   Calcium gluconate monohydrate: -H2O 
Reliability:      (2)  valid with restrictions 
                  Data from Handbook or collection of data 
Flag:             Critical study for SIDS endpoint 
09-AUG-2004                                                                  (2) 
 
 
2.2 Boiling Point 
 
Value:            = 731.1 degree C 
 
Method:           other: calculated 
   GLP:           no 
Test substance:   as prescribed by 1.1 - 1.4 
 
Remark:           Estimated with MPBPVP (v1.41) program from US EPA (EPI 
                  v3.11) 
Reliability:      (2)  valid with restrictions 
                  Accepted calculation method 
Flag:             Critical study for SIDS endpoint 
09-AUG-2004 
 
 
2.3 Density 
 
Type:             bulk density 
Value:            ca. 300 - 650 kg/m3 
 
Method:           other: no data 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Reliability:      (4)  not assignable 
                  Data from an MSDS. No data on method used 
Flag:             Critical study for SIDS endpoint 
09-AUG-2004                                                                  (9) 
 
 
2.3.1 Granulometry 
 
 
2.4 Vapour Pressure 
 
Value:            = 0 hPa at 25 degree C 
 
Method:           other (calculated) 
   GLP:           no 
Test substance:   as prescribed by 1.1 - 1.4 
 
Remark:           Estimated with MPBPVP (v1.41) program from US EPA (EPI OECD SIDS    CALCIUM GLUCONATE 
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                  v3.11): 
 
                  Vapor Pressure Estimations (25 deg C): 
                    (Using BP: 731.14 deg C (estimated)) 
                    (Using MP: 320.57 deg C (estimated)) 
                      VP:  8.69E-034 mm Hg (Antoine Method) 
                      VP:  1.19E-022 mm Hg (Modified Grain Method) 
                      VP:  5.84E-017 mm Hg (Mackay Method) 
Result:           Selected VP:  1.19E-022 mm Hg or 1.58E-022 hPa (Modified 
                  Grain Method) 
Reliability:      (2)  valid with restrictions 
                  Accepted calculation method 
Flag:             Critical study for SIDS endpoint 
09-AUG-2004 
 
 
2.5 Partition Coefficient 
 
Partition Coeff.: octanol-water 
log Pow:          = -7.51 at 25 degree C 
 
Method:           other (calculated) 
   GLP:           no 
 
Remark:           Estimated with Kowwin  (v1.67) program from US EPA (EPI 
                  v3.11): 
Reliability:      (2)  valid with restrictions 
                  Accepted calculation method 
Flag:             Critical study for SIDS endpoint 
09-AUG-2004 
 
 
2.6.1 Solubility in different media 
 
Solubility in:    Water 
Value:            = 30 g/l at 20 degree C 
pH       value:   = 6 - 8.5 
         Conc.:   1 vol% degree C 
 
Method:           other: no data 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Reliability:      (4)  not assignable 
                  Data from an MSDS. No data on method used 
Flag:             Critical study for SIDS endpoint 
09-AUG-2004                                                                  (9) 
 
Solubility in:    Water 
Value:            = 35 g/l at 25 degree C 
 
Method:           other: no data 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Reliability:      (4)  not assignable 
                  Data from an MSDS. No data on method used 
Flag:             Critical study for SIDS endpoint OECD SIDS    CALCIUM GLUCONATE 
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09-AUG-2004                                                                  (4) 
 
Solubility in:    other: alcohol 
Descr.:           insoluble (< 0.1 mg/L) 
 
Method:           other: no data 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Reliability:      (4)  not assignable 
                  Data from an MSDS. No data on method used 
Flag:             Critical study for SIDS endpoint 
09-AUG-2004                                                                  (9) 
 
 
2.6.2 Surface Tension 
 
 
2.7 Flash Point 
 
 
2.8 Auto Flammability 
 
 
2.9 Flammability 
 
 
2.10 Explosive Properties 
 
 
2.11 Oxidizing Properties 
 
 
2.12 Dissociation Constant 
 
Acid-base Const.: pKa=3.70 
 
Method:           other: no data 
   GLP:           no data 
Test substance:   other TS 
 
Remark:           The dissociation in water is expected to be complete as the 
                  pKa values of gluconic acid found in literature range from 
                  3.5 to 3.8 
Test substance:   gluconic acid 
Reliability:      (2)  valid with restrictions 
                  Data from Handbook or collection of data 
Flag:             Critical study for SIDS endpoint 
12-AUG-2004                                                                 (20) 
 
Acid-base Const.: pKa = 1.22 
 
Method:           other: no data specified 
  Year:           1964 
   GLP:           no 
Test substance:   as prescribed by 1.1 - 1.4 
 
Reliability:      (4)  not assignable OECD SIDS    CALCIUM GLUCONATE 
2. PHYSICO-CHEMICAL DATA    ID: 299-28-5 
   DATE:  25.01.2006 
 
 UNEP  PUBLICATIONS  177
                  Secondary litterature. Old study 
Flag:             Critical study for SIDS endpoint 
09-AUG-2004                                                                 (16) 
 
 
2.13 Viscosity 
 
 
2.14 Additional Remarks 
 
 
11-JUN-2003 
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3.1.1 Photodegradation 
 
Type:             air 
 
Method:           other (calculated): Estimated with AOP (v1.91) program from US 
                  EPA (EPI v3.11) 
   GLP:           no 
Test substance:   as prescribed by 1.1 - 1.4 
 
Remark: 
                  OVERALL OH Rate Constant =  76.2553 E-12 cm3/molecule-sec 
 
                  HALF-LIFE =     0.140 Days (12-hr day; 1.5E6 OH/cm3) 
                  HALF-LIFE =     1.683 H 
Reliability:      (2)  valid with restrictions 
                  Accepted calculation method 
Flag:             Critical study for SIDS endpoint 
12-AUG-2004 
 
 
3.1.2 Stability in Water 
 
Type:             abiotic 
 
Method:           other: no data 
  Year:           1993 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Remark:           Stability constant for Ca2+  (25°C, µ=0.1) with gluconic 
                  acid = 1.22 
Reliability:      (2)  valid with restrictions 
                  Data from Handbook or collection of data 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                 (19) 
 
Type:             abiotic 
 
Method:           other: no data 
  Year:           1962 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Remark:           Stability constant of Calcium with gluconic acid : pK= 1.22 
Reliability:      (4)  not assignable 
                  Secondary litterature. Old study 
14-NOV-2005                                                                 (16) 
 
 
3.1.3 Stability in Soil 
 
 
3.2.1 Monitoring Data (Environment) 
 
 
3.2.2 Field Studies 
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3.3.1 Transport between Environmental Compartments 
 
Type:             fugacity model level III 
Media:            other 
Method:           other: calculated 
 
Remark:           Estimated with the Level III Fugacity Model program LEVEL3NT 
                  from US EPA (EPI v3.11) 
 
                  Chem Name   : D-Gluconic acid, calcium salt (2:1)  Molecular 
                  Wt: 430.38 
                  Henry's LC  : 6.74e-029 atm-m3/mole (calc VP/Wsol) 
                  Vapor Press : 1.19e-022 mm Hg  (Mpbpwin program) 
                  Liquid VP   : 9.97e-020 mm Hg  (super-cooled) 
                  Melting Pt  : 321 deg C (Mpbpwin program) 
                  Log Kow     : -7.51  (Kowwin program) 
                  Soil Koc    : 1.27e-008  (calc by model) 
 
                            Mass Amount    Half-Life    Emissions 
 
                  ---------------------------------------------------- 
                            (percent)        (hr)       (kg/hr) 
                  Air       1.06e-007       3.37         1000 
                  Water     38.8            55.9         1000 
                  Soil      61.2            55.9         1000 
                  Sediment  0.0345          224          0 
                  _______________________________________________________ 
 
                            Fugacity   Reaction   Advection  Reaction 
                  Advection (atm)      (kg/hr)    (kg/hr)   (percent)(percent) 
                  Air      1.57e-032  5.12e-005  2.49e-006  1.71e-006 8.3e-008 
                  Water    7.13e-035  1.13e+003  91.1       37.6      3.04 
                  Soil     4.17e-033  1.78e+003   0         59.3        0 
                  Sediment  3.17e-035  0.251      0.00162   0.00837   5.4e-005 
 
                  Persistence Time: 78.3 hr 
                  Reaction Time:    80.7 hr 
                  Advection Time:   2.58e+003 hr 
                  Percent Reacted:  97 
                  Percent Advected: 3.04 
 
                  Half-Lives (hr), (based upon Biowin (Ultimate) and Aopwin): 
 
                  Air:      3.367 
                  Water:    55.92 
                  Soil:     55.92 
                  Sediment: 223.7 
                  Biowin estimate: 3.848  (days ) 
 
                  Advection Times (hr): 
 
                  Air:      100 
                  Water:    1000 
                  Sediment: 5e+004 
Reliability:      (3)  invalid 
                  Limited reliability because the Henry's LC can neither be 
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                  group estimation method because of missing values for 
                  certain bonds/groups. 
 
                  The Henry's LC is therefore estimated by VP/Wsol. 
 
                  However, this program does not use the entered solubility 
                  (30 g/l) but the solubility determined by the WATERNT 
                  program (1000 g/l) for the estimation of the Henry's LC that 
                  is then used in the LEVEL3NT program. 
 
                  Indeed the Henry's LC estimated with the entered solubility 
                  is: 
                  Henrys LC [VP/WSol estimate using EPI values]: 
                  HLC:  2.246E-027 atm-m3/mole 
 
                  Whereas the Henry's LC estimated with the solubility 
                  determined by the WATERNT program is: 
                  Henrys LC [VP/WSol estimate using EPI values]: 
                  HLC:  6.739E-029 atm-m3/mole 
25-JAN-2006 
 
 
3.3.2 Distribution 
 
Media:            air - biota - sediment(s) - soil - water 
Method:           other (calculation) 
 
Remark:           Henry's law constant estimated with HENRY (v3.10) program 
                  from US EPA (EPI v3.11) 
 
                  Can neither be calculated with the bond estimation method 
                  nor with the group estimation method because of missing 
                  values for certain bonds/groups. 
 
                  -------------------------------------- 
 
                  Soil Adsorption Coefficient estimated with PCKOC (v1.66) 
                  program from US EPA (EPI v3.11) 
 
                  First Order Molecular Connectivity Index  : 12.487 
                  Non-Corrected Log Koc  :  7.2631 
                  Fragment Correction(s): 
                             2   Aliphatic Alcohol  (-C-OH)    : -3.0386 
                             2   Misc (C=O) Group (aliphatic attach)  : 
                  -2.4000 
                  Corrected Log Koc  . :  1.8245 
 
                  Estimated Koc:  66.76 
Reliability:      (2)  valid with restrictions 
                  Accepted calculation method 
Flag:             Critical study for SIDS endpoint 
09-AUG-2004 
 
 
3.4 Mode of Degradation in Actual Use 
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3.5 Biodegradation 
 
Type:             aerobic 
Inoculum:         other: secondary effluent of a municipal sewage plant 
                  (Breisgauer Bucht, 500000 population equivalent), 0.4 ml/l 
Concentration:    3 mg/l related to Test substance 
Contact time:     28 day(s) 
Degradation:      = 89 % after 28 day(s) 
Result:           readily biodegradable 
Kinetic:              3 day(s)    = 61.13 % 
                      7 day(s)    = 74.35 % 
                     14 day(s)    = 66.09 % 
                     21 day(s)    = 71.94 % 
                     28 day(s)    = 88.88 % 
Control Subst.:   Acetic acid, sodium salt 
Kinetic:               3 day(s)    = 67.15 % 
                      28 day(s)    = 80.93 % 
Deg. product:     not measured 
 
Method:           Directive 92/69/EEC, C.4-E 
  Year:           2001 
   GLP:           yes 
Test substance:   other TS 
 
Remark:           The 89% degradation indicated here relates to the 
                  Theoritical Oxygen Demand (ThOD). 
 
                  Data for the category: see details of study under sodium 
                  gluconate SIDS dossier. 
Test substance:   Sodium gluconate: 99.0-101.0% 
Reliability:      (1)  valid without restriction 
                  study conducted according to OECD guidelines, valid 
                  test,quality assurance and GLP certificates 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                  (7) 
 
Type:             anaerobic 
Inoculum:         other: Digesting sludge of a municipal sewage plant 
                  (Breisgauer Bucht, 500000 population equivalent), 2.9 g total 
                  solids/l 
Concentration:    303 mg/l related to Test substance 
Contact time:     35 day(s) 
Degradation:      = 100 % after 35 day(s) 
Result:           readily biodegradable 
Kinetic:              1 day(s)    = 8 % 
                      8 day(s)    = 51 % 
                     15 day(s)    = 57 % 
                     22 day(s)    = 61 % 
                     35 day(s)    = 100 % 
Control Subst.:   Benzoic acid, sodium salt 
Kinetic:               8 day(s)    = 6 % 
                      35 day(s)    = 100 % 
Deg. product:     not measured 
 
Method:           other: DIN EN ISO 11734 
  Year:           2001 
   GLP:           yes 
Test substance:   other TS OECD SIDS    CALCIUM GLUCONATE 
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Remark:           Data for the category: see details of study under sodium 
                  gluconate SIDS dossier. 
Test substance:   sodium gluconate 
Reliability:      (1)  valid without restriction 
                  study conducted according to OECD guidelines, valid 
                  test,quality assurance and GLP certificates 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                  (8) 
 
 
3.6 BOD5, COD or BOD5/COD Ratio 
 
 
3.7 Bioaccumulation 
 
 
3.8 Additional Remarks 
 OECD SIDS    CALCIUM GLUCONATE 
4. ECOTOXICITY    ID: 299-28-5 
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AQUATIC ORGANISMS 
 
4.1 Acute/Prolonged Toxicity to Fish 
 
Type:             semistatic 
Species:          Oryzias latipes  (Fish, fresh water) 
Exposure period:  96 hour(s) 
Unit:             mg/l                   Analytical monitoring: yes 
NOEC:             > 100 - 
LC0:              > 100 - 
Limit Test:       yes 
 
Method:           OECD Guide-line 203  "Fish, Acute Toxicity Test" 
  Year:           2002 
   GLP:           yes 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under sodium 
                  gluconate SIDS dossier. 
Test substance:   sodium gluconate : 99.6% 
Reliability:      (1)  valid without restriction 
                  study conducted according to OECD guidelines, valid 
                  test,quality assurance and GLP certificates 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                 (11) 
 
 
4.2 Acute Toxicity to Aquatic Invertebrates 
 
Type:             static 
Species:          Daphnia magna  (Crustacea) 
Exposure period:  48 hour(s) 
Unit:             mg/l                   Analytical monitoring: yes 
NOEC:             > 1000 - 
EC100:            > 1000 - 
Limit Test:       yes 
 
Method:           OECD Guide-line 202 
  Year:           2002 
   GLP:           yes 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under sodium 
                  gluconate SIDS dossier. 
Test substance:   sodium gluconate : 99.6% 
Reliability:      (1)  valid without restriction 
                  study conducted according to OECD guidelines, valid 
                  test,quality assurance and GLP certificates 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                 (12) 
 
 
4.3 Toxicity to Aquatic Plants e.g. Algae 
 
Species:          Selenastrum capricornutum  (Algae) 
Endpoint:         growth rate 
Exposure period:  72 hour(s) 
Unit:             mg/l                   Analytical monitoring: yes OECD SIDS    CALCIUM GLUCONATE 
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NOEC:             = 560 - 
EC50:             > 1000 - 
Limit Test:       yes 
 
Method:           OECD Guide-line 201  "Algae, Growth Inhibition Test" 
  Year:           2002 
   GLP:           yes 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under sodium 
                  gluconate SIDS dossier. 
Test substance:   sodium gluconate : 99.6% 
Reliability:      (1)  valid without restriction 
                  study conducted according to OECD guidelines, valid 
                  test,quality assurance and GLP certificates 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                 (13) 
 
 
4.4 Toxicity to Microorganisms e.g. Bacteria 
 
 
4.5 Chronic Toxicity to Aquatic Organisms 
 
4.5.1 Chronic Toxicity to Fish 
 
 
4.5.2 Chronic Toxicity to Aquatic Invertebrates 
 
 
TERRESTRIAL ORGANISMS 
 
4.6.1 Toxicity to Sediment Dwelling Organisms 
 
Species:          other 
 
 
Remark:           No data available but exposure in sediment expected to be 
                  extremely limited according to the Level III Fugacity Model 
                  program LEVEL3NT from US EPA (EPI v3.11) on sodium gluconate 
14-AUG-2003 
 
 
4.6.2 Toxicity to Terrestrial Plants 
 
 
Method:           other 
 
Remark:           No data available 
14-AUG-2003 
 
 
4.6.3 Toxicity to Soil Dwelling Organisms 
 
 
Method:           other 
 
Remark:           no data available but due to the low intrinsic toxicity in OECD SIDS    CALCIUM GLUCONATE 
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                  aquatic organisms, it is reasonable to expect a similar low 
                  toxic impact on terrestrial organisms. 
09-AUG-2004 
 
 
4.6.4 Toxicity to other Non-Mamm. Terrestrial Species 
 
 
4.7 Biological Effects Monitoring 
 
 
4.8 Biotransformation and Kinetics 
 
 
4.9 Additional Remarks 
 OECD SIDS    CALCIUM GLUCONATE 
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5.0 Toxicokinetics, Metabolism and Distribution 
 
In Vitro/in vivo:              In vivo 
Type:                          Toxicokinetics 
Species:                       other: mice, dogs and monkeys 
 
 
 
Method:           other: no data 
  Year:           1962 
   GLP:           no 
Test substance:   as prescribed by 1.1 - 1.4 
 
Result:           The pharmacologic and toxic properties of calcium kinate 
                  gluconate, calcium gluconate, and calcium chloride have been 
                  studied in mice, dogs, and monkeys.  The pharmacologic 
                  properties appeared to be based on the calcium concentration 
                  except for acute intravenous tolerance where calcium kinate 
                  gluconate was better tolerated than calcium gluconate. 
                  Calcium kinate gluconate and calcium gluconate injections 
                  produced transient decrease in blood clotting time, but 
                  increased platelet counts were observed only following 
                  calcium kinate gluconate injections.  The calcium kinate 
                  gluconate effect on blood probably was attributable to the 
                  presence of calcium and kinic acid. 
 
                  No toxic properties of calcium kinate gluconate and calcium 
                  gluconate were observed in a 6-month tolerance study in 
                  dogs.  Good clinical tolerance of calcium kinate gluconate 
                  was reported on over 200 cases. 
Reliability:      (3)  invalid 
                  old comparative study not compliant with OECD guidelines, 
                  for reference only 
14-NOV-2005                                                                  (1) 
 
 
5.1 Acute Toxicity 
 
 
5.1.1 Acute Oral Toxicity 
 
Type:             LDLo 
Species:          rat 
Strain:           Crj: CD(SD) 
Sex:              male/female 
No. of Animals:   10 
Vehicle:          no data 
Doses:            500, 1000, 2000 mg/kg 
Value:            > 2000 mg/kg bw 
 
Method:           other: no data 
  Year:           1995 
   GLP:           no data 
Test substance:   other TS 
 
Test substance:   sodium gluconate 
Reliability:      (2)  valid with restrictions 
                  Short abstract not well documented but key study for initial OECD SIDS    CALCIUM GLUCONATE 
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                  assessment 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                 (15) 
 
 
5.1.2 Acute Inhalation Toxicity 
 
 
5.1.3 Acute Dermal Toxicity 
 
 
5.1.4 Acute Toxicity, other Routes 
 
Type:             other 
Species:          dog 
Strain:           no data 
Sex:              no data 
No. of Animals:   18 
Vehicle:          no data 
Doses:            no data 
Route of admin.:  i.v. 
 
Method:           other 
  Year:           1940 
   GLP:           no 
Test substance:   as prescribed by 1.1 - 1.4 
 
Method:           18 adult dogs were used.  The animals received 10 mg/kg bw 
                  morphine sulfate subcutaneously 30 minutes before injection 
                  of the calcium salt was began.  The calcium solutions (0.205 
                  M) were injected through a cannula into the femoral vein at 
                  varying rates. 
 
                  A blood sample was taken from the femoral vein just prior to 
                  cannulation and a second at death by direct cardiac 
                  puncture. 
 
                  The concentration of calcium in the serum was determined by 
                  the method of Kramer and Tisdall (Kramer, B., and Tisdall, 
                  F. F.: A simple techniqe for the determination of calcium 
                  and magnesium in small amounts of serum, J. Biol. Che. 47: 
                  475, 1921). 
 
                  Electrocardiograms from Lead II were taken at frequent 
                  intervals during the injection. 
Result:           Appreciably larger quantities of calcium given as 
                  gluconate-idonate or calcium gluconate was necessary to 
                  produce death than are needed when calcium is given as the 
                  chloride.  It is possible that the difference between the 
                  chloride and the sugar acid salts can be explained in part 
                  by the different amounts of calcium ions they yield. 
 
 
                  Calcium gluconate-idonate and calcium gluconate differ very 
                  little in their toxicity for dogs. 
Test substance:   calcium gluconate, calcium gluconate-idonate and calcium 
                  chloride 
Reliability:      (3)  invalid OECD SIDS    CALCIUM GLUCONATE 
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                  very old study not compliant with OECD guidelines 
14-NOV-2005                                                                 (17) 
 
 
5.2 Corrosiveness and Irritation 
 
5.2.1 Skin Irritation 
 
Species:          other: no data on calcium gluconate. See gluconic acid 
 
 
10-AUG-2004 
 
 
5.2.2 Eye Irritation 
 
Species:          other: no data on calcium gluconate. See gluconic acid 
 
 
10-AUG-2004 
 
 
5.3 Sensitization 
 
 
5.4 Repeated Dose Toxicity 
 
Type:                    Sub-acute 
Species:                 rat                               Sex: male/female 
Strain:                  Crj: CD(SD) 
Route of administration: gavage 
Exposure period:         4 weeks 
Frequency of treatment:  daily 
Doses:                   0, 500, 1000, 2000 mag/kg bw 
Control Group:           yes, concurrent no treatment 
NOAEL:                   = 1000 mg/kg bw 
NOAEL females :          = 2000 mg/kg bw 
 
Method:           other: no data 
  Year:           1995 
   GLP:           no data 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under sodium 
                  gluconate SIDS dossier. 
Test substance:   sodium gluconate 
Reliability:      (2)  valid with restrictions 
                  Secondary litterature but described in sufficient detail ina 
                  recognised WHO report.  Acceptable for initial assessment 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                 (14) 
 
Type:                    Chronic 
Species:                 rat                               Sex: no data 
Strain:                  no data 
Route of administration: gavage 
Exposure period:         70 days 
Frequency of treatment:  6 days/weekly OECD SIDS    CALCIUM GLUCONATE 
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Doses:                   400 mg calcium/kg bw 
Control Group:           no data specified 
 
Method:           other: no data 
  Year:           1940 
   GLP:           no 
Test substance:   other TS 
 
Result:           All the animals that received the equivalent of 2 g/kg bw 
                  calcium died after a single dose. 
 
                  Administration of 1 g calcium /kg bw as calcium chloride 
                  produced death after one or two doses and 4 animals from the 
                  calcium gluconate-idonate group receiving the equivalent of 
                  1 g calcium survived throughout the experience. 
 
                  At a dose of 0.4 g calcium/kg bw, 5 out of 10 animals 
                  survived in the calcium chloride group while all the animals 
                  receiving calcium gluconate-idonate survived.  2 of the 
                  gluconate animals died (at 56 and 63 days) but the entire 
                  gluconate-idonate group was still alive. 
 
                  The heart, kidney, and liver tissue examinations did not 
                  show any abnormality which could be ascribed to the effect 
                  of the drug. 
 
 
                  Toxicity of calcium chloride is higher than calcium 
                  gluconate-idonate or calcium gluconate.  Calcium gluconate 
                  and calcium gluconate-idonate differ very little in their 
                  toxicity. 
Test condition:   Calcium  gluconate-idonate, calcium chloride and calcium 
                  gluconate were all given in amounts equivalent to 0.4 g 
                  calcium per kg bw daily in solution for the 
                  gluconate-idonate and chloride salts and in heavy suspension 
                  for calcium gluconate.  Calcium  gluconate-idonate and 
                  calcium chloride were also tested at levels equivalent to 1 
                  and 2 g calcium/kg bw /day. 
 
                  Each group of animals contained 10 animals except the one 
                  receiving the equivalent of 1 g calcium/kg bw calcium 
                  gluconate-idonate which contained 20 animals. 
Test substance:   calcium gluconate, calcium gluconate-idonate and calcium 
                  chloride 
Reliability:      (3)  invalid 
                  very old study not compliant with OECD guidelines 
14-NOV-2005                                                                 (17) 
 
 
5.5 Genetic Toxicity 'in Vitro' 
 
Type:                    other: saccharomyces cervisiae and salmonella 
                         typhimurium reverse mutation assay 
System of testing:       bacterial and non bacterial 
Concentration:           bacteria: 1.25%, 2.50 %,  5.00 % and yeast: 0.75%, 
                         1.50% and 3.00% 
Cytotoxic Concentration: 50% survival in bacteria calculated was at 5.00 % test 
                         substance and 3.00% for yeast OECD SIDS    CALCIUM GLUCONATE 
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Metabolic activation:    with and without 
Result:                  negative 
 
Method:           OECD Guide-line 471 
  Year:           1975 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Method:           A. Toxicity: 
 
                  The solubility, toxicity and doses for all chemicals 
                  were determined prior to screening. 
 
                  Each chemical was tested for survival against the specific 
                  strains over a range of doses (10, 1.0, 0.1, 0.01, 0.001 
                  %) to determine the 50% survival dose.  Bacteria were tested 
                  in phosphate buffer, pH 7.4 for one hour at 37°c on a 
                  shaker. 
 
                  Yeasts were tested in phosphate buffer, pH 7.4 for 4 hours 
                  at 30°c on a shaker.  The 50% survival curve and the 1/4 and 
                  1/2 50% doses calculated.  If no toxicity was obtained for a 
                  chemical with a given strain, a maximum dose of 5% (w/v) was 
                  used. The doses calculated for the tests in buffer were 
                  applied to the activation tests.  The solubility of the test 
                  substance under treatment conditions was measured and 
                  Calcium gluconate is not completely soluble at treatment 
                  concentrations in a suspension 10% saline. 
 
                  --------------------------------------------- 
 
                  B. Plate tests 
 
                  In the non activation procedure, approximately 10 exp9 cells 
                  from a log-phase culture of the bacterial indicator strains 
                  were spread over the surface of a minimal plate, and a 
                  measured amount of the test chemical was placed in the 
                  center of the test plate. 
 
                  In activation tests, the test chemical was added to the 
                  cells, and an aliquot of the mixture was spread on the 
                  surface of the test plate.  The reaction mixture (0.1 ml) 
                  plus tissue extract was then spotted on the surface of the 
                  plate. 
 
                  All plates were incubated for 4 days at 37°C, and then 
                  scored.  Each compound, (test, positive and solvent controls 
                  were run with each assay. 
 
                  ------------------------------------------------ 
                  C.  Suspension tests 
 
                  1. Non activation 
 
                  Log phase bacteria and stationary-phase yeast cultures of 
                  the indicator organisms were grown in complete broth, washed 
                  and resuspended in 0.9% saline to densities of  1 x 10 exp9 
                  cells/ml and 5 x 10 exp7 cells/ml respectively. OECD SIDS    CALCIUM GLUCONATE 
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                  Tests were conducted in plastic tissue culture plates. Cells 
                  plus chemicals were added to the wells to give a final 
                  volume of 1.5 ml.  The solvent replaced the test chemical in 
                  the negative controls.  Treatment was at 30°C for 4 hours 
                  for yeast tests and at 37°c for one hour for bacterial 
                  tests.  All flasks were shaken during treatment. 
                  After treatments, the plates wereset on ice.  Aliquots of 
                  cells were removed, diluted in sterile saline (4°c) and 
                  plated on the appropriate complete media.  Undiluted samples 
                  from flasks containing the bacteria were plated on minimal 
                  selective medium in reversion experiments.  Samples from a 
                  1/10 dilution of treated cells were plated on the selected 
                  media for enumeration of gene conversion with strain D4. 
 
                  Bacterial plates were scored after incubation for 48 hours 
                  at 37°C.  The yeast plates were incubated at 30°C for 
                  3-5days before scoring. 
 
                  2. Activation 
 
                  Bacteria and yeast cells were grown and prepared as 
                  described in the non activation tests.  Measured amounts of 
                  the test and control chemicals plus 0.25 ml of the 
                  stock-cell suspension were added to wells of the Linbro 
                  plate containing the appropriate tissue fraction and 
                  reaction mixture.  All flasks (bacteria and yeast) were 
                  incubated at 37°c in an oxygen atmosphere with shaking. The 
                  treatment times, dilutions, plating procedure and scoring of 
                  the plates were the same as described for non activation 
                  tests. 
Result:           A. Salmonella typhimurium: 
 
                  1. Plate tests: negative 
 
                  2. Nonactivation suspension tests: negative 
 
                  3. Activation suspension tests: negative (some tests using 
                  mouse and rat tissues with TA-1538 appeared slightly 
                  increased but were not considered positive. One high dose 
                  with primate tissue was repeated.  The results were 
                  negative.  The positive and negative control values for 
                  TA-1537 and TA-1538 tests were lower than usual. 
 
                  No information or discussion are reported on the results 
                  from the positive controls, nor on their origin (same 
                  laboratory ?) 
 
                  -------------------------------------------------- 
                  B. Saccharomyces cerevisiae 
 
                  1. Non-activation suspension tests: negative 
 
                  2. Activation suspension tests: negative (A higher than 
                  normal spontaneous background at the TRY locus was observed 
                  in these tests.) 
 
                  Conclusion: Calcium gluconate did not exhibit genetic 
                  activity in any of the assays employed in study. OECD SIDS    CALCIUM GLUCONATE 
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Test condition:   Strains tested: 
                  Yeast: Saccharomyces Cerevisiae, Strain D4 
                  Bacteria: Salmonella typhimurium, strains: TA1535, 
                  TA1537,TA1538 
 
                  ------------------------------ 
                  Reaction mixture: 
 
                  Component:                 Final concentration/ml 
                  TNP (sodium salt)               6 µM 
                  Isocitric acid                  49µM 
                  Tris buffer, pH 7.4             28 µM 
                  MgCl2                           1.7 µM 
                  Tissue homogenate fraction      72 mg 
 
                  -------------------------------- 
                  Tissue homogenates and supernatants:The tissue homogenates 
                  and supernatants (9000 g) were prepared from tissues of 
                  mouse (ICR random bred adult males); rat (Sprague-Dawnley 
                  adult males) and monkey (Macaca mulatta adult males) 
 
                  --------------------------------- 
                  Positive controls in direct and activation assays: 
 
                  Non-activation: 
 
                  Chemical                 Solvent        Probable mutagenic 
                                                                specificity 
 
                  Ethyl                    water or saline    base-pair 
                  methanesulfonate (EMS)                      substitution 
                  2-nitrofluorene  (NF)     dimethylsulfoxide  frameshift 
                  Quinacrine mustard (QM)  water or saline    Frameshift 
 
                  *************************** 
                  Activation: 
                  Chemical                    Solvent       Probable mutagenic 
                                                                specificity 
                  Dimethylnitrosamine (DMN)   water or saline    base-pair 
                                                                 substitution 
                  2-acetylaminofluorene (AAF) dimethylsulfoxide  Frameshift 
 
 
                  Concentration of positive controls: 
 
                  Non activation: 
                  TA-1535  EMS 10µl/plate 
                  TA-1537 QM 20 µg/plate 
                  TA-1538 NF 100 µg/plate 
 
                  Activation: 
                  TA-1535 DMN 50 µM/plate 
                  TA-1537 AAF  100 µg/plate 
                  TA-1538 AAF  100 µg/plate 
Test substance:   calcium gluconate 
Reliability:      (2)  valid with restrictions 
                  OECD guideline 471 recommend 5 strains of bacteria at least 
                  to be tested: 4 strains of S. typhimurium (TA1535,TA1537 or OECD SIDS    CALCIUM GLUCONATE 
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                  TA97 or TA97a, TA98, TA100) and E. Coli WP2uvrA or E. Coli 
                  WP2uvrA (pKM101) or S.typhirmurium TA102. 
 
                  The study was made on one yeast strain : saccharomyces 
                  cerevisiae, strain D4 and 3 bacteria strains: S. 
                  typhimuriumTA1535, TA1537 and TA 1538 
 
                  Positive controls different from the ones recommended in 
                  OECD guideline 471. 
 
                  At least 5 concentrations should be tested, the study only 
                  test 3 concentrations. 
Flag:             Critical study for SIDS endpoint 
25-JAN-2006                                                                 (10) 
 
 
5.6 Genetic Toxicity 'in Vivo' 
 
Type:             other: in vivo chromosomal aberration test with mouse bone 
                  marrow cells 
Species:          mouse                             Sex: male 
Strain:           C57BL 
Route of admin.:  oral feed 
Exposure period:  single dose and 4 days 
Doses:            single dose administration : 2.5, 5 and 10 g/kg. 
                  4 day repeated dose: 1.25 and 2.5 g/kg 
Result:           negative 
 
Method:           other: no data specified 
  Year:           1974 
   GLP:           no data 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under sodium 
                  gluconate SIDS dossier 
Test substance:   sodium gluconate 
Reliability:      (2)  valid with restrictions 
                  translation of a report not fully documented but acceptable 
                  for initial assessment 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                 (18) 
 
 
5.7 Carcinogenicity 
 
 
5.8.1 Toxicity to Fertility 
 
 
5.8.2 Developmental Toxicity/Teratogenicity 
 
Species:                   rat                               Sex: female 
Strain:                    Wistar 
Route of administration:   gavage 
Exposure period:           from day 6 to day 15 of gestation 
Frequency of treatment:    daily 
Duration of test:          10 days 
Doses:                     0, 5.94, 27.6, 128.0, 594.0 mg/kg OECD SIDS    CALCIUM GLUCONATE 
5. TOXICITY    ID: 299-28-5 
   DATE:  25.01.2006 
 
 UNEP  PUBLICATIONS  194
Control Group:             yes, concurrent vehicle 
NOAEL Maternal Toxity:     > 594 mg/kg bw 
NOAEL Teratogenicity:      > 594 mg/kg bw 
Result:                    non teratogen 
 
Method:           other: no data specified 
  Year:           1973 
   GLP:           no 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under 
                  glucono-delta-lactone SIDS dossier. 
Test substance:   Glucono-delta-lactone 
Reliability:      (1)  valid without restriction 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                  (3) 
 
Species:                   mouse                             Sex: female 
Strain:                    CD-1 
Route of administration:   gavage 
Exposure period:           from day 6 to day 15 of gestation 
Frequency of treatment:    daily 
Duration of test:          10 days 
Doses:                     0, 6.95, 32.5, 150, 695 mg/kg 
Control Group:             yes, concurrent vehicle 
NOAEL Maternal Toxity:     > 695 mg/kg bw 
NOAEL Teratogenicity:      > 695 
Result:                    non teratogen 
 
Method:           other: no data specified 
  Year:           1973 
   GLP:           no 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under 
                  glucono-delta-lactone SIDS dossier. 
Test substance:   Glucono-delta-lactone 
Reliability:      (1)  valid without restriction 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                  (3) 
 
 
Species:                   rabbit                            Sex: female 
Strain:                    Dutch 
Route of administration:   gavage 
Exposure period:           from day 6 to 18 of gestation 
Frequency of treatment:    daily 
Duration of test:          13 days 
Doses:                     0, 7.80, 36.2, 168.5, 780.0 mg/kg 
Control Group:             yes, concurrent vehicle 
NOAEL Maternal Toxity:     > 780 mg/kg bw 
NOAEL Teratogenicity:      > 780 mg/kg bw 
Result:                    non teratogen 
 
Method:           other: no data specified 
  Year:           1973 
   GLP:           no 
Test substance:   other TS OECD SIDS    CALCIUM GLUCONATE 
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Remark:           Data for the category: see details of study under 
                  glucono-delta-lactone SIDS dossier. 
Test substance:   Glucono-delta-lactone 
Reliability:      (1)  valid without restriction 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                  (3) 
 
Species:                   hamster                           Sex: female 
Route of administration:   gavage 
Exposure period:           from day 6 to day 10 of gestation 
Frequency of treatment:    daily 
Duration of test:          5 days 
Doses:                     0, 5.60, 26.0, 121, 560 mg/kg 
Control Group:             yes, concurrent vehicle 
NOAEL Maternal Toxity:     > 560 mg/kg bw 
NOAEL Teratogenicity:      > 560 mg/kg bw 
Result:                    non teratogen 
 
Method:           other: no data specified 
  Year:           1973 
   GLP:           no 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under 
                  glucono-delta-lactone SIDS dossier. 
Test substance:   Glucono-delta-lactone 
Reliability:      (1)  valid without restriction 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                  (3) 
 
 
Species:                   rat                               Sex: female 
Strain:                    Sprague-Dawley 
Route of administration:   oral unspecified 
Exposure period:           from day 6 to day 15 of gestation 
Frequency of treatment:    daily 
Duration of test:          10 days 
Doses:                     1000 and 4000 mg/kg 
Control Group:             no data specified 
NOAEL Maternal Toxity:     > 4000 mg/kg bw 
NOAEL Teratogenicity:      > 4000 mg/kg bw 
Result:                    non teratogen 
 
Method:           other: No data specified 
  Year:           1978 
   GLP:           no data 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under 
                  glucono-delta-lactone SIDS dossier. 
Test substance:   Glucono-delta-lactone 
Reliability:      (2)  valid with restrictions 
                  short abstract but acceptable for initial assessment. 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                  (5) 
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Strain:                    ICR 
Route of administration:   oral unspecified 
Exposure period:           from day 6 to day 15 of gestation 
Frequency of treatment:    daily 
Duration of test:          10 days 
Doses:                     1000 and 4000 mg/kg 
Control Group:             no data specified 
NOAEL Maternal Toxity:     > 4000 mg/kg bw 
NOAEL Teratogenicity:      > 4000 mg/kg bw 
Result:                    non teratogen 
 
Method:           other: no data specified 
  Year:           1978 
   GLP:           no data 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under 
                  glucono-delta-lactone SIDS dossier. 
Test substance:   Glucono-delta-lactone 
Reliability:      (2)  valid with restrictions 
                  short abstract but acceptable for initial assessment. 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                  (6) 
 
 
5.8.3 Toxicity to Reproduction, Other Studies 
 
 
5.9 Specific Investigations 
 
 
5.10 Exposure Experience 
 
Type of experience:  Direct observation, clinical cases 
 
Remark:              In cases of hypocalcemia in premature neonates, treatment 
                     by 
                     intraveinous administration of calcium gluconate is given 
                     (scalp-vein infusion). 
 
                     The author reports observation of localised skin necrosis 
                     of 
                     the scalp on 4 premature infants out of 45 who received 
                     calcium gluconate infusions via scalp veins. The 
                     infusions lasted up to 15 days with frequent changes of the 
                     cannulation sites.  All the lesions developed at the site 
                     of 
                     the last infusion, usually during the first 48 hours after 
                     removal of the needle. The necrosis never appeared during 
                     the infusion. 
 
                     The areas of necrosis were 2-4 cm2 and were treated by wet 
                     dressings and healed well after 15 to 40 days. 
 
                     The author assumes that this local necrosis appearing after 
                     the last infusion (which is usually the longest) is 
                     probably 
                     due 1) to the long duration which may lead to phlebitis, 2) OECD SIDS    CALCIUM GLUCONATE 
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                     a minor degree of leakage during the infusion,and 3) a 
                     sudden extravasation which occurs after removal of the 
                     needle. 
 
                     Advise is given as to avoid administration of calcium 
                     gluconate into scalp veins except for the most stringent 
                     indications and if unavoidable, it is suggested that the 
                     infusion site is changed frequently 
14-AUG-2003                                                                 (21) 
 
Type of experience:  Human - Medical Data 
 
Remark:              Calcium gluconate is the treatment of choice in case of 
                     hydrofluoric acid burns. 
 
                     Calcium gluconate is used in calcium supplements. 
 
                     Company         Product           Calcium gluconate content 
                     ----------------------------------------------------------- 
                     Adams Labs Ltd 
                                     Calcium gluconate Tab 10gr      648 mg 
                     AstraZeneca Canada Inc 
                                     Calcium gluconate 10% Inj 100 mg/ml 100 
                     mg/ml 
 
                     Pharmetics Inc  Calcium gluconate tablets USP 650 mg 60 mg 
                     D.C. Labs Ltd   Calcium gluconate Tab 650 mg   650 mg 
                     Pharmaceutical Partners of Canada 
                                     Calcium gluconate Injection USP 10% 94 
                     mg/ml 
                     Abbott Laboratories Ltd 
                                     Calcium gluconate Inj 100mg/ml 100 mg/ml 
                     Novopharm Ltd  Calcium gluconate Tab 650 mg    650 mg 
                     Hall Laboratories Ltd 
                                     Calcium gluconate Tab 648 mg    648 mg 
                     Professional Veterinary Laboratories 
                                     Dextrose Calcium Gluconate Magnesium Phos 
                                                                 100 g / 500 ml 
                     And many others at 
                     http://www.hc-sc.gc.ca/hpb/drugs-dpd/ 
20-OCT-2003 
 
 
5.11 Additional Remarks 
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1.0.1 Applicant and Company Information 
 
Type:             lead organisation 
Name:             The Gluconic acid and its sodium, potassium and calcium salts 
                  and glucono-delta-lactone consortium 
Contact Person:   Jean-Philippe Montfort    Date: 02-APR-2003 
Street:           Rue Blanche 25 
Town:             1060 Brussels 
Country:          Belgium 
Phone:            +32 2 541 05 70 
Telefax:          + 32 2 541 05 80 
Email:            montfort@khlaw.be 
 
Remark:           Sponsor Country for this Category: Belgium; Co-sponsor 
                  country: Japan. 
12-DEC-2005 
 
Type:             manufacturer 
Name:             FUSO Chemical Co. Ltd 
Contact Person:   Ph.D. Shinichi Sugita     Date: 
Street:           Iwamoto-cho Toyo Building, 1-2 Iwamoto-cho 3-chome, Chiyoda-ku 
Town:             101 0032  Tokyo 
Country:          Japan 
Phone:            +81 3 5820 1611 
Telefax:          +81 3 5820 1634 
Email:            Shinichi.Sugita@fusokk.co.jp 
 
03-AUG-2004 
 
Type:             manufacturer 
Name:             Jungbunzlauer International AG 
Contact Person:   Raphaël Singer            Date: 17-APR-2003 
Street:           St. Alban-Vorstadt 90 
Town:             4002 Basel 
Country:          Switzerland 
Phone:            +41 61 295 51 25 
Telefax:          +41 61 295 52 66 
Email:            raphael.singer@jungbunzlauer.ch 
 
17-OCT-2003 
 
Type:             manufacturer 
Name:             Roquette Freres 
Contact Person:   Johnny Pallot             Date: 
Town:             62080 Lestrem Cedex 
Country:          France 
Phone:            +33 3 21 63 37 40 
Telefax:          +33 3 21 63 38 50 
Email:            JOHNNY.PALLOT@roquette.com 
 
31-JUL-2003 
 
Type:             manufacturer 
Name:             PURAC 
Contact Person:   Ton van Dongen            Date: 
Street:           PO BOX 21 
Town:             4200 AA Gorinchem 
Country:          Netherlands OECD SIDS    POTASSIUM GLUCONATE 
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Phone:            +31 183 695 730 
Telefax:          +31 183 695 603 
Email:            t.van.dongen@purac.com 
 
03-AUG-2004 
 
 
1.0.2 Location of Production Site, Importer or Formulator 
 
 
1.0.3 Identity of Recipients 
 
 
1.0.4 Details on Category/Template 
 
 
Remark:           Glucono-delta-lactone, gluconic acid and its sodium, calcium 
                  and potassium salts have been proposed in a category, as the 
                  salts of gluconic acid freely dissociate to the gluconate 
                  anion and the respective cation. 
 
                  Glucono-delta-lactone (GDL) is the inner ester of gluconic 
                  acid formed by the removal of water. 
 
                  When glucono-delta-lactone is used in aqueous solution, it 
                  is slowly hydrolysed until an equilibrium is reached between 
                  gluconic acid and its delta-lactone. 
12-AUG-2004 
 
 
1.1.0 Substance Identification 
 
IUPAC Name:       potassium penta-hydroxy hexanoate anhydrate 
Smiles Code:      [K]OC(=O)C(O)C(O)C(O)C(O)CO 
Mol. Formula:     C6H11O7K 
Mol. Weight:      234.25 
 
20-OCT-2003 
 
 
1.1.1 General Substance Information 
 
Purity type:      typical for marketed substance 
Substance type:   organic 
Physical status:  solid 
Purity:           ca. 97 - 103 % w/w 
Colour:           white 
Odour:            none 
 
06-AUG-2004 
 
 
1.1.2 Spectra 
 
 
1.2 Synonyms and Tradenames 
 
potassium penta-hydroxyhexanoate anhydrate OECD SIDS    POTASSIUM GLUCONATE 
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06-AUG-2004 
 
 
1.3 Impurities 
 
Purity type:      typical for marketed substance 
 
Remark:           For food and/or medical applications the level of impurities 
                  complies with the restrictions laid down in the 
                  corresponding EU Directives. 
09-AUG-2004 
 
 
1.4 Additives 
 
 
Remark:           For all the chemicals of the category: no additives used 
10-NOV-2005 
 
 
1.5 Total Quantity 
 
Quantity:         ca. 1000 - 2000 tonnes produced in 2000 
 
Flag:             confidential 
06-AUG-2004 
 
 
1.6.1 Labelling 
 
 
Remark:           For all the chemicals in the category: proposal of Industry: 
                  no labelling required 
10-NOV-2005 
 
 
1.6.2 Classification 
 
Classified:       other, as in legislation 
 
Remark:           For all chemicals of the category: proposal of Industry: no 
                  classification required 
10-NOV-2005 
 
 
1.6.3 Packaging 
 
 
1.7 Use Pattern 
 
Type:             type 
Category:         Non dispersive use 
 
Remark:           Data for the category: see sodium gluconate 
14-AUG-2003 
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Category:         Wide dispersive use 
 
Remark:           Data for the category: see sodium gluconate 
14-AUG-2003 
 
 
1.7.1 Detailed Use Pattern 
 
 
1.7.2 Methods of Manufacture 
 
 
1.8 Regulatory Measures 
 
 
1.8.1 Occupational Exposure Limit Values 
 
 
1.8.2 Acceptable Residues Levels 
 
 
1.8.3 Water Pollution 
 
 
1.8.4 Major Accident Hazards 
 
 
1.8.5 Air Pollution 
 
 
1.8.6 Listings e.g. Chemical Inventories 
 
 
1.9.1 Degradation/Transformation Products 
 
 
1.9.2 Components 
 
 
1.10 Source of Exposure 
 
Source of exposure: other 
 
Remark:             Data for the category: see sodium gluconate 
14-AUG-2003 
 
 
1.11 Additional Remarks 
 
Memo:             Regulatory status 
 
Remark:           Potassium gluconate is the potassium salt of gluconic acid, 
                  obtained from glucose by fermentation. 
 
                  In the European Parliament and Council Directive 95/2/EC, 
                  potassium gluconate is listed as a generally permitted food 
                  additive (E577) and may be added to all foodstuffs, 
                  following the "quantum satis" principle, as long as no OECD SIDS    POTASSIUM GLUCONATE 
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                  special regulations restrict the use. 
 
                  The US Food and Drug Administation (FDA) assigned potassium 
                  gluconate the "generally recognised as safe" (GRAS) status 
                  and permitted its use in food without limitation other than 
                  the current good manufacturing practice. 
06-AUG-2004 
 
1.12 Last Literature Search 
 
 
1.13 Reviews 
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2.1 Melting Point 
 
Decomposition:    yes at = 180 degree C 
 
Method:           other: no data specified 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Reliability:      (2)  valid with restrictions 
                  Data from Handbook or collection of data 
Flag:             Critical study for SIDS endpoint 
12-AUG-2004                                                                 (20) 
 
Value:            ca. 174 - 176 degree C 
 
Method:           other: no data 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Reliability:      (4)  not assignable 
                  Data from an MSDS. No data on method used. 
Flag:             Critical study for SIDS endpoint 
12-AUG-2004                                                                 (12) 
 
 
2.2 Boiling Point 
 
Value:            = 613.1 degree C 
 
Method:           other: calculated 
   GLP:           no 
Test substance:   as prescribed by 1.1 - 1.4 
 
Remark:           Estimated with MPBPWIN (v1.41) program from US EPA (EPI 
                  v3.11) 
Reliability:      (2)  valid with restrictions 
                  Accepted calculation method 
Flag:             Critical study for SIDS endpoint 
09-AUG-2004 
 
 
2.3 Density 
 
Type:             bulk density 
Value:            ca. 800 kg/m3 
 
Method:           other: no data 
   GLP:           no 
Test substance:   as prescribed by 1.1 - 1.4 
 
Reliability:      (4)  not assignable 
                  Data from an MSDS. No data on method used. 
Flag:             Critical study for SIDS endpoint 
09-AUG-2004                                                                 (12) 
 
 
2.3.1 Granulometry 
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2.4 Vapour Pressure 
 
Value:            = 0 hPa at 25 degree C 
 
Method:           other (calculated) 
   GLP:           no 
Test substance:   as prescribed by 1.1 - 1.4 
 
Remark:           Estimated with MPBPVP (v1.41) program from US EPA (EPI 
                  v3.11): 
 
                  Vapor Pressure Estimations (25 deg C): 
                    (Using BP: 613.05 deg C (estimated)) 
                    (Using MP: 174.00 deg C (user entered)) 
                      VP:  3.11E-022 mm Hg (Antoine Method) 
                      VP:  8.94E-017 mm Hg (Modified Grain Method) 
                      VP:  2.39E-012 mm Hg (Mackay Method) 
Result:           Selected VP:  8.94E-017 mm Hg = 11.89E-017 hPa (Modified 
                  Grain Method) 
Reliability:      (2)  valid with restrictions 
                  Accepted calculation method 
Flag:             Critical study for SIDS endpoint 
06-AUG-2004 
 
 
2.5 Partition Coefficient 
 
Partition Coeff.: octanol-water 
log Pow:          = -5.99 
 
Method:           other (calculated) 
   GLP:           no 
 
Remark:           Estimated with Kowwin  (v1.67) program from US EPA (EPI 
                  v3.11) 
Reliability:      (2)  valid with restrictions 
                  Accepted calculation method 
Flag:             Critical study for SIDS endpoint 
06-AUG-2004 
 
 
2.6.1 Solubility in different media 
 
Solubility in:    Water 
Value:            = 450 g/l at 20 degree C 
pH       value:   ca. 6.8 - 8.3 
         Conc.:   10 vol% at 20 degree C 
 
Method:           other: no data 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
Deg. product:     not measured 
 
Reliability:      (4)  not assignable 
                  Data from an MSDS. No data on method used. 
Flag:             Critical study for SIDS endpoint 
06-AUG-2004                                                                 (12) OECD SIDS    POTASSIUM GLUCONATE 
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Solubility in:    Water 
Value:            = 1000 g/l at 25 degree C 
 
Method:           other: no data 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Reliability:      (4)  not assignable 
                  Data from Commercial brochure 
Flag:             Critical study for SIDS endpoint 
12-AUG-2004                                                                  (8) 
 
Solubility in:    Water 
Descr.:           other: freely soluble 
 
Method:           other: no data specified 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Reliability:      (2)  valid with restrictions 
                  Data from Handbook or collection of data 
Flag:             Critical study for SIDS endpoint 
12-AUG-2004                                                                 (20) 
 
 
2.6.2 Surface Tension 
 
 
2.7 Flash Point 
 
 
2.8 Auto Flammability 
 
 
2.9 Flammability 
 
 
2.10 Explosive Properties 
 
 
2.11 Oxidizing Properties 
 
 
2.12 Dissociation Constant 
 
Acid-base Const.: pka = 3.70 
 
Method:           other: no data 
   GLP:           no data 
Test substance:   other TS 
 
Remark:           The dissociation in water is expected to be complete as the 
                  pKa values of gluconic acid found in literature range from 
                  3.5 to 3.8 
Test substance:   gluconic acid 
Reliability:      (2)  valid with restrictions 
Flag:             Critical study for SIDS endpoint OECD SIDS    POTASSIUM GLUCONATE 
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12-AUG-2004                                                                 (23) 
 
 
2.13 Viscosity 
 
 
2.14 Additional Remarks 
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3.1.1 Photodegradation 
 
Type:             air 
 
Method:           other (calculated): Estimated with AOP (v1.91) program from US 
                  EPA (EPI v3.11) 
   GLP:           no 
Test substance:   as prescribed by 1.1 - 1.4 
 
Remark:           Estimated with AOP (v1.91) program from US EPA (EPI v3.11) 
 
                  OVERALL OH Rate Constant =  38.1277 E-12 cm3/molecule-sec 
 
                  HALF-LIFE =     0.281 Days (12-hr day; 1.5E6 OH/cm3) 
                  HALF-LIFE =     3.366 Hrs 
Reliability:      (2)  valid with restrictions 
                  Accepted calculation method 
Flag:             Critical study for SIDS endpoint 
12-AUG-2004 
 
 
3.1.2 Stability in Water 
 
Type:             abiotic 
 
 
Remark:           The dissociation in water is expected to be complete as the 
                  pKa values of gluconic acid found in literature range from 
                  3.5 to 3.8 
Reliability:      (2)  valid with restrictions 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                 (23) 
 
 
3.1.3 Stability in Soil 
 
 
3.2.1 Monitoring Data (Environment) 
 
 
3.2.2 Field Studies 
 
 
3.3.1 Transport between Environmental Compartments 
 
Type:             fugacity model level III 
Media:            other 
Method:           other: calculated 
 
Remark:           Estimated with the Level III Fugacity Model program LEVEL3NT 
                  from US EPA (EPI v3.11) 
 
                  Chem Name   : Potassium gluconate 
                  Molecular Wt: 234.25 
                  Henry's LC  : 2.76e-023 atm-m3/mole (calc VP/Wsol) 
                  Vapor Press : 8.94e-017 mm Hg  (Mpbpwin program) 
                  Liquid VP   : 2.66e-015 mm Hg  (super-cooled) 
                  Melting Pt  : 174 deg C (user-entered) OECD SIDS    POTASSIUM GLUCONATE 
3. ENVIRONMENTAL FATE AND PATHWAYS  ID: 299-27-4 
   DATE:  25.01.2006 
 
 UNEP  PUBLICATIONS  211
                  Log Kow     : -5.99  (Kowwin program) 
                  Soil Koc    : 4.2e-007  (calc by model) 
 
                            Mass Amount    Half-Life    Emissions 
                            (percent)        (hr)       (kg/hr) 
                  ------------------------------------------------- 
                   Air       4.78e-007       6.73         1000 
                   Water     42.8            208          1000 
                   Soil      57.1            208          1000 
                   Sediment  0.0638          832          0 
                  _________________________________________________ 
 
 
                        Fugacity    Reaction    Advection   Reaction  Advection 
                  (atm)      (kg/hr)    (kg/hr)    (percent)   (percent) 
                  ------------------------------------------------------------ 
                  Air    1.18e-026  0.000393    3.82e-005  1.31e-005 1.27e-006 
                  Water  2.01e-028  1.14e+003   342          37.9       11.4 
                  Soil   9.94e-027  1.52e+003   0           50.7        0 
                  Sediment 1.5e-028  0.424      0.0102      0.0141    0.00034 
                  ____________________________________________________________ 
 
                  Persistence Time: 266 hr 
                  Reaction Time:    300 hr 
                  Advection Time:   2.34e+003 hr 
                  Percent Reacted:  88.6 
                  Percent Advected: 11.4 
 
                  Half-Lives (hr), (based upon Biowin (Ultimate) and Aopwin): 
 
                  Air:      6.732 
                  Water:    208.1 
                  Soil:     208.1 
                  Sediment: 832.3 
                  Biowin estimate: 3.481  (days-weeks  ) 
 
                  Advection Times (hr): 
                  Air:      100 
                  Water:    1000 
                  Sediment: 5e+004 
 
Reliability:      (3)  invalid 
                  Limited reliability because the Henry's LC can neither be 
                  calculated with the bond estimation method nor with the 
                  group estimation method because of missing values for 
                  certain bonds/groups. 
 
                  The Henry's LC is therefore estimated by VP/Wsol. 
 
                  However, this program does not use the entered solubility 
                  (500 g/l) but the solubility determined by the WATERNT 
                  program (1000 g/l) for the estimation of the Henry's LC that 
                  is then used in the LEVEL3NT program. 
25-JAN-2006 
 
 
3.3.2 Distribution 
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Media:            air - biota - sediment(s) - soil - water 
Method:           other (calculation) 
 
Remark:           Henry's law constant estimated with HENRY (v3.10) program 
                  from US EPA (EPI v3.11) 
 
                  Can neither be calculated with the bond estimation method 
                  nor with the group estimation method because of missing 
                  values for certain bonds/groups. 
                  --------------------------------------------------- 
 
                  Soil Adsorption Coefficient estimated with PCKOC (v1.66) 
                  program from US EPA (EPI v3.11) 
 
                  NOTE: THE METAL (Na, Li or K) HAS BEEN REMOVED TO ALLOW 
                  ESTIMATION! 
 
                  First Order Molecular Connectivity Index  :  5.913 
                  Non-Corrected Log Koc  :  3.7674 
                  Fragment Correction(s): 
                      *   Organic Acid  (-CO-OH)   : -1.7512 
                     2   Aliphatic Alcohol  (-C-OH)   : -3.0386 
                  Corrected Log Koc   : -1.0224 
 
                  Over Correction Adjustment to Lower Limit Log Koc :  1.0000 
 
                  Estimated Koc:  10 
 
                  NOTE:   The Koc of this structure may be sensitive to pH! 
Reliability:      (2)  valid with restrictions 
                  Accepted calculation method 
Flag:             Critical study for SIDS endpoint 
09-AUG-2004 
 
 
3.4 Mode of Degradation in Actual Use 
 
 
3.5 Biodegradation 
 
Type:             aerobic 
Inoculum:         other: secondary effluent of a municipal sewage plant 
                  (Breisgauer Bucht, 500000 population equivalent), 0.4 ml/l 
Concentration:    3 mg/l related to Test substance 
Contact time:     28 day(s) 
Degradation:      = 89 % after 28 day(s) 
Result:           readily biodegradable 
Kinetic:              3 day(s)    = 61.13 % 
                      7 day(s)    = 74.35 % 
                     14 day(s)    = 66.09 % 
                     21 day(s)    = 71.94 % 
                     28 day(s)    = 88.88 % 
Control Subst.:   Acetic acid, sodium salt 
Kinetic:               3 day(s)    = 67.15 % 
                      28 day(s)    = 80.93 % 
Deg. product:     not measured 
 
Method:           Directive 92/69/EEC, C.4-E OECD SIDS    POTASSIUM GLUCONATE 
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  Year:           2001 
   GLP:           yes 
Test substance:   other TS 
 
Remark:           The 89% degradation indicated here relates to the 
                  Theoritical Oxygen Demand (ThOD) 
                  Data for the category: see details of study under  sodium 
                  gluconate SIDS dossier. 
Test substance:   Sodium gluconate: 99.0-101.0% 
Reliability:      (1)  valid without restriction 
                  study conducted according to OECD guidelines, valid 
                  test,quality assurance and GLP certificates 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                 (10) 
 
Type:             anaerobic 
Inoculum:         other: Digesting sludge of a municipal sewage plant 
                  (Breisgauer Bucht, 500000 population equivalent), 2.9 g total 
                  solids/l 
Concentration:    303 mg/l related to Test substance 
Contact time:     35 day(s) 
Degradation:      = 100 % after 35 day(s) 
Result:           readily biodegradable 
Kinetic:              1 day(s)    = 8 % 
                      8 day(s)    = 51 % 
                     15 day(s)    = 57 % 
                     22 day(s)    = 61 % 
                     35 day(s)    = 100 % 
Control Subst.:   Benzoic acid, sodium salt 
Kinetic:               8 day(s)    = 6 % 
                      35 day(s)    = 100 % 
Deg. product:     not measured 
 
Method:           other: DIN EN ISO 11734 
  Year:           2001 
   GLP:           yes 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under sodium 
                  gluconate SIDS dossier. 
Test substance:   sodium gluconate 
Reliability:      (1)  valid without restriction 
                  study conducted according to OECD guidelines, valid 
                  test,quality assurance and GLP certificates 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                 (11) 
 
 
3.6 BOD5, COD or BOD5/COD Ratio 
 
 
3.7 Bioaccumulation 
 
 
3.8 Additional Remarks 
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AQUATIC ORGANISMS 
 
4.1 Acute/Prolonged Toxicity to Fish 
 
Type:             semistatic 
Species:          Oryzias latipes  (Fish, fresh water) 
Exposure period:  96 hour(s) 
Unit:             mg/l                   Analytical monitoring: yes 
NOEC:             > 100 - 
LC0:              > 100 - 
Limit Test:       yes 
 
Method:           OECD Guide-line 203  "Fish, Acute Toxicity Test" 
  Year:           2002 
   GLP:           yes 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under sodium 
                  gluconate SIDS dossier. 
Test substance:   sodium gluconate : 99.6% 
Reliability:      (1)  valid without restriction 
                  study conducted according to OECD guidelines, valid 
                  test,quality assurance and GLP certificates 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                 (14) 
 
 
4.2 Acute Toxicity to Aquatic Invertebrates 
 
Type:             static 
Species:          Daphnia magna  (Crustacea) 
Exposure period:  48 hour(s) 
Unit:             mg/l                   Analytical monitoring: yes 
NOEC:             > 1000 - 
EC100:            > 1000 - 
Limit Test:       yes 
 
Method:           OECD Guide-line 202 
  Year:           2002 
   GLP:           yes 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under sodium 
                  gluconate SIDS dossier. 
Test substance:   sodium gluconate : 99.6% 
Reliability:      (1)  valid without restriction 
                  study conducted according to OECD guidelines, valid 
                  test,quality assurance and GLP certificates 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                 (15) 
 
4.3 Toxicity to Aquatic Plants e.g. Algae 
 
Species:          Selenastrum capricornutum  (Algae) 
Endpoint:         growth rate 
Exposure period:  72 hour(s) 
Unit:             mg/l                   Analytical monitoring: yes 
NOEC:             = 560 - OECD SIDS    POTASSIUM GLUCONATE 
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EC50:             > 1000 - 
Limit Test:       yes 
 
Method:           OECD Guide-line 201  "Algae, Growth Inhibition Test" 
  Year:           2002 
   GLP:           yes 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under sodium 
                  gluconate SIDS dossier. 
Test substance:   Sodium gluconate: 99.6% 
Reliability:      (1)  valid without restriction 
                  study conducted according to OECD guidelines, valid 
                  test,quality assurance and GLP certificates 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                 (16) 
 
 
4.4 Toxicity to Microorganisms e.g. Bacteria 
 
 
4.5 Chronic Toxicity to Aquatic Organisms 
 
4.5.1 Chronic Toxicity to Fish 
 
 
4.5.2 Chronic Toxicity to Aquatic Invertebrates 
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TERRESTRIAL ORGANISMS 
 
4.6.1 Toxicity to Sediment Dwelling Organisms 
 
Species:          other 
 
 
Remark:           No data available but exposure in sediment expected to be 
                  extremely limited according to the Level III Fugacity Model 
                  program LEVEL3NT from US EPA (EPI v3.11). 
09-AUG-2004 
 
 
4.6.2 Toxicity to Terrestrial Plants 
 
 
Method:           other 
 
Remark:           No data available 
14-AUG-2003 
 
 
4.6.3 Toxicity to Soil Dwelling Organisms 
 
 
Method:           other 
 
Remark:           no data available but due to the low intrinsic toxicity in 
                  aquatic organisms, it is reasonable to expect a similar low 
                  toxic impact on terrestrial organisms 
19-JAN-2004 
 
 
4.6.4 Toxicity to other Non-Mamm. Terrestrial Species 
 
 
4.7 Biological Effects Monitoring 
 
 
4.8 Biotransformation and Kinetics 
 
 
4.9 Additional Remarks OECD SIDS    POTASSIUM GLUCONATE 
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5.0 Toxicokinetics, Metabolism and Distribution 
 
In Vitro/in vivo:              In vivo 
Type:                          Absorption 
Species:                       rat 
No. of animals, males:         9 
Doses, males:                  2.1 and 6.4 mEq/kg/day 
Vehicle:                       no data 
Route of administration:       oral unspecified 
 
 
 
Method:           other: no data specified 
  Year:           1975 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Result: 
                  1. After oral administration of 2.1 mEq/kg of potassium 
                  gluconate and potassium chloride, the potassium ion 
                  concentrations in the serum in both the potassium gluconate 
                  and potassium chloride groups started to increase, reached 
                  the maximum in 3 hours and recovered to the initial value in 
                  9 hours.  During this time, the potassium ion concentration 
                  in the urine increased with time, reached the maximum in 6 
                  hours and recovered almost to the normal level in 10 hours. 
                  The concentration of the potassium ion in the serum and the 
                  urine increased more by potassium gluconate than by 
                  potassium chloride. 
 
 
                  2. Distribution of the potassium ion in the organs in 3 and 
                  7 hours after oral administration of 2.1 mEq/kg of potassium 
                  gluconate and potassium chloride was examined and an 
                  increase in the potassium ion contents in the liver, 
                  kidneys, heart, cerebrum, diaphragm and serum were observed. 
                   The potassium ion contents in the kidneys and the serum 
                  were larger in the potassium gluconate group than in the 
                  potassium chloride group whereas there was no differences 
                  detected in the potassium ion contents in the other organs 
                  between the two groups.  Also, the distribution of the 
                  potassium ion in the organs was found larger when examined 
                  in 3 hours after the administration than when examined in 7 
                  hours after the administration. 
 
                  3. With the continuous oral administration of 6.4 mEq/kg of 
                  potassium gluconate and potassium chloride, potassium 
                  concentrations both in the serum and the urine increased and 
                  reached the maximum on the 3rd day, but the concentrations 
                  decreased thereafter and maintained a constant value. 
                  During this time, urinary excretion increased with the 
                  number of days for medication. The increase in 
                  concentrations of potassium ion in the serum and the urine 
                  induced by potassium gluconate was almost the same as the 
                  one induced by potassium chloride.  However, the urinary 
                  excretion increased more with potassium gluconate than with 
                  potassium chloride.  Also, the continous administration of 
                  potassium gluconate and potassium chloride did not cause OECD SIDS    POTASSIUM GLUCONATE 
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                  changes in the concentrations of the sodium ion in the serum 
                  and in the urine. 
 
                  4. When 2.1 mEq/kg and 6.4 mEq/kg of potassium gluconate and 
                  potassium chloride were daily administered to aldosteronized 
                  rats having reduced concentrations of the potassium ion in 
                  the serum and the urine, concentrations of the potassium ion 
                  both in the serum and the urine recovered to the normal 
                  level in all cases.  There was no difference observed in the 
                  state of recovery between the potassium gluconate groups and 
                  the potassium chloride groups.  Urinary excretion increased 
                  in all groups.  Further, when the administration of the 
                  drugs was withheld, the concentrations of the potassium ion 
                  in the serum and the urine decreased but the rate of 
                  decrease was faster in the potassium gluconate group than 
                  the potassium chloride. 
 
                  Concentration of the sodium ion in the serum and urine did 
                  not change during and after administration of potassium 
                  gluconate and potassium chloride. 
 
                  Many studies relating to the in vivo variations of gluconic 
                  acid in potassium gluconate used as a potassium supplement 
                  (Stetten and Steen 1950, Stetten and Topper 1953) showed 
                  that gluconic acid did not only migrates in the body in its 
                  original form but also transforms to a nucleic acid, 
                  glycogen and glucose, or may change to CO2 and be excreted 
                  during the expiratio 
Test condition:   Wistar male rats were used. 
 
                  They were raised in thermo-hygrostat metabolic cages where 
                  room temperature was kept at 23+/- 1 °C and the humidity was 
                  kept at 55 +/- 5%.  After oral administration of potassium 
                  gluconate / potassium chloride, the potassium ion contents 
                  in the serum, organs and urine were measured by a flame 
                  spectrometer. 
 
                  The tests were conducted using 3 rats to a group and the 
                  average value was designated as the value. 
Reliability:      (2)  valid with restrictions 
                  report not well documented. No GLP. 
14-NOV-2005                                                                 (22) 
 
In Vitro/in vivo:              In vivo 
Type:                          Toxicokinetics 
Species:                       rat 
Doses, males:                  2.3 g/kg bw 
 
 
 
Method:           other: no data specified 
  Year:           1957 
 
   GLP:           no 
Test substance:   as prescribed by 1.1 - 1.4 
 
Remark:           Quantitative nutritional studies on water-soluble, 
                  chemically defined diets have been conducted by Greenstein OECD SIDS    POTASSIUM GLUCONATE 
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                  et al. (1957).  Their basal diet, containing the equivalent 
                  of 23 g of potassium gluconate per kg, was supplemented with 
                  various amino acid mixtures and fed (daily intake of 
                  potassium gluconate about 2.3 g/kg body weight assuming an 
                  average animal weight of 100 g) to Sprague-Dawnley  rats for 
                  60-100 days without evidence of adverse effects. 
Reliability:      (3)  invalid 
                  secondary litterature, old study 
14-NOV-2005                                                                  (9) 
 
 
5.1 Acute Toxicity 
 
 
5.1.1 Acute Oral Toxicity 
 
Type:             LD50 
Species:          rat 
Strain:           Wistar 
Sex:              male/female 
No. of Animals:   50 
Vehicle:          water 
Doses:            3000, 3600, 4320, 5190, 6210 mg/kw bw 
Value:            = 6060 mg/kg bw 
 
Method:           other: no data specified 
  Year:           1978 
   GLP:           no data 
Test substance:   as prescribed by 1.1 - 1.4 
 
Method:           After some preliminary observations, the test compound was 
                  given by gavage, as a 30% (w/v) aqueous solution to groups 
                  of five males and five females in single doses. 
 
                  After treatment, the rats received stock diet and tap water 
                  ad libitum.  They were observed for signs of intoxication 
                  during a 14-day period, after which autopsies were carried 
                  out on the survivors. 
 
                  The LD50 was calculated according to the method of Weil. 
Remark:           We note that the doses of the test substance were high and 
                  and the observations made at the highest doses (from which 
                  the LD50 was determined) occur above the accepted limit dose 
                  of 5000 mg/kg bw. Those results could therefore be linked to 
                  the high dosage. 
Result:           Within a few hours after dosing, the rats showed 
                  sluggishness, humpback behavior and severe diarrhoea. 
                  Deaths occurred between 5 and 21 hours after treatment. 
                  Afterwards the survivors recovered gradually and looked 
                  quite healthy again at the end of the observation period. 
                  Macroscopic examination of the survivors at autopsy revealed 
                  no treatment-related gross alterations. 
 
                  Dose        Mortality 
                  ---------------------------------------------------------- 
                  Solution    test substance   Number      % 
                  (ml/kg)      (g/kg)       males    females 
                  --------------------------------------------------------- OECD SIDS    POTASSIUM GLUCONATE 
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                  10.0        3.00    0/5  0/5    0 
                  12.0      3.60    0/5  0/5    0 
                  14.4      4.32    0/5  0/5    0 
                  17.3      5.19    1/5  1/5    20 
                  20.7      6.21    4/5  3/5    70 
 
                  From the mortality figures, the LD50 of potassium gluconate 
                  was calculated to be 6.06 g/kg bw with 5.64 and 6.51 as the 
                  95 % confidence limit. 
Test condition:   Young adult albino rats (wistar derived) from the 
                  Institute's colony were used. 
 
                  Body weights: 
                  Males : from 240 to 382 g 
                  Females: from 156 to 206 g 
 
                  Rats were housed in groups of five in screen-bottomed, 
                  stainless steel cages, in a well-ventilated room, maintained 
                  at 23-25°C.  Before dosing the rats were fasted overnight 
Reliability:      (2)  valid with restrictions 
                  No data on method, GLP etc. 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                 (21) 
 
Type:             LDLo 
Species:          rat 
Strain:           Crj: CD(SD) 
Sex:              male/female 
No. of Animals:   10 
Vehicle:          no data 
Doses:            500, 1000, 2000 mg/kg 
Value:            > 2000 mg/kg bw 
 
Method:           other: no data 
  Year:           1995 
   GLP:           no data 
Test substance:   other TS 
 
Test substance:   sodium gluconate 
Reliability:      (2)  valid with restrictions 
                  Short abstract not well documented but key study for initial 
                  assessment 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                 (18) 
 
 
5.1.2 Acute Inhalation Toxicity 
 
 
5.1.3 Acute Dermal Toxicity 
 
 
5.1.4 Acute Toxicity, other Routes 
 
Type:             other: intestinal toxicity 
Species:          dog 
Strain:           no data 
Sex:              no data OECD SIDS    POTASSIUM GLUCONATE 
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No. of Animals:   7 
Vehicle:          no data 
Doses:            tablets containing 10 meq  (2.3g), 15 meq (3.5 g) and 30 meq 
                  (7.0 g) potassium gluconate. 
Route of admin.:  other: tablets of test substance fixed in the ileum or distal 
                  jejunum 
 
Method:           no data 
  Year:           1967 
   GLP:           no 
Test substance:   as prescribed by 1.1 - 1.4 
 
Method:           Tablets of potassium gluconate, potassium citrate and 
                  potassium chloride were fixed within the ileum or distal 
                  jejunum of dogs so that their dissolution and absorption 
                  occurred within a limited segment of the intestine.  Tablets 
                  containing 10 meq potassium gluconate (2.3g) were implanted 
                  in 2 dogs, 15 meq (3.5 g) in three dogs and 30 meq (7.0 g) 
                  in 2 dogs.  The dogs were killed 5 to 7 days later and 
                  microscopic examinations performed on all tissue surrounding 
                  the tablet site. 
Result:           Minimal superficial hemorrhage was noted at two sites (of 
                  five) where 30 meq potassium gluconate had been given and in 
                  one (of ten) site with 15 meq potassium gluconate tablets. 
                  The pathology was much less marked than with potassium 
                  chloride. 
Reliability:      (3)  invalid 
                  secondary litterature, old study. 
14-NOV-2005                                                                  (1) 
 
 
5.2 Corrosiveness and Irritation 
 
5.2.1 Skin Irritation 
 
Species:          other: no data on potassium gluconate. See gluconic acid 
 
 
10-AUG-2004 
 
 
5.2.2 Eye Irritation 
 
Species:          other: no data on potassium gluconate. See gluconic acid 
 
 
10-AUG-2004 
 
 
5.3 Sensitization 
 
 
5.4 Repeated Dose Toxicity 
 
Type:                    Sub-acute 
Species:                 rat                               Sex: male/female 
Strain:                  Crj: CD(SD) 
Route of administration: gavage OECD SIDS    POTASSIUM GLUCONATE 
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Exposure period:         4 weeks 
Frequency of treatment:  daily 
Doses:                   0, 500, 1000, 2000 mg/kg bw 
Control Group:           yes, concurrent no treatment 
NOAEL:                   = 1000 mg/kg bw 
NOAEL females :          = 2000 mg/kg bw 
 
Method:           other: no data 
  Year:           1995 
   GLP:           no data 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under sodium 
                  gluconate SIDS dossier. 
Test substance:   sodium gluconate 
Reliability:      (2)  valid with restrictions 
                  Secondary litterature but described in sufficient detail ina 
                  recognised WHO report.  Acceptable for assessment. 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                 (17) 
 
 
5.5 Genetic Toxicity 'in Vitro' 
 
Type:                    other: Saccharomyces Cerevisiae and Salmonella 
                         typhimurium reverse mutation assay 
System of testing:       bacterial and non bacterial 
Concentration:           bacteria: 0.006%, 0.0012 %,  0.0024 % and yeast: 1.25%, 
                         2.50% and 5.00% 
Cytotoxic Concentration: 50% survival in bacteria calculated was at 0.0024 % 
                         test substance and 5% for yeast 
Metabolic activation:    with and without 
Result:                  negative 
 
Method:           OECD Guide-line 471 
  Year:           1975 
   GLP:           no data 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under sodium 
                  gluconate SIDS dossier. 
                  This study was conducted using 3 bacteria strains 
                  (salmonella typhimurium) and one yeast strain (saccharomyces 
                  cervisiae) rather than a fourth bacteria strain as 
                  indicators for this in vitro microbial assay with and 
                  without metabolic activation.  Therefore, the results of 
                  this report on bacteria and yeast are included in the same 
                  entry. 
Test substance:   sodium gluconate 
Reliability:      (2)  valid with restrictions 
                  OECD guideline  No. 471 followed except that the study was 
                  made on one yeast strain : saccharomyces cerevisiae, strain 
                  D4 and 3 bacteria strains: S. typhimurium TA1535, TA1537 and 
                  TA 1538. 
 
                  Positive controls different from the ones described in the 
                  OECD guideline No 471. 
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                  The study was made only on 3 test concentrations. 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                 (13) 
 
 
5.6 Genetic Toxicity 'in Vivo' 
 
Type:             other: in vivo chromosomal aberration test with mouse bone 
                  marrow cells 
Species:          mouse                             Sex: male 
Strain:           C57BL 
Route of admin.:  oral feed 
Exposure period:  single dose and 4 days 
Doses:            single dose administration : 2.5, 5 and 10 g/kg. 4 day 
                  repeated dose: 1.25 and 2.5 g/kg 
Result:           negative 
 
Method:           other: no data specified 
  Year:           1974 
   GLP:           no data 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under sodium 
                  gluconate SIDS dossier. 
Test substance:   sodium gluconate 
Reliability:      (2)  valid with restrictions 
                  translation of a report not fully documented but acceptable 
                  for initial assessment 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                 (19) 
 
 
5.7 Carcinogenicity 
 
 
5.8.1 Toxicity to Fertility 
 
 
5.8.2 Developmental Toxicity/Teratogenicity 
 
Species:                   rat                               Sex: female 
Strain:                    Wistar 
Route of administration:   gavage 
Exposure period:           from day 6 to day 15 of gestation 
Frequency of treatment:    daily 
Duration of test:          10 days 
Doses:                     0, 5.94, 27.6, 128.0, 594.0 mg/kg 
Control Group:             yes, concurrent vehicle 
NOAEL Maternal Toxity:     > 594 mg/kg bw 
NOAEL Teratogenicity:      > 594 mg/kg bw 
Result:                    non teratogen 
 
Method:           other: no data specified 
  Year:           1973 
   GLP:           no data 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under OECD SIDS    POTASSIUM GLUCONATE 
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                  glucono-delta-lactone SIDS dossier. 
Test substance:   Glucono-delta-lactone 
Reliability:      (1)  valid without restriction 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                  (4) 
 
Species:                   mouse                             Sex: female 
Strain:                    CD-1 
Route of administration:   gavage 
Exposure period:           from day 6 to day 15 of gestation 
Frequency of treatment:    daily 
Duration of test:          10 days 
Doses:                     0, 6.95, 32.5, 150, 695 mg/kg 
Control Group:             yes, concurrent vehicle 
NOAEL Maternal Toxity:     > 695 mg/kg bw 
NOAEL Teratogenicity:      > 695 mg/kg bw 
Result:                    non teratogen 
 
Method:           other: no data specified 
  Year:           1973 
   GLP:           no 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under 
                  glucono-delta-lactone SIDS dossier. 
Test substance:   Glucono-delta-lactone 
Reliability:      (1)  valid without restriction 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                  (4) 
 
 
Species:                   rabbit                            Sex: female 
Strain:                    Dutch 
Route of administration:   gavage 
Exposure period:           from day 6 to 18 of gestation 
Frequency of treatment:    daily 
Duration of test:          13 days 
Doses:                     0, 7.80, 36.2, 168.5, 780.0 mg/kg 
Control Group:             yes, concurrent vehicle 
NOAEL Maternal Toxity:     > 780 mg/kg bw 
NOAEL Teratogenicity:      > 780 mg/kg bw 
Result:                    non teratogen 
 
Method:           other: no data specified 
  Year:           1973 
   GLP:           no 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under 
                  glucono-delta-lactone SIDS dossier. 
Test substance:   Glucono-delta-lactone 
Reliability:      (1)  valid without restriction 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                  (4) 
 
Species:                   hamster                           Sex: female 
Route of administration:   gavage 
Exposure period:           from day 6 to day 10 of gestation OECD SIDS    POTASSIUM GLUCONATE 
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Frequency of treatment:    daily 
Duration of test:          5 days 
Doses:                     0, 5.60, 26.0, 121, 560 mg/kg 
Control Group:             yes, concurrent vehicle 
NOAEL Maternal Toxity:     > 560 mg/kg bw 
NOAEL Teratogenicity:      > 560 mg/kg bw 
Result:                    non teratogen 
 
Method:           other: no data specified 
  Year:           1973 
   GLP:           no 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under 
                  glucono-delta-lactone SIDS dossier. 
Test substance:   Glucono-delta-lactone 
Reliability:      (1)  valid without restriction 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                  (4) 
 
 
Species:                   rat                               Sex: female 
Strain:                    Sprague-Dawley 
Route of administration:   oral unspecified 
Exposure period:           from day 6 to day 15 of gestation 
Frequency of treatment:    daily 
Duration of test:          10 days 
Doses:                     1000 and 4000 mg/kg 
Control Group:             no data specified 
NOAEL Maternal Toxity:     > 4000 mg/kg bw 
NOAEL Teratogenicity:      > 4000 mg/kg bw 
Result:                    non teratogen 
 
Method:           other: No data specified 
  Year:           1978 
   GLP:           no data 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under 
                  glucono-delta-lactone SIDS dossier. 
Test substance:   Glucono-delta-lactone 
Reliability:      (2)  valid with restrictions 
                  short abstract but acceptable for initial assessment. 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                  (6) 
 
Species:                   mouse                             Sex: female 
Strain:                    ICR 
Route of administration:   oral unspecified 
Exposure period:           from day 6 to day 15 of gestation 
Frequency of treatment:    daily 
Duration of test:          10 days 
Doses:                     1000 and 4000 mg/kg 
Control Group:             no data specified 
NOAEL Maternal Toxity:     > 4000 mg/kg bw 
NOAEL Teratogenicity:      > 4000 mg/kg bw 
Result:                    non teratogen 
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Method:           other: no data specified 
  Year:           1978 
   GLP:           no data 
Test substance:   other TS 
 
Remark:           Data for the category: see details of study under 
                  glucono-delta-lactone SIDS dossier. 
Test substance:   Glucono-delta-lactone 
Reliability:      (2)  valid with restrictions 
                  short abstract but acceptable for initial assessment 
Flag:             Critical study for SIDS endpoint 
14-NOV-2005                                                                  (7) 
 
 
5.8.3 Toxicity to Reproduction, Other Studies 
 
 
5.9 Specific Investigations 
 
 
5.10 Exposure Experience 
 
Type of experience:  Human - Medical Data 
 
Remark:              Potassium gluconate is used clinically to replenish 
                     potassium in patients experiencing hypokalemia.  The usual 
                     adult dose is about 9 gr in equal portions after meals and 
                     at bedtime (Physicians' Desk Reference, 1978). 
Reliability:         (4)  not assignable 
20-OCT-2003                                                                  (2) 
 
Type of experience:  other 
 
Remark:              Circumferential small-bowel ulcers have been associated 
                     with 
                     the irritant effects of potassium chloride used in 
                     potassium 
                     replenishment therapy (Morgenstern et al., 1965). 
 
                     Potassium gluconate appears to be less irritating in this 
                     respect.  This has been tested by fixing tablets within the 
                     ileum or distal jejunum of dogs so that absorption would 
                     occur within a limited segment of the intestine (Boley et 
                     al., 1967). 
 
                     The dogs were sacrificed after 5-7 days and all tissues 
                     surrounding the tablet site were examined microscopally. 
                     No 
                     remarkable gross changes were seen at any of the sites 
                     where 
                     potassium gluconate was implanted.  Minimal superficial 
                     hemorrhage was noted in 40% of the sites where tablets 
                     containing 7.0 g potassium gluconate where used; 10% of the 
                     sites with 3.5 g tablets; none of the sites with 2.3 g 
                     tablets.  While histologic changes were minimal, the 
                     authors 
                     suggested that high concentration of potassium ions  was 
                     not OECD SIDS    POTASSIUM GLUCONATE 
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                     completely without physiologic and anatomic effect on the 
                     bowel.  Pathological changes were less with potassium 
                     gluconate tablets than with potassium chloride tablets at 
                     the same dose level. 
Reliability:         (3)  invalid 
                     secondary litterature, old study. 
14-AUG-2003                                                                  (2) 
 
Type of experience:  Direct observation, clinical cases 
 
Remark:              Potassium gluconate in syrup was tested: 
 
                     1 aromatized syrup (oral route) : a soup spoon corresponds 
                     to 9.5 mEq of potassium or 0.375 g 
 
 
                     Patients suffering from cardiac insufficiency (and subject 
                     to different saluretics) were given potassium gluconate in 
                     syrup for 6 months.  From these numerous clinical material, 
                     10 cases were observed and studied on the ionic side. 
 
                     In 4 cases, the patients were already given saluretics with 
                     an insufficient potassium recharge but without signs of 
                     potassium deficiency. 
 
                     In 4 other cases, patients were not given recently 
                     saluretics. 
 
                     The 2 last cases concerned patients entered into the 
                     service 
                     with a clinical and biological picture of potassium 
                     deficiency. 
 
                     All were subjected to a hospital regime without salt which 
                     brings for 24 hours (average) 40 mEq potassium.  This 
                     average has been calculated on one week taking into account 
                     the loss of nutrition due to cooking. 
 
                     Control of the treatment: 
                     ------------------------- 
 
                     Minor consideration was given to the dosage of electrolytes 
                     in blood as a normal kaliemia or a slightly high kaliemia 
                     coincidates oftenly with an hypokalicytia, and, under some 
                     therapeutic circumstances, ie. injection of intraveinous 
                     glucose, an hypokaliemia can show a positive potassium 
                     result. 
 
                     Therefore, the balance method was used.  The admissions are 
 
                     represented by 40 mEq food requirements to which is added 
                     the quantity of potassium ingested in the form of syrup. 
 
                     The outlets are established on the basis of urinary 
                     potassium determined each day in the 24 hour urine. The 10% 
                     fecal potassium as well as sweat potassium from patients 
                     (none of them have shown important sudoral crises) were not 
                     taken into account.  However, frequent plasmatic dosages OECD SIDS    POTASSIUM GLUCONATE 
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                     were undergone and except for 2 cases, there was no 
                     perturbation. 
 
                     Observations: 
                     ------------- 
 
                     The product is remarkably tolerated.  No digestive 
                     intolerance was observed which is appreciable for a 
                     potassium therapy applied per os. Also, no surcharge 
                     accident and no metabolic trouble were observed. 
 
                     The doses varied between 3 and 6 soup spoons per day, which 
                     represent a potassium intake of 28-56 mEq.  The therapy 
                     started several days after the beginning of the diuretic 
                     treatment in order to prevent an oveload accident in the 
                     case of marked oliguria. 
 
                     The efficiency of potassium gluconate was clearly 
                     demonstrated by 2 cases where clinically evident 
                     hypokalemia 
                     is spectacularly improved after a few days of treatment. 
Reliability:         (3)  invalid 
09-AUG-2004                                                                  (5) 
 
Type of experience:  Human - Medical Data 
 
Remark:              Potassium gluconate is used in potassium supplements 
 
                     Company             Product             Potassium gluconate 
                                                             Content 
                     ----------------------------------------------------------- 
                     Pharmetics Inc      Potassium gluconate 550 mg tablets USP 
                                                                          92 mg 
 
                     Trophic Canada Ltd  Potassium gluconate Tab 1g         1 g 
 
                     Pharmascience Inc   PMS- Potassium gluconate solution 
                                                                     20 meq/15 
                     ml 
                     General Nutrition Canada Inc 
                                        Timed Release Potassium 100mg      100 
                     mg 
                     Rheingold Food International Ltd 
                                        Potassium Tab 99 mg                99 mg 
 
                     And many others at http://www.hc-sc.gc.ca/hpb/drugs-dpd/ 
20-OCT-2003 
 
 
5.11 Additional Remarks 
 
Type:             other: Opinion of the Select Committee on GRAS substances on 
                  the health aspects of using potassium gluconate as a food 
                  ingredient 
 
Remark:           The Select Committee on GRAS substances has concluded that 
                  there is no evidence in the available information on 
                  potassium gluconate that demonstrates or suggests reasonable OECD SIDS    POTASSIUM GLUCONATE 
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                  grounds to suspect a hazard to the public should it be used 
                  as a food ingredient at levels now used for sodium 
                  gluconate, or that might be expected in the future. 
 
                  Indeed, potassium, the cation of potassium gluconate, is an 
                  essential nutrient.  It is widely distributed in foods and 
                  2-6 g are consumed by adults daily from all sources. 
                  Gluconic acid, the anion of potassium gluconate, is a normal 
                  metabolic product of glucose metabolism, 25-30 g being 
                  produced daily.  For these reasons, and because potassium 
                  gluconate is widely used therapeutically as a source of 
                  potassium in cases of hypokalemia, conventional 
                  toxicological studies of potassium gluconate have not been 
                  regarded as necessary, explaining the lack of direct animal 
                  data on the compound.  Orally administered gluconate is 
                  absorbed rapidly; a major part is excreted in the urine and 
                  the remainder is metabolized. 
Reliability:      (4)  not assignable 
 
09-AUG-2004                                                                  (3) 
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